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Abstract 
Pain is a complex process involving numerous underlying genetic contributions still not completely 
appreciated, which may explain the high degree of interindividual differences seen with nociception. 
Chronic pain is responsible for a significant socioeconomic burden on the individual as well as society 
and is affected by several patient specific aspects including physiological, psychological and 
environmental factors. Interindividual response to current analgesics is exceedingly inconsistent and 
the functional basis for the unpredictable efficacies of medications has not been elucidated. It is highly 
probable that variation seen in nociception is due to undiscovered genetic mechanisms, and specific 
polymorphisms within genes can be potentially singled out by observing deviations in spontaneous 
pain responses between animals of differing genotypes using the ciguatoxin marine poison. 
Ciguatoxin is isolated from the Gambierdiscus toxicus dinoflagellate, a specific type of plankton, 
which is shown to produce spontaneous pain as well as cold allodynia in a dose dependent manner. 
The objectives of this thesis are centred on the demonstration of the genotypic influence on pain 
perception, identifying possible genetic sources implicated in nociception, and validating these 
potential targets with in vivo methods. In Chapter 2, pain behaviours of sixteen mouse strains with 
recognised genotypes were quantified after administration of the ciguatoxin, which is known to 
induce spontaneous flinching and licking pain reactions after intraplantar injection. The mechanism 
of this interaction is reliant on the actions of mainly voltage-gated sodium channels, particularly 
NaV1.6 and NaV1.7, but also voltage-gated potassium channels. Utilisation of inbred mouse strains 
with differing genotypes provides the foundation for the study, as the established SNP characteristics 
can be contrasted against the pain phenotype observed. Inoculation of numerous mouse strains 
employed with ciguatoxin produced measurable pain responses and a significant difference in the 
number of flinches as well as the time spent licking between each mouse strain was seen. The 
contrasting pain responses between the different strains implicates genotype discrepancies as the 
likely source of variation, therefore, variation between flinching and licking responses were analysed 
to ascertain further details. In Chapter 3, the enumerated pain phenotypes were interrogated using the 
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haplotype-based computational genetic mapping (HBCGM) technique aimed at matching phenotypic 
differences to the unique SNP fingerprint established when utilising a combination of mouse strains 
of diversified genotypes. Genes recognised to have correlation to the pain phenotype based on their 
SNP profile were screened according to their likelihood to impact nociception using various 
techniques. Gene expression sites and gene ontology were considered in order to direct the search 
towards specific genes or gene clusters with potential ramifications in pain transmission. Via these 
methods, it was seen that the HBCGM gene lists exhibited features very similar to that of the native 
mouse genome, signifying that specific genetic loci have not been clearly attributed to the phenotype 
differences using this approach, and search for potential pain genes will need to be continued further. 
Despite this finding, the Nedd4-2 gene was selected as a putative target for further validation with 
knockout mice in Chapter 4, given that the NEDD4-2 E3 ubiquitin ligase product has been implicated 
in the trafficking of multiple NaV subtypes at the dorsal root ganglia. The native function of E3 
ubiquitin ligases involves maintaining membrane populations of specific proteins, which includes 
NaV1.6-1.8, but the roles of Nedd4-2 with respect to ciguatoxin-induced pain have not yet been 
investigated. During observation, Nedd4-2 knockout mice demonstrated a significant increase in 
licking times after administration of ciguatoxin compared to their wild-type counterparts, the possible 
result of increased NaV membrane populations secondary to a reduction in E3 ubiquitin ligase 
mediated trafficking. This discovery suggests that Nedd4-2 may be responsible for modulation of 
ciguatoxin-induced spontaneous pain and is therefore a potential pain gene which will require further 
characterisation. 
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1. CHAPTER ONE: Nociception and Ciguatoxin 
1.1 INTRODUCTION 
The sensation of pain is a widely recognised phenomenon, however, despite the experience being 
familiar to everyone around the world, the degree of variability seen between individuals is not 
completely understood. Pain is a subjective and unpleasant sensory and emotional experience, 
according to the International Association for the Study of Pain’s definition of pain (2). It is the 
normal physiological response to noxious stimuli and the expression of pain is influenced positively 
or negatively by a multiplicity of contributors including comorbid medical conditions, physical states, 
emotional states, cognitive states, cultural factors and environments. Therefore, one person’s 
experience of pain is not the same in every situation and also differs to the next person’s experiences 
(3). Normally, pain has the purpose of signalling potential tissue damage and creates an avoidance 
behaviour towards hazardous actions or environments; in addition, immobility due to painful 
sensations promotes the healing process and hence recovery of function (4). Despite its vital role in 
injury prevention and healing, pain management is still required in the healthcare setting (3). The 
implications of chronic pain on individuals contributes to a significant burden on not only the 
afflicted, but also their families and the healthcare system. Issues surrounding chronic pain include 
decreased quality of life, reduced overall standard of health and a decline in workforce opportunities 
(5). It should be known that pain is not a static sensation and must be continually monitored for 
optimal pain control. The use of standardised tools for quantifying pain such as pain scales have a 
role in assessing pain and guiding analgesic use, although each tool is limited by its inability to fully 
objectify pain (3). A better understanding of pain is needed to correctly quantify the subjective 
experience, especially with chronic pain, which has a deleterious course lasting more than 3 months. 
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1.2 LITERATURE REVIEW 
1.2.1 Prevalence of Pain 
Due to its highly subjective nature, pain manifests in numerous ways, creating a dilemma when 
defining its incidence and prevalence (6). In terms of emergency department presentations, greater 
than 60% of patients have pain as their primary complaint. Of those presenting with pain, 
approximately 45% present with acute pain and up to 40% with underlying chronic pain (3). Looking 
at Australian statistics from 2007 via the Australian Bureau of Statistics (ABS), it was documented 
that 67% or 11.1 million people complained of bodily pain within the 4 weeks leading up to the survey 
in subjects greater than 15 years old, with 9% experiencing severe or very severe pain in a similar 
distribution between genders. The chances of having severe or very severe pain in both men and 
women was directly proportional to age, with the highest rates of severe to very severe pain being 
highest in the age group greater than 75 years old (7). Shifting the attention to chronic pain, it was 
shown in a 2007 NSW health survey that an estimated 3.2 million Australians live with chronic pain 
– 1.4  million of those being male and 1.7 million being female – and the projected prevalence was 
also estimated to reach 5 million chronic pain sufferers in by 2050 (2). The peak ages of chronic pain 
from 2007 figures was 50-54 in females and 55-59 in males (2), younger than the previous study in 
2000 which reported peak ages of 80-84 for females and 65-69 for males (8).  
1.2.2 Risk Factors 
The struggle in determining risk factors for pain arises from the complex nature of nociception, being 
influenced by gender, race, ethnicity, social context and the individual’s interpretation of pain (9). 
The main risk factors covered in various pain studies recognised in a meta-analysis (6) included age, 
sex, social factors, and individual factors, however this list is not extensive. Those aged over 45 were 
two times as likely to experience severe to very severe pain compared to those under 45 years old (7). 
Conversely, the level of interference in daily living was more profound in younger age groups (8). It 
was also noted that males are more affected by prolonged pain and women are more able to adapt 
over time to the changes required when living with chronic pain (5). However, it was also found that 
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in adult women, pain was reported as more severe, more frequent and lasting for longer durations 
than in men (6). Taking into account all the aspects contributing to chronic pain, those at greatest risk 
tend to be older, female, of low socioeconomic status, and of poor health status (8). Another viewpoint 
on pain is genetic factors, and there is increasing interest and information regarding certain genes and 
their role in pain sensitivity, reporting, and susceptibility (9). This attention towards genetics implies 
an area which requires greater understanding to compliment current knowledge of traditional risk 
factors. 
1.2.3 Socioeconomic Impact 
When describing the impact of pain on an individual, it is sometimes difficult to determine if the pain 
experienced is a contributor or a consequence of a disease (6), therefore it is most prudent to consider 
relationships to be strong associations rather than causal features (2). Pain undoubtingly has a huge 
negative impact on the individual, however it also has an overflow effect on society; the impact of 
such is best characterised by the burden of chronic pain on individuals and society (2). Chronic pain 
has both short and long-term considerations with respect to socioeconomic, health, employment, and 
psychological implications. The World Health Organisation (WHO) utilises measures such as 
disability-adjusted life years (DALYs) and years lived with disability (YLDs) to quantify the burden 
of disease. Considering the burden of disease on a worldwide scale, five of the top ten conditions 
responsible for the most YLDs are conditions with pain as a key component of the disease. Lower 
back pain for example, accounted for 10.7% of all YLD – the largest contributor of all conditions – 
and responsible for 83 million DALYs. Other conditions associated with pain with a comparable 
burden included neck pain, migraine and headache, musculoskeletal disorders, osteoarthritis, and 
road injuries (6). In Australia, the annual cost of chronic pain in 2007 was estimated to be $34.3 
billion, equivalent to almost $11,000 per person living with chronic pain (7). The leading constituent 
of this cost being productivity costs which tallied in at $11.7 billion, contributing to 34% of the total 
expenditure (2). This demonstrates the significant burden of chronic pain on work productivity and 
employment consequences, the results including departure from the market, income reduction and a 
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negative influences on the individual’s perception of their role in society (2, 5). The other major 
contributors included burden of disease, health system costs, opportunity cost of informal care, 
indirect costs and deadweight losses from transfer payments (tax revenue forgone and welfare 
payments). The costs of chronic pain are predominantly supported by the individual, with most 
coming from costs attributable to burden of disease which accounts for 55% of the total cost. The 
Federal Government bears 22% of the costs – mainly through health system and productivity costs – 
while society, employers, State Governments, and family and friends bear 10%, 5%, 5% and 3% 
respectively. Comparing these costs to that of other chronic diseases, chronic pain is third to 
cardiovascular and musculoskeletal diseases with $4.4 billion being allocated to health expenditure 
between 2000 and 2001 (2). Patients afflicted with pain were found to utilise nearly twice the health 
care resources compared with the rest of the population (6). The psychological health of a chronic 
pain sufferer is detrimentally affected, with a loss of societal role, lack of self-esteem and scarcity of 
personal contacts (5, 8). A noteworthy association between chronic pain and anxiety, depression and 
somatisation was found using certain mental health scale (8). The 2007 Australian statistics showed 
that 31% of adults suffering from severe or very severe pain were subjected to high or very high levels 
of psychological distress, and about one in five suffered from depression or other mood disorders. 
This is not surprising, considering 90% of these patients reported interference with work outside the 
home as well as normal housework in the past 4 weeks (7). It was also noted that with debilitating 
chronic pain, women suffered from greater psychological distress than men (8). These effects not 
only take a toll on the individual, but also their family and relationships (5).  
1.2.4 Anatomy of Pain Pathways 
Pain signals are transmitted via the peripheral nervous system (PNS) to the central nervous system 
(CNS) in the presence of noxious stimuli, hence pain signalling can be divided into peripheral and 
central mechanisms (10). The peripheral component comprises primary sensory afferent neurons, 
motor neurons and sympathetic postganglionic neurons (11). Within the dorsal root ganglion (DRG) 
of the vertebra foramina exists the cell bodies of the primary sensory afferents, occurring at each 
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spinal level. These neurons are pseudo-unipolar, whereby one axon projects centrally to the DRG 
within the spinal cord while the other end projects peripherally to the tissues being innervated (10-
12); hence, signals can be sent peripherally to centrally and vice versa within a common axonal stalk 
(12). Within the central nervous system, bodily pain signals are transmitted by the spinothalamic and 
the spinoreticular systems, and also via the trigeminal system if in the facial distribution (13). The 
lateral component of the spinothalamic tract is thought to carry the physical characteristics of pain 
including location, intensity and duration; whilst the medial component is thought be responsible for 
autonomic and emotional features (10). 
The spinothalamic system is a three-neuron pathway consisting of first order, second order and third 
order neurons. First order neurons travel from distal pain receptors to the proximal dorsal spinal root 
where it synapses with second order neurons in the spinal cord. From the spinal cord the second order 
neurons decussate close to their spinal level and eventually project to different regions of the thalamus 
and other brainstem structures. Third order neurons originate from the thalamus and project to the 
primary somatosensory cortex (1, 10); cortical regions are responsible for localisation and perception 
of pain (10). 
Inhibitory signals sent from the midbrain can modulate pain signals within the spinal cord. These 
signals suppress pain transmission and can be potentiated by opiates and endorphins with the help of 
interneurons (1, 14). Endorphins are found in their highest concentrations in the midbrain but are also 
located within spinal interneurons. The inhibitory actions function by preventing the release of 
substance P, a neuropeptide which promotes pain, from the primary sensory neuron onto the second 
order neuron. Exogenous opiates, such as morphine, act via the same mechanism as endogenous 
endorphins. Other descending signalling pathways of note include noradrenergic and serotonergic 
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systems which are also thought to interrupt spinal transmission, explaining the potential role of certain 
antidepressants in pain management (14). 
1.2.5 Nociception 
Nociception is the body’s neural response to traumatic or noxious triggers and can be dividing into 
two categories. Acute pain is thought to be chiefly due to nociception while chronic pain has the 
addition of psychological and behavioural influences (10). The purpose of nociception is to detect, 
localise and limit tissue damage via four main stages of pain transmission including transduction, 
transmission, modulation, and perception (10). Peripheral nociceptors are components of the primary 
afferent sensory system and are also referred to as primary afferent nociceptors (4, 11). These 
specialised receptors respond to various stimuli from thermal, mechanical and chemical origins, and 
transmit a signal along the axon of the sensory afferent neuron to the DRG (4). Several substances 
Figure 1. Spinothalamic tract ascending pathway: 
The spinothalamic tract is a three neuron pathway 
responsible for pain and temperature (1). 
Figure 2. Spinothalamic tract descending 
pathway: Inhibitory pathways modulate the 
transmission of pain and can be modulated by 
endogenous endorphins or exogenous opiates (1). 
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released during inflammation can activate peripheral nociceptors and include histamine, 
prostaglandins, serotonins, and kinins. Nociceptors are free nerve endings which are diffusely spread 
within a specific area in the skin or in other organs. These receptors can be further categorised by into 
mechanoreceptors, thermoreceptors, and polymodal nociceptors depending on the stimuli they detect 
(14); polymodal receptors contribute the majority of nociceptors subtypes (15). Specific tissues react 
to individual stimuli differently, therefore certain injuries such as pricking, cutting, crushing, burning 
and freezing may or may not elicit a pain response in an organ. To illustrate this occurrence, if we 
compare the mucosa of the intestines to the wall of the heart, distention of the intestinal wall produces 
pain in the gut whilst ischaemia is the most important cause of pain regarding the myocardium (14). 
Pain is divided into either somatic or visceral pain, depending on which organ is affected. Somatic 
pain detected by nociceptors in the skin, subcutaneous tissue or mucosal surfaces is referred to as 
superficial somatic pain. Conversely, somatic pain detected by deeper structures such as muscles, 
tendons, joints and bones are referred to as deep somatic pain. Visceral pain differs to somatic pain 
as it originates from internal organs and their coverings, examples including the peritoneum, 
pericardium and parietal pleura. This type of pain is also associated with parasympathetic and 
sympathetic manifestations resulting in bodily effects such as nausea, vomiting, sweating, and 
changes in heart rate and blood pressure (10). Nociceptors can also be classified based on the triggers 
which activate them, for example, TRPV1 receptors are heat-sensitive, TRPM8 receptors are cold-
sensitive, ASIC receptors are acid-sensitive, and TRPA1 receptors are sensitive to various chemical 
irritants (4, 12) The TRP channels, or transient receptor potential channels, are specialised ion 
channels activated by ambient changes in temperature or specific ligands which directly activate the 
receptor. TRPV1 receptors can be activated by either ambient temperatures exceeding threshold 
levels of approximately 43˚C or directly activated when compounds such as capsaicin and other 
vanilloid compounds are present. This explains why TRPV1 activation can be achieved with foods 
containing potential ligands, such the capsaicin in chilli peppers, which produces the sensation of heat 
in the absence of threshold temperatures. This is also the case for TRPM8 receptors, which are 
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designed to activate in ambient cold temperatures below approximately 25˚C as well as from direct 
stimulation of the receptor by menthol (12). TRPA1 receptors have a diverse role and are thought to 
detect various environmental irritants in addition to cold temperatures (12, 16). Temperatures below 
15˚C, cooling compounds such as icilin and menthol, or inflammatory compounds such as mustard, 
garlic, isothiocyanates and thiosulfinates appear to activate these channels (12). Acid sensing ion 
channels, or ASICs, respond to low pH environments associated with ischaemic and inflammatory 
processes (4). Activation of nociceptors marks the initiation of a chain of events, beginning with 
membrane depolarisation and resulting in pain conduction. 
1.2.6 Pain Conduction 
The four main constituents of a nociceptor includes a peripheral terminal which transduces external 
stimuli into action potentials, an axon that conducts these action potentials, a cell body to maintain 
the neuron’s intactness, and a central end which forms half of the first synapse in the sensory pathway 
(17). Nociceptors can be segregated based on the conduction velocities of the primary afferent pain 
fibre. Type Aδ fibres are myelinated, small diameter fibres responsible for sharp, localised pain 
known as the “first pain”, as these signals arrive in the spinal cord first. Type C fibres have an even 
smaller diameter and are unmyelinated, resulting in a slower, duller and more poorly localised pain 
known as the “second pain”. Therefore, the size and the degree of myelination dictates the speed of 
transmission, such that larger, myelinated fibres conduct faster than thinner, unmyelinated fibres. 
This phenomenon describes the biphasic response perceives as an initial sharp pain followed by a 
dull, more constant pain occurring as a consequence to injury (10, 11, 14, 18). Activation of 
nociceptors depends on a stimulus being able to initiate an action potential, meaning only the signals 
from potentially damaging stimuli are capable of reaching threshold levels required for transmission 
(12, 17). Sensory stimuli are received by the peripheral terminal of primary afferent neurons and 
cause a conformational change within the receptor to initiate the signal transduction process via 
membrane depolarisation. These depolarisations are called generator or receptor potentials, which are 
summative and must collectively be of a sufficient strength to be transmitted along the axon; thus, 
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signals are only sent when generator potentials combine to reach the threshold required for an action 
potential (12, 17-19). This threshold prerequisite differentiates a nociceptor from a low-threshold 
sensory neuron, which is able to transmit action potentials in the presence of less stimuli (17). The 
propagation of the signal to the DRG is governed by the presence of the voltage-gated ion channels 
sodium (NaV), potassium (KV), and calcium (CaV) channels (12, 19). The main role of NaV and KV 
channels is in the generation and transmission of action potentials down the axon while CaV is 
responsible for vesicular neurotransmitter release at the presynaptic terminal (12). Therefore, 
variation in the populations of these ion channels can affect the characteristics neuron signal 
transduction (19). 
1.2.7 Peripheral Sensitisation 
Pain transmission undergoes a type of stimulus-induced functional plasticity, where nociception is 
influenced by local inflammatory mechanisms activated during cell injury, causing sensitisation of 
peripheral nociceptors (17). During an inflammatory response, the adjacent environment is exposed 
to a chemical mix of cell contents and secretions which directly and indirectly affects the workings 
of receptors, ion channels and second messenger systems (17, 19). The net result is a reduction in the 
activation threshold required for action potential generation, therefore nociceptors become more 
responsive in the presence of inflammatory processes. In this event, stimuli which are usually 
innocuous or slightly noxious have the capacity to excite these sensitised neurons and transmit pain 
signals through to the CNS (17, 19, 20). These occurrences are known as allodynia, where an 
innocuous stimulus causes pain, or hyperalgesia, where a noxious stimulus causes an exaggerated 
pain response (18). Hyperalgesia can also be split into primary and secondary types, where primary 
hyperalgesia occurs at the site of injury and secondary hyperalgesia occurs in the neighbouring intact 
tissues (18, 20). Therefore inflammation is thought to be the basis for intractable nociceptor activation 
seen in inflammatory pain models with unremitting pain (19). In addition to the typical type Aδ and 
type C pain fibres which are the predominant sensory neurons responsible for nociception, other 
‘silent nociceptors’ can be recruited in certain situations to perceive pain (21). Inflammatory 
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mediators released not only reduce activation threshold of typical nociceptors but also convert non-
nociceptor sensory fibres to nociceptors, such as mechano-insensitive Aβ fibres to mechano-sensitive 
fibres (22, 23). Type Aβ fibres are large, myelinated, low-threshold sensory neurons usually 
transmitting light touch, vibration and proprioception under normal conditions (15, 22). Persistent 
hyperactivity of Aβ fibres in chronic pain can be attributed to central sensitisation whereby these 
natively non-pain fibres are now sensitive to innocuous stimuli, observed as a reversal of phenotype 
when normal low-threshold Aβ fibres are converted to Aβ nociceptors (20, 24). 
1.2.8 Genetics of Pain 
It is becoming increasingly clear that the broad variability in human pain susceptibility is reliant on 
some degree to genetic contributions. Many genes associated in pain perception have been identified, 
having implications in determining the extent of pain perceived by individuals as well as providing a 
potential target for new drugs. Variation in cell components such as ion channels, enzymes, 
transcription factors and neurotrophins can be subjected to single gene mutations; the end result being 
a range of possible targetable phenotypes (25, 26). Single nucleotide polymorphisms (SNPs) are 
alterations of individual nucleotides in a DNA sequence and occurs at a frequency of more than 1% 
in the human population. The significance of SNPs is that minor disparities may contribute to varied 
pain responses between two subjects (26). Mutations which are coded can be divided in to loss of 
function or gain of function mutations based on the expression of their phenotype. 
Using the SCN9A gene as an example, which encodes the NaV1.7 ion channel, it is known that loss 
of function mutations of this gene results in the condition known as congenital insensitivity to pain 
(CIP), where the lack of voltage-gated sodium channel activity leads to impaired harm avoidance 
behaviour and subsequent injury or infection (26, 27). Ion channels have a key role in nociception 
and the voltage-gated sodium channels known to be involved in pain – NaV1.7, NaV1.8 and NaV1.9 – 
are found predominantly in the peripheral nervous system (16, 28). In contrast to inactivating 
mutations, gain of function mutations of SCN9A result in exaggerated pain responses characterised 
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in multiple diseases such as inherited erythromelalgia (IEM) and paroxysmal extreme pain disorder 
(PEPD) (28, 29). Another non-selective cation channel, the TRPA1 channel, has been associated with 
familial episodic pain syndrome (FEPS) when activation mutations are present. Hyperexcitability to 
environmental irritants underlies this pathology, demonstrating other ways minor alterations in genes 
can cause aberrant activity of native nociceptors (16). An alternative mechanisms include Na+-K+-
ATPases gain of function mutations, which have been linked to recurrent migraines, and nerve growth 
factor β (NGFB) loss of function mutations, which are associated with CIP (26). 
The list of genes associated with clinical pain states is extensive, being connected to angina, arthritis, 
back pain, fibromyalgia and irritable bowel syndrome (30), however this list is not exhaustive and 
many more genes have yet to be discovered. The identification of genes has largely surrounded SNP 
genotyping and haplotype mapping, and when paired with the human genome database, it is possible 
to determine associations between genetics and pain phenotypes. The usefulness of this approach in 
the field of pain and analgesia is vast and the process of isolating target genes in humans, determining 
the importance of this gene in vivo, and applying these findings to clinical care, will provide a valuable 
addition to the medical field (30). 
A haplotype is defined as a bundle of SNPs located on a chromosome which are implied to be 
inherited as one, therefore animal strains can be bred expansively with confidence of the offspring 
bearing the same haplotype. Inbreeding of mouse strains allows for genes to be mapped consistently 
and accurately since a genotype can be safely predicted based on controlled breeding methods. 
Haplotypes are found in distinct genomic regions, known as haplotype blocks, and an appropriate 
algorithm is required to determine if a population has an acceptable percentage of genotypes by 
defining a set number of haplotype blocks and unique haplotypes within that population (31). At least 
twelve inbred strains are required to produce a population of mice where >95% of variable haplotypes 
are represented consistently by the mouse strains selected. The purpose of haplotype mapping is to 
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rapidly outline the common genetic variants within a population in order to find relationships amongst 
genotypes and disease states (31, 32). 
The use of mammals in pain studies has been advantageous in the discovery of various pain traits 
(33). The common house mouse known as Mus musculus has been identified as a key model for 
genetic studies due to the ease of inbreeding and development of knockout variants. Inbreeding 
requires twenty generations of breeding between brothers and sisters to net homozygous mouse 
strains described as isogenic clones (30, 33). The application of inbred mice can be employed to 
explore the effect of the environmental changes on mice of identical genotypes. This permits 
investigation into the effects of specific environmental influences as the genetic factors are kept 
consistent, as opposed to studies where genotype characteristics cannot confidently be kept equal 
(33). Transgenic mouse knockouts, where their DNA has exposed been genome modification, are 
considered simpler to study compared with other animals and can be used to investigate specific genes 
and their associated proteins, such as examining genes implicated in pain transmission. Knockouts, 
otherwise known as null mutants, can be produced easily and consistently via the transgenic knockout 
method in mice. In partnership with a fully sequenced genome, mouse models have become a 
remarkably valuable tool when conducting genetic research for pain (30). Problems accompanying 
mouse studies are irregularities in the environment such as housing factors, enclosure factors, 
experimental factors, seasonal factors and time factors which all could influence the genotype and 
lead to errors due to altered phenotypical expression (26). Animal models are also limited by accuracy 
when extrapolating outcomes in humans, as positive findings in animals may not yield the same 
results in human trials. Direct correlations between rodent models and human models are difficult to 
find, with only a couple examples having been found (30). Nonetheless, utilisation animals in pain 
studies is crucial as they are the most manageable and cost-effective model to examine the multitude 
of targets in the animal genome. 
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1.2.9 Ciguatera 
Present across the world with higher incidences in tropical and subtropical regions of the Indo-Pacific 
Oceans and Caribbean Sea (34, 35), ciguatoxin is found in contaminated fish and is responsible for 
causing ciguatera, the poisoning resulting from ingestion of the toxin (35, 36). Ciguatoxins (CTX) 
are lipophilic, polycyclic polyether molecules derived from dinoflagellates of the Gambierdiscus 
genus, which bioaccumulate within the marine food chain (34, 36). Ciguatoxin variants are named 
depending on the location found, hence the names Caribbean, Pacific and Indian Ocean subtypes (C-
CTX, P-CTX and I-CTX respectively); P-CTX being the most potent variant of the three (35). 
Ciguatera is estimated to affect more than 25,000 Australians each year (37), with other endemic 
areas around the world having incidences between 50,000 and 500,000 cases annually (34). The oral 
route is the most common entrance into the body, with the number of fish consumed despite 
containing toxic levels of ciguatoxin being on the rise, making ciguatera one of the most significant 
marine toxin affecting public health and economy. Analysis of the epidemiology of ciguatera has 
difficulties due to the absence of laboratory tests to detect its presence; this forces symptom 
recognition to be the key component in diagnosis of ciguatera (34). Ciguatoxin remains viable even 
after preparation of contaminated fish as it is exceedingly heat-stable; still being present in meat 
despite frying or boiling and even freezing (38). Via the oral route, ciguatera initially manifests as 
gastrointestinal symptoms such as abdominal pain, nausea and vomiting, diarrhoea, which lasts up to 
a few days. Neurological symptoms including circumoral tingling, pruritus, fatigue and cold allodynia 
follow the gastrointestinal symptoms and can last several weeks to months (34, 37, 39). Severe 
reactions can present with autonomic dysfunction namely hypersalivation, bradycardia and 
hypotension; with cardiovascular signs needing urgent treatment as they are associated with a worse 
prognosis (34). The effects of ciguatoxin are dose-dependent, therefore the duration, severity and 
range of symptoms are related to the amount of toxin introduced into the body and also the subtype 
of ciguatoxin was ingested (34). Cold allodynia is the pathognomonic symptom of ciguatoxin 
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poisoning and occurs in up to 95% of those affected, suggesting that ciguatoxin interferes with normal 
nociceptive pathways to produce a temperature dysesthesia (35, 39).  
Generally, the mechanism of action of ciguatoxin has been defined as a sodium channel activator, 
however the development of cold allodynia has now been linked with potassium channels and TRPA1 
nociceptors (35). Activation of voltage-gated sodium channels via binding of ciguatoxin to a specific 
site within the pore of the channel leads to membrane depolarisation and therefore increased 
excitability or neurons, slowed inactivation, increased intracellular calcium and neurotransmitter 
release, and Schwann cell oedema (34, 36, 39, 40). A recent study exploring the in vitro selectivity 
of ciguatoxin for NaV isoforms has shown that ciguatoxin non-selectively binds to all nine NaVs at 
varying degrees. It appears that ciguatoxin binds with NaV1.3 and NaV1.8 to the greatest degree, while 
having the least effect on NaV1.4. Despite ciguatoxin being able to hyperpolarise voltage-dependent 
activation across all nine NaVs, steady-state fast inactivation was only seen in NaV1.2, NaV1.3 and 
NaV1.9 (41). The study also demonstrated that P-CTX-1-induced effects are most importantly 
mediated via the TTX-sensitive NaV1.1, NaV1.6 and NaV.17, as well as the TTX-resistant NaV1.8. It 
was also shown that NaV1.8 had a major role in P-CTX-1 induced action potential firing in C-fibres 
in skin-saphenous nerve and colonic models. The maintenance of this firing was driven by NaV1.8 
and introduction of a NaV1.8 antagonist ameliorated this response (41). The action potential inducing 
effects of P-CTX-1 in A-fibres was explained by the activation of NaV1.7, which lead to increased 
action potential firing in Aδ fibres expressing NaV1.7. The effects of the hyperpolarising shift in 
voltage-dependent activation of NaV1.7 would be increased neuronal excitability and action potential 
firing. It appears that in vivo effects of P-CTX-1 are mainly perpetuated by via NaV1.6, NaV1.7 and 
NaV1.8, with inhibitors of these channels able to attenuate the hyperpolarising effects of the toxin 
(41). This hyperexcitability is further compounded by inactivation of voltage-gated potassium 
channels (KV), allowing spontaneous activation even at resting membrane potential (35, 39, 40). 
These channels normally regulate membrane excitability by opening in response to depolarising 
membrane potentials, therefore, inhibition of these channels in the DRG results in tonic firing of 
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action potentials (42). TRPA1 becomes involved when neuronal hyperexcitability indirectly allows 
activation of TRPA1 and therefore generation of cold-induced, burning pain at innocuous 
temperatures. Without the effects of ciguatoxin on membrane potentials, TRPA1 must be activated 
by noxious cold temperatures; ciguatoxin has not been found to interact directly with the channel but 
rather the indirect lowering of threshold for action potential generation (35). This phenomenon 
underpins the pathognomonic sensation of cold allodynia associated with ciguatoxin poisoning. The 
toxin may also activate TRPV1 channels and directly activate peripheral sensory neurons to cause the 
other neurological symptoms accompanying ciguatera (36, 39). 
In animals, ciguatoxin has also been known to cause symptoms similar to those seen in humans (34). 
A mouse study using P-CTX-1 introduced into the foot of a mouse via local intraplantar injection 
demonstrated a rapid, dose-dependent nocifensive behaviours characterised by lifting, shaking and 
flinching of the afflicted paw. Cold allodynia was also demonstrated as increased withdrawal 
responses and nocifensive responses in the presence of a cooled surface (less than 20°C) (34, 35). 
Conversely, exposure to warmer temperatures (up to 42°C) did not elicit the same level of nocifensive 
behaviour as with room temperature. The results of this study were in line with the response seen in 
human ciguatera cases (34, 35), inferring that the mouse model is an appropriate animal model to 
study the peripheral sensitisation of nociceptors related to human symptoms (35). It was also noted 
that intradermal injection of P-CTX-1 in humans yielded similar results to those found from 
intraplantar injection in mice with reported thresholds of cold allodynia being comparable (35, 41). 
Although recent discoveries have provided a greater understanding of mechanisms underlying 
ciguatera associated cold allodynia, it is still unclear how these mechanisms contribute to the overall 
effects on pain (35). To complicate matters further, genetic influences may alter the perception of 
pain (25), resulting in discrepancies in pain expression.  
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1.3 RESEARCH HYPOTHESES, AIMS AND SIGNIFICANCE 
Pain management can be medically difficult due to large interpatient variability in pain responses. 
Chronic pain is particularly troublesome due to limited treatment options available and lack of 
knowledge of the underlying mechanism, resulting in poorly managed morbidity. The presence of 
differing genetic foci existing within the animal genome has a high likelihood of contributing to 
discrepancies in pain behaviours between individual subjects. The use of a mouse model to further 
investigate the genetic influences on pain underpins the purpose of this thesis. 
1.3.1 Hypotheses 
1.3.1.1 Specific genetic foci contribute to the variation seen in ciguatoxin-induced pain 
responses between mice of different genotypes. 
1.3.1.2 Specific genetic foci can be identified by correlation of ciguatoxin-induced pain 
response variability via haplotype-based computational genetic mapping. 
1.3.1.3 Specific genetic foci can be targeted to alter the degree of pain responses exhibited by 
an animal subject. 
1.3.2 Aims 
1.3.2.1 Quantify ciguatoxin-induced spontaneous pain responses of inbred mice with differing 
genotypes. 
1.3.2.2  Determine if meaningful patterns of variability in the pain phenotype exists between 
mouse strains of differing genotypes. 
1.3.2.3  Explore the effects of gender on murine pain behaviours. 
1.3.2.4  Analyse phenotypic differences using haplotype-based computational genetic mapping 
to isolate potential pain genes or gene clusters. 
1.3.2.5  Validate potential pain genes in vivo using methods such as knockout mice. 
1.3.3 Significance 
This thesis intends to contribute to the greater knowledge of pain genetics by outlining possible 
genomic influences implicated in ciguatoxin-induced pain responses and describing the method of 
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haplotype-based computational genetic mapping for investigating genetic ramifications on 
nociception. If specific pain genes can be determined with this method, a novel approach to pain gene 
identification will be exposed, allowing underlying genetic contributors to be directly addressed to 
more accurately target pain symptoms. Tailoring treatment of chronic pain based on a person’s 
genetic susceptibility would assist in managing the highly variable nature of pain. 
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2. CHAPTER TWO: Strain-dependent Phenotypic Differences in 
Ciguatoxin-Induced Spontaneous Pain 
2.1 FOREWORD 
Ciguatoxin induces spontaneous pain behaviours after intraplantar injection into the hind paw of mice 
(35). Quantifying the degree of pain responses is the first step to characterising ciguatoxin-induced 
nociception, however measuring subjective behaviours can be achieved by a number of different 
methods. The mechanism of ciguatoxin outline in Chapter 1 involves voltage-gated sodium and 
potassium channels which may be affected by genetic differences due to SNP variations, reflected as 
altered intensities of pain in subjects. 
I would like to acknowledge Katharina Zimmermann of Friedrich-Alexander University in Germany 
for providing the mouse strains and technical assistance in preparing the subjects.  
2.2 INTRODUCTION 
Pain perception is controlled by various biological processes including sensitisation of peripheral 
tissues, transmission of the signals through nerves and ganglia, and processing of the stimuli at higher 
centres in the brain. Alterations at any location along this pathway due to genetic anomalies could 
influence the transmission of pain, which could explain differences observed in pain perception 
between individuals. Currently, chronic pain management is poorly accomplished and there are no 
treatments for pain which specifically target genetic aberrations, leaving a novel field of potential 
treatments yet to be explored. The ability to detect and target genes associated with pain in a mouse 
model is one of the initial steps required for exploring genetic anomalies in the human population. To 
investigate this area, inbred mouse strains can be used to determine the extent of nociceptive 
variability due to genetics. The genotypes of each mouse strain are known, therefore the differences 
seen in the behaviour of a strain can potentially be correlated to the underlying genetic properties. 
Phenotypic data gathered from observing different mouse strains can then be used in haplotype-based 
computational genetic mapping to determine the genetic influences underlying ciguatoxin-induced 
spontaneous pain. 
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The aims of this chapter are to: 1) quantify ciguatoxin-induced spontaneous pain in inbred mouse 
strains using flinching and licking responses, 2) find meaningful patterns of variance in phenotypes 
between the different mouse strains which can be attributed to their underlying genotype. The results 
will be used to determine if ciguatoxin-induced spontaneous pain produces altered pain responses 
between mice of varying genetic characteristics.  
2.3 METHODS 
2.3.1 Animals 
Ethics approval from relevant Animal Ethics Committees at The University of Queensland (UQ) and 
Friedrich-Alexander University (FAU) have been completed. 
The mus musculus species was used in this experiment because of the ease of acquiring inbred strains 
with known genomic data. Strains were chosen based on the following characteristics: are inbred 
mice, already genotyped, readily available and affordable. Sixteen mouse strains were used to in this 
study, with the number of mice for each strain ranging from 10 to 29 mice (Table 2.1). Each specific 
genotype of the strains selected in this study is not so important as it is only necessary for strains to 
have diverse combination of genotypic differences such that they could be compared. Mice were also 
identified based on their gender, to explore the effects of sex differences on nociception. The mouse 
strains used in the experiments were acquired from Jackson Laboratory by Katharina Zimmermann 
and housed at FAU.  
2.3.2 Ciguatoxin-Induced Spontaneous Pain 
Preparation of mice for observation was undertaken by Katharina Zimmerman and her team at FAU. 
Pacific ciguatoxin-1 (P-CTX-1) was used to induce spontaneous pain in mice, able to produce pain 
when administered as a shallow intraplantar injection while avoiding the systemic side effects of 
ciguatera (35). Mice in this study were inoculated with an intraplantar injection of 40 microlitres of 
P-CTX-1 (3nM with 1% bovine serum albumin) into right hind paw of mouse. Mice were 
anaesthetised prior to injection in a chamber with an ether-soaked swab and inhaled sevoflurane (3-
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5%) as a general anaesthetic. After ciguatoxin was administered, mice were immediately placed in 
one of eight adjoining Perspex cells approximately ten by ten centimetres in size. The light source 
was positioned above the clear cells with the camera located underneath, therefore observation of the 
mice was conducted with the ventral view of the mouse in frame (Figure 2.1). The mice resided in 
Germany where the laboratory experiments took place while observation was conducted in Australia 
from video recordings sent from FAU to UQ. A digital timer was used to record the time for licking 
responses and a manual clicker to count the individual flinching responses. 
Table 2.1: Mouse strain details. 306 mice from 16 different mouse strains, with an average of 19 mice per 
stain. A brief description of each mouse was obtained for The Jackson Laboratory (43). 
 
Strain Males (n) Females (n) Total (n) Description 
SJL 14 15 29 High incidence of reticulum cell sarcomas resembling Hodgkin's 
disease 
NOD 15 12 27 High incidence of type I insulin-dependent diabetes 
C57B6J 12 15 27 General purpose strain; good breeding performance 
CBA 12 14 26 General purpose strain 
129S1 13 13 26 High incidence of spontaneous testicular teratomas 
FVB 11 13 24 Multipurpose inbred strain 
B_C 10 9 19 General purpose strain 
NZW 8 11 19 Widely used as a model for autoimmune disease resembling 
human systemic lupus erythematosus 
DBA1 11 7 18 Widely used as a model for rheumatoid arthritis 
AKR 6 11 17 Widely used in cancer research for their high leukemia incidence 
and in immunology as a source of the Thy1.1 (theta AKR) antigen 
SWR 8 8 16 General purpose strain 
RIIS 8 8 16 Model for human von Willebrand disease 
NON 7 7 14 Model for type 2 (NIDDM) diabetes with certain tendencies toward 
autoimmune disease 
SM 7 7 14 Carry a number of rare polymorphic alleles and are often matched 
to other strains for quantitative trait locus analysis 
NZB 3 8 11 Widely used as a model for autoimmune disease resembling 
human systemic lupus erythematosus 
MRL 5 5 10 Useful in the study of their comparable defects and diseases, 
including systemic lupus erythematosus and Sjogren syndrome 
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2.3.3 Observation of Pain Behaviours 
Blinded observation of the mouse pain reaction videos was undertaken by the author. Following 
injection with ciguatoxin, mice were placed in their designated cell still under the effects of 
anaesthesia. Two rules were established to maintain consistency when counting each mouse since the 
time for each subject to awaken from anaesthesia was unpredictable. The first rule was that counting 
only commenced after the mouse being watched was awake, which was signified when they were 
able to stand up completely and achieve proper footing without falling. The second rule was the timer 
was started when the first flinch or lick occurred, and this was done for all mice. Any flinching or 
licking occurring while the mouse was still asleep was disregarded. Pain responses were counted in 
five minute intervals for a total of forty minutes; hence eight blocks in total per mouse. Each 
individual flinch of the injected paw was counted with the manual clicker, however for continuous 
flinching movements, such as continuous shaking, the movement was counted as approximately one 
flinch per second of the entire movement (i.e. ten seconds of continuous shaking was counted as ten 
flinches). Time spent licking was timed with a digital timer for the duration the mouse licked the 
affected paw.  
Figure 2.1: Setup for mouse observation step. 8 adjacent cells viewed from underneath with the light source from 
above. The mouse in the bottom right corner can be seen licking their paw. This behaviour is quantified by a blinded 
observer. 
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2.3.4 Statistical Analysis 
2.3.4.1 Outlier analysis 
The Systat outlier analysis was used to remove outliers from the raw data. After flinching and licking 
values were tallied for each mouse, the data was run through Systat to remove values straying too far 
from the mean using the Hadi outlier detection and estimation method (44). The modified data was 
then used for the rest of the calculations and graphs. 
2.3.4.2 Data presentation 
GraphPad Prism 7 was used to produce graphical plots as well as to calculate certain statistics. The 
results from the observation of each mouse strain were tallied for each 5 minute interval and plotted. 
Initially, male and female data were contrasted against each other to define any gender discrepancies. 
Graphs for each strain with flinching and licking results were produced to display the differences 
between each strain as well as between the two phenotypes. Graph with all strains shown together 
were also generated to better represent the variation seen between each strain.  
2.3.4.3 Statistical significance analysis 
F-test and t-test analyses were conducted to determine if differences seen between two groups being 
compared were significant; these calculations were conducted via Microsoft Excel’s Data Analysis 
plugin with an alpha level set at 0.05. F-tests were calculated first to determine if variances were 
equal or unequal as required for the two-tailed Student’s t-test, which was used to compare two 
separate datasets. If the t-stat exceeded the t-crit parameters, a difference was deemed as significant. 
In this chapter, male and female data was analysed to determine if gender played a role in nociception. 
In addition, flinching and licking phenotypes were also compared to see if there was then association 
present between each type of reaction.   
2.3.4.4 Z-transformation 
The standard deviations and z-scores were calculated to compare the degree of variation between the 
differing mouse strain phenotypes. The mean and standard deviation were calculated from the total 
flinching numbers and licking durations of the 40 minutes. Z-scores were calculated from the mean 
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and the standard deviation for each mouse strain as well as the population mean the entire population 
of strains. The z-score data from both flinching and licking data was then ranked from lowest to 
highest to display any differences in mouse strain reactions in respect to spontaneous pain. Therefore, 
the z-scores would be used as the numerical equivalent of the phenotypic differences seen between 
the mouse strains. 
 Figure 2.2: Flow diagram of overall experiment. 1) Various inbred mouse strains selected with differing genotypes. 
2) Intraplantar injection of ciguatoxin into hind foot of each mouse. 3) Each mouse is observed to compare differences 
in pain expression. 4) Pain phenotypes quantified in terms of number of flinches and time spent licking. 5) Phenotype 
data analysed via various methods including HBCGM. 6) Potential genetic targets isolated and validated. 
 
2.4. RESULTS 
2.4.1 Gender differences between mouse strains not impactful on ciguatoxin pain phenotype 
The data for males and females was plotted directly against one another (Figure 2.3) to determine if 
sex differences influenced ciguatoxin-induced nociception. The correlation (R2) between the two 
genders for flinching and licking datasets was 0.77 and 0.92 respectively. This refers to 77% of the 
male flinching data explaining the female data, and 92% of the male licking data explaining the 
female data. In addition, the two-tailed test (Table 2.2) reveals all but one strain in the flinching data 
as well as one strain in the licking data showing no difference between male and female pain 
responses. The p-values for this data exceeds the cut-off of 0.05, indicating that this difference is not 
significant. Conversely, the NON mouse strain from the flinching data as well as the MRL strain from 
licking data show a significant difference (p-value: 0.02 and 0.01 respectively). Therefore, the 
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findings investigating gender influences on ciguatoxin-induced pain show no difference between 
male and female mice, however this difference is not significant. 
0.7651 0.9154
Figure 2.3: Male and female pain responses are highly correlated for both flinching and licking pain behaviours. 
The total number of flinches or time spent licking was compiled for each sex for all mouse strains. Males were plotted 
on the X-axis and females on the Y-axis, with 95% confidence intervals shown as error bars. Linear regression 
correlation line is shown in red with a correlation R2 of 77% for flinches and 92% for licks. 
 
Two-tail t-test of Flinching data: Males vs. Females
   F-test t-test (two tail)
Strain ♂ (n) ♀ (n) F P-value F Crit t Stat P-value t Crit
129S1 13 13 1.29 0.33 2.69 0.46 0.65 2.06
AKR 6 11 4.14 0.07 4.74 -0.14 0.89 2.13
B_C 10 9 1.17 0.42 3.39 -1.71 0.10 2.11
C57B6J 12 15 2.13 0.11 2.74 0.18 0.86 2.06
CBA 12 14 1.31 0.33 2.76 0.88 0.39 2.06
DBA1 11 7 5.11 0.01 3.22 1.98 0.08 2.31
FVB 11 13 1.20 0.39 2.91 0.79 0.44 2.07
MRL 5 5 2.21 0.23 6.39 0.59 0.57 2.31
NOD 15 12 3.02 0.03 2.57 1.16 0.26 2.11
NON 7 7 4.79 0.04 4.28 2.95 0.02 2.31
NZB 3 8 10.14 0.09 19.35 0.81 0.44 2.26
NZW 8 11 1.57 0.25 3.14 1.99 0.06 2.11
RIIIS 8 8 1.92 0.21 3.79 0.71 0.49 2.14
SJL 14 15 1.64 0.19 2.51 -0.16 0.88 2.05
SM 7 7 13.03 0.00 4.28 2.13 0.07 2.36
SWR 8 8 2.14 0.17 3.79 -0.46 0.65 2.14
    
 
Two-tail t-test of Licking data: Males vs. Females
   F-test t-test (two tail)
Strain ♂ (n) ♀ (n) F P-value F Crit t Stat P-value t Crit
129S1 13 13 7.69 0.00 2.69 -0.14 0.89 2.06
AKR 6 11 2.07 0.17 3.64 0.81 0.43 2.11
B_C 10 9 2.02 0.16 3.23 0.64 0.53 2.11
C57B6J 12 15 3.53 0.02 2.74 1.17 0.25 2.06
CBA 12 14 1.07 0.46 2.76 1.29 0.21 2.06
DBA1 11 7 1.13 0.42 3.37 1.75 0.10 2.13
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FVB 11 13 2.37 0.09 2.91 1.32 0.20 2.07
MRL 5 5 1.35 0.39 6.39 -3.45 0.01 2.31
NOD 15 12 1.28 0.33 2.57 -0.11 0.91 2.06
NON 7 7 3.15 0.10 4.39 2.03 0.07 2.20
NZB 3 8 3.38 0.25 19.35 0.09 0.93 2.26
NZW 8 11 1.73 0.24 3.64 -0.29 0.77 2.11
RIIIS 8 8 1.07 0.47 3.79 0.91 0.38 2.14
SJL 14 15 1.76 0.15 2.48 0.88 0.39 2.05
SM 7 7 5.15 0.03 4.28 2.25 0.05 2.31
SWR 8 8 1.61 0.27 3.79 0.43 0.67 2.14
 Table 2.2: No difference between male and female pain responses. Two-tailed Student’s t-test comparing 
male and female pain response for flinching and licking. Alpha level set at 0.05. Significant differences between 
the males and females have been highlighted yellow. Majority of p-values are not significant as they exceed 
0.05. 
 
2.4.2 Flinching and licking pain reactions are two distinct phenotypes 
As the influence of gender on ciguatoxin-induced nociception was found to be minimally influential, 
the data gathered from males and females were combined. Flinching and licking pain responses were 
compared against one another by plotting the variables of each axis (Figure 2.4). Linear regression of 
the data yielded a correlation of 0.56, denoting 56% of the flinching data being explained by licking 
data. The variation between flinching and licking responses has also been shown for each individual 
mouse strain (Figure 2.5) which also demonstrates the expression pattern of pain over time. The 
graphs show variable curves and amplitudes for each strain, as well as differences between flinching 
and licking within each graph. The differences between these two reactions is made clearer via the t-
test comparing flinches against licks (Table 2.3). The majority of strains demonstrated a significant 
difference between flinching and licking modalities, with only the B_C strain showing no difference, 
however the p-value for this discrepancy was 0.724 meaning it was not significant. Hence, it can be 
concluded that flinching and licking pain responses are two distinct reactions for ciguatoxin-induced 
spontaneous pain.  
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Figure 2.4: Comparison of flinching and licking for both genders combined. Total number of flinches versus total 
time spent licking for data of both genders combined. Number of flinches were plotted on the X-axis and seconds spent 
licking on the Y-axis. Linear regression correlation line in red. 
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Figure 2.5: Flinches and licking of each individual mouse strain have distinct degrees of responses. The number 
of flinches (left Y-axis) and seconds spent licking (right Y-axis) for each strain plotted over 40 minutes. Flinches are 
coloured purple and licks coloured orange. Error bars denote 95% confidence intervals. Each mouse strains 
demonstrate different pain expression characteristics over the given time. 129S1 (n): 26, AKR (n): 17, B_C (n): 19, 
C57B6J (n): 27, CBA (n): 26, DBA1 (n): 18, FVB (n): 24, MRL (n): 10, NOD (n): 27, NON (n): 14, NZB (n) 11, NZW 
(n) 19, RIIS (n): 16, SJL (n): 29, SM (n): 14, SWR (n): 16. 
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Two-tail t-test of both genders: Flinching vs. Licking
 F-test t-test
 n F P-value F Crit t Stat P-value t Crit
SJL 29 1.26 2.75E-01 1.88 11.22 4.63E-16 2.00
C57B6J 27 2.64 8.00E-03 1.93 9.89 1.22E-12 2.02
NOD 27 1.43 1.85E-01 1.93 6.01 1.83E-07 2.01
CBA 26 6.00 1.42E-05 1.96 9.28 1.02E-10 2.03
129S1 26 23.40 7.74E-12 1.96 5.10 2.36E-05 2.05
FVB 24 11.64 6.71E-08 2.01 12.83 5.28E-13 2.05
B_C 19 1.04 4.69E-01 2.22 0.36 7.24E-01 2.03
NZW 19 2.19 5.25E-02 2.22 7.51 7.13E-09 2.03
DBA1 18 1.07 4.47E-01 2.32 -3.54 1.22E-03 2.03
AKR 17 1.20 3.57E-01 2.30 3.16 3.30E-03 2.03
SWR 16 1.62 1.79E-01 2.40 7.10 6.76E-08 2.04
RIIIS 16 22.87 1.20E-07 2.40 10.97 7.47E-09 2.12
NON 14 16.17 7.08E-06 2.60 9.79 2.29E-07 2.16
SM 14 3.40 1.78E-02 2.58 7.15 6.37E-07 2.09
NZB 11 3.28 3.92E-02 3.02 2.93 1.11E-02 2.14
MRL 10 5.01 1.24E-02 3.18 4.99 3.16E-04 2.18
 Table 2.3: Significant difference between flinching and licking pain responses. 
Comparison to determine if flinching and licking pain modalities are distinct. Alpha 
level set at 0.05. Differences between the two groups have been highlighted yellow. 
2.4.3 Variation in ciguatoxin-induced pain responses exists between each mouse strain 
A number of different mouse strains were utilised to determine differences with nociception in the 
setting of a diversified genetic sample. Differences in pain expression between each mouse strain for 
flinches and licks (Figures 2.5 & 2.6), are shown as separate pain expression curves over time with 
dissimilar amplitudes of pain responses. Mouse strains from the flinching data were grouped based 
on the degree of flinching exhibited over total forty minutes, yielding three arbitrary groups (Figure 
2.6). This grouping system for each phenotype was used to demonstrate the dissimilarities between 
the two phenotypic measures as evident by distinct assortments of the mouse strains. This same 
grouping was used to compare the overall distribution of flinching responses with the licking 
responses, such that the same colour scheme was implemented in the graph for licking data. It can be 
noted that not all mouse strains reacted equally in terms of flinching or licking responses, and this 
inequality between the two responses becomes as apparent when comparing the degree of flinching 
for each mouse to that of licking. There is also an obvious disparity in the intensity of pain responses 
observed amongst each mouse strain, which can be seen clearly when viewing the average degree of 
each response over the total forty minutes (Figure 2.7). To confirm that the means for each strain 
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were not equal, a one-way ANOVA analysis was conducted (Table 2.4), which elaborates that at least 
one of the means is not equal to the rest. Z-transformations for each strain were calculated to display 
this variation in a numerical form and establish a distinct degree of pain for each strain (Figure 2.8). 
Strains reacting to a lesser degree yielded negative Z-scores whilst those reacting more frequently 
possessed a z-score above baseline. The net result from these steps showed each mouse strain used to 
explore ciguatoxin-induced spontaneous pain reacted to different extents and a significant difference 
in pain responses for the strains used for both licking and flinching modalities exists. 
Figure 2.6: Mouse strains behave to different extents in terms of flinching and licking pain responses. The 
number of flinches and seconds spent licking for each strain over 40 minutes shown as two separate graphs. Strains 
were coloured based on the degree of flinching and crudely separately into three groups to highlight that flinching and 
licking do not correlate for individual mouse stains. 129S1 (n): 26, AKR (n): 17, B_C (n): 19, C57B6J (n): 27, CBA 
(n): 26, DBA1 (n): 18, FVB (n): 24, MRL (n): 10, NOD (n): 27, NON (n): 14, NZB (n) 11, NZW (n) 19, RIIS (n): 16, 
SJL (n): 29, SM (n): 14, SWR (n): 16. 
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One-way ANOVA of Flinching data 
 n Sum Average Variance
C57B6J 27 6317 233.96 6008.50
AKR 17 3523 207.24 9692.07
SJL 29 5676 195.72 9492.64
CBA 26 4377 168.35 3243.20
B_C 19 3103 163.32 5142.45
DBA1 18 2327 129.28 8118.09
SWR 16 1516 94.75 6055.13
NOD 27 1899 70.33 2411.31
NZB 11 758 68.91 868.89
NZW 19 1078 56.74 1262.76
MRL 10 454 45.40 849.38
SM 14 627 44.79 907.10
NON 14 568 40.57 432.88
FVB 24 779 32.46 240.87
RIIS 16 462 28.88 303.05
129S1 26 701 26.96 149.48
 
ANOVA   
Source of 
Variation F P-value F crit
Between Groups 29.44 5.31E-50 1.70
 
One-way ANOVA of Licking data 
n Sum Average Variance
C57B6J 27 13917 515.44 15882.18
SJL 30 14952 498.40 11914.87
CBA 26 11509 442.65 19472.64
SWR 16 5095 318.44 9824.26
AKR 19 6015 316.58 11671.70
NON 13 3565 274.23 6999.69
RIIS 16 4194 262.13 6931.85
DBA1 17 4001 235.35 7575.12
FVB 24 4247 176.96 2802.74
NZW 19 3156 166.11 2767.54
SM 14 2316 165.43 3083.19
NOD 27 4290 158.89 3444.10
MRL 10 1581 158.10 4258.99
B_C 19 2947 155.11 4952.10
NZB 10 1247 124.70 2847.34
129S1 26 2270 87.31 3497.34
 
ANOVA  
Source of 
Variation F P-value F crit
Between Groups 53.04 1.05E-74 1.70
Table 2.4: Variation exists between the different mouse strains. A one-way ANOVA analysis of flinching and 
licking data was conducted to compare means of each strain. Total number of flinches and total seconds spent licking 
were used; alpha level set at 0.05. A significant difference between at least two of the strains is proven. 
Figure 2.7: The intensity of pain exhibited between individual mouse strains differs to varying degrees. The 
average number of flinches and average seconds spent licking over the total observation time for each strain shown 
as two separate graphs. Error bars denote 95% confidence intervals. Strains were coloured with the same colour 
scheme as in Figure 6 to highlight disparities between flinching and licking data, which is supported by the distinct 
order of mouse strains between the two graphs. 129S1 (n): 26, AKR (n): 17, B_C (n): 19, C57B6J (n): 27, CBA (n): 
26, DBA1 (n): 18, FVB (n): 24, MRL (n): 10, NOD (n): 27, NON (n): 14, NZB (n) 11, NZW (n) 19, RIIS (n): 16, 
SJL (n): 29, SM (n): 14, SWR (n): 16. 
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Figure 2.8: Variation between mouse strains for ciguatoxin-induced pain exists. Z-scores were calculated using 
the averages for flinching and licking over the total observation times. Each strain was ranked from lowest to highest 
for both flinching and licking. Strains were coloured with the same colour scheme as in Figure 6 to indicate disparities 
between flinching and licking data. Differences in pain responses between strains are depicted as variation in the Z-
scores. 129S1 (n): 26, AKR (n): 17, B_C (n): 19, C57B6J (n): 27, CBA (n): 26, DBA1 (n): 18, FVB (n): 24, MRL (n): 
10, NOD (n): 27, NON (n): 14, NZB (n) 11, NZW (n) 19, RIIS (n): 16, SJL (n): 29, SM (n): 14, SWR (n): 16.
2.5 DISCUSSION AND CONCLUSIONS 
In animal models, despite subjects not being able to score their pain with methods used with human 
participants, their behaviours can be witnessed after introduction of a noxious stimuli and reliably 
and objectively indexed. In observational studies for pain in animals, the cues which can be assayed 
are reflex, spontaneous, operant and complex behaviours (45). Regarding the cue most commonly 
and consistently measured, spontaneous behaviours appears to be the most favourable. This cue 
includes simple or innate responses such as flinches and licking of the affected limb, and is widely 
used yet still lacking clinical face validity due a multitude of reasons including unpredictability (45). 
When using animal models in pain studies, certain tactics can be used to determine the degree of pain 
exhibited. For acute pain assays, which includes ciguatoxin-induced spontaneous pain, the classical 
approach involving introduction of a noxious stimulus followed by recording of native behaviours 
remains a popular method (45). Many different patterns can be recorded for spontaneous pain such 
as directed behaviours including flinching and licking, as well as gait or postural changes (45). It was 
anticipated that intraplantar injection of P-CTX-1 would cause a measurable pain response seen as 
flinches, lifts, shakes and licks of the injected paw, as seen in a previous study utilising C57BL/6 
mice (35). Subjects would display recordable spontaneous pain behaviours at room temperature in a 
dose-dependent manner after the introduction of ciguatoxin. It was then inferred that intraplantar 
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injection of the same P-CTX-1 dose would cause a consistent response in all mice inoculated, and 
any significant disparities would be attributed to other variables, including the possibility of a genetic 
influences when using mice of different genotypes. In this study, the cues recorded were the number 
of flinches of the affected limb and the time spent licking of the affected limb due to both cues being 
most predominantly seen and the simplest behaviours to quantify, although it must be noted that these 
two reactions were not the only behaviours seen during observation. Subjects would also participate 
in lifts and shakes, but these reactions were labelled as flinches to classify behaviours in a manageable 
counting system.  
The impact of gender on spontaneous pain was examined first, as it was uncertain whether the sex of 
a mouse would play a significant role in ciguatoxin-induced nociception. A different study exploring 
the effect of gender in the setting of morphine analgesia via different mechanisms of N-methyl-D-
aspartate (NMDA) receptor blockade showed female mice having no modulation of pain when a non-
competitive antagonist were used, compared to analgesic effects exhibited in males. (46). When 
isolating the responses for ciguatoxin-induced pain for the two genders in this study, gross similarities 
were seen amongst the sexes, however this was not found to be statistically significant. The two-
tailed t-test conducted between male and female mice demonstrated weak evidence for overall 
similarities between males and females, whereas only two strains showed a statistically significant 
difference between males and females. This comparison suggests that gender is unlikely to impart a 
dramatic effect on ciguatoxin-induced spontaneous pain, but it also does not exclude the possibility 
that a gender influence may be contributing to variation seen in ciguatoxin-induced pain. The decision 
was made to examine both genders as collectively as it was predicted that examining the phenotypes 
of each individual sex would not be produce any additional findings. 
When comparing flinching and licking pain reactions against each other for the numerous mouse 
strains, a more obvious variation was observed. After observing the mouse strains, it was determined 
that flinching and licking behaviours displayed unrelated patterns and showed distinct characteristics 
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for pain expression. Graphs of the data produced quite distinct curves between the two reactions and 
the two-tailed Student’s t-test was able to prove this difference. All but one strain supported the view 
that flinching and licking are two unrelated responses to pain, and this anomaly was not found to be 
statistically significant. The overwhelming number of strains showed a significant difference between 
the number of flinches and the seconds spent licking. This finding leads to the conclusion that no 
meaningful correlation exists between the number of flinches exhibited and the time each mouse 
spent licking for ciguatoxin-induced spontaneous pain, therefore, flinching and licking reactions were 
analysed as separate entities. 
The most important finding investigated in this chapter is the existence of distinct pain responses 
between each mouse strain. This difference is important as it is necessary to determine if genotypic 
variations amongst the assortment of mouse strains is contributing to the variation observed in the 
pain phenotype. If no difference is seen, it would be difficult to prove that genetic influences have an 
impact of pain perception in mice. When looking specifically at flinching responses, disparities 
amongst the mouse strains have been depicted in various graphs displaying flinches over specific 
time intervals as well as total number of flinches over the entire counting time. The differences in the 
shape of pain response curves for each five minute block is noteworthy as it shows each strain 
behaving in a manner that does not follow a consistent pattern, signifying their reaction to pain over 
a given time is also distinct between mouse strains. The ANOVA test conducted demonstrates an 
inequality of the means across the various mouse strains for both licking and flinching responses, 
which is necessary to claim that genetic discrepancies are important in ciguatoxin-induced 
nociception. Any incongruities seen amongst the pain responses between mice allows for further 
investigation into how the different genotypes could potentially play a role in pain perception. The 
graphs with z-scores clearly represent the differing extents of pain behaviours seen within subjects of 
varying genetic backgrounds. The ranking of each mouse strain is not the notable feature of these 
findings as it is not known which exact genetic trait is contributing to the variation at this stage, hence 
knowledge of which specific strains reacting more than others is not important. 
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Expectedly, the quantification of pain from mice observation studies is a challenging task as it is not 
always apparent whether an action seen is caused by pain or is a native reflex. In addition to this, the 
degree of pain cannot be accurately determined by simple visual inspection of the animal since 
behaviours and postures exhibited by mice do not directly translate to severity of pain being felt (45). 
To accomplish the feat of objectifying pain, the approach in this study was to record the most obvious 
behaviours the mice demonstrated, hence the flinches and the licks. This approach may be criticised 
as an oversimplification of the nature of pain, which may lead to the following inaccuracies. Firstly, 
the severity of pain does not correlate with the overt behaviours seen in mice, therefore having more 
flinches or licks may not truly signify a subject is suffering from more intense pain. Secondly, pain 
perception in a complex physiological response composed of sensory, emotional and behavioural 
aspects (4), and the method used in this study attempts to neatly classify responses as finite cues, 
which may not capture the true essence of the pain experience a mouse is feeling.  
Observing pain using simple cues fails to account for other influences of pain such as level of anxiety, 
social factors, poor sleep, breeding conditions and pre-existing disability of the mouse (45). Some of 
these factors can be kept constant by handling each mouse in an identical manner, however the impact 
of these factors can be quite significant if one is not aware of their effects. An example of one 
condition with potential to affect pain severity is social communication between mice. 
Communication can occur between mice held in the same vicinity via visual, auditory or olfactory 
means. One study explored the effect of visual communication on inflammatory pain in mice 
examined in pairs. A bidirectional, increased level of pain behaviours was noted in the pair of mice 
allowed to visually interact when compared to mice left visually isolated (47). This finding reiterates 
the multitude of confounding factors relevant for animal studies. 
Overall, the measurement of pain continues to remain an area fraught with great difficulty, and no 
gold standard approach to quantify pain seems to exist (45). Even though the accuracy of the method 
used in this study can be easily scrutinised for its inadequacy, one must consider other factors when 
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employing alternative techniques to quantify pain such a costs, feasibility and time consumption. A 
novel approach to pain quantification using vocal cues in the ultrasonic range has been described in 
rodents as an indication of pain from acute injuries or electric shocks (45). The measurement of 
ultrasonic vocalisations was investigated in monoarthritic rats subjected to noxious mechanical 
stimulation. The conclusions from this study were that ultrasonic vocalisation could not be used as a 
measurement of pain, which further emphasises the difficulties developing methods to index pain 
(48). Lastly, the misinterpretation of physical actions of pain can impact the accuracy of the results. 
The subjects being observed are not only seen exhibiting pain behaviours, but also participating in 
non-pain behaviours, which may be misconstrued as pain reactions. There is no apparent solution to 
this problem and strict observation rules implemented to keep conditions as constant as possible when 
viewing all mice may or may not be enough. In the attempt to improve the accuracy current 
approaches, newer methods of quantification are continually being explored to avert this dilemma. 
Newer technological directions include photocell and video tracking systems capable of computing 
spontaneous behaviours in animals via complex measures and algorithms previously not available in 
the field (45). Examples include signal processing devices, mechanical devices and video image 
analysis (49). Utilisation of automated technology to quantify pain also allows for standardisation in 
pain studies and eliminates human error seen with manual observation (45, 49). 
It is apparent that ciguatoxin-induced spontaneous pain varies between mouse strains of distinct 
genotypes in this study, and despite the reasons for this being numerous, one reason of interest is the 
presence of specific genes or gene clusters that could be playing an influential role in nociception. 
The perception of pain relies on mainly the nervous system (4), however systems such as the immune 
system may also influence pain perception, especially in chronic pain models (15). Psychosocial 
factors have also been known to modulate the perception of pain (4), adding more complexity into 
the investigation of underlying mechanisms. It is unknown what underlying pathophysiology causes 
the differences seen between mouse strains at this stage, however the pool of multiple genotypes will 
be used to explore if any obvious genetic contributions can be used to explain this difference. 
37 
 
This allows the hypothesis that differences seen between inbred mouse strains of varying genotypes 
contributes to differences seen in pain responses to be tested. As flinching and licking behaviours 
have been shown to be two discrete pain responses, the different mechanisms of each phenotype were 
examined separately to determine if a distinct mechanism underpins each pain modality. The main 
finding to take from this observational step is that each mouse strain reacted to varying degrees when 
identical quantities of P-CTX-1 were introduced, as indexed as either flinching or licking. This 
asymmetry is what will be used to correlate the phenotype incongruities to the known variations 
between the mice genotypes. The discrepancies pain behaviours enable genetic influences to be 
examined, which could lead to the possibility of defining genetic patterns implicated in the altered 
pain perceptions. 
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3. CHAPTER THREE: Haplotype-Based Computational Genetic 
Mapping 
3.1 FOREWORD 
Demonstration that pain behaviours seen between mice of different genotypes are dissimilar after 
administration of identical amounts of ciguatoxin is a necessary step in the search for genetic effects 
on nociception. Both flinching and licking responses were distinct between each mouse strain, and 
the disparities seen between the strains in terms of the extent of pain expression can be used in 
haplotype-based computational genetic mapping (HBCGM). This process relies on variation between 
the data to isolate SNPs for genes that may have an association with nociception explaining the 
discrepancies in pain responses. The process essentially matches variation in SNP distribution of all 
the genotypes of the mouse strains with the variation seen for the pain phenotypes, hence the 
differences shown is Chapter 2 are vital for this step to occur. 
I would like to acknowledge Ming Zheng from the Stanford University in the United States for 
processing the phenotype data through the genetic mapping program at the Peltz Lab. 
3.2 INTRODUCTION 
HBCGM is a specific method with distinct features, distinguishes this method from traditional 
quantitative trait locus (QTL) approaches used in murine genetic analysis (50). QTL analysis differs 
from HBCGM as it involves generating, genotyping and phenotyping various intercross progeny 
produced from only two parental strains while HBCGM is implemented on a select group of inbred 
mouse strains. The outcomes of each method are also dissimilar, as QTL analysis recognises only 
large chromosomal regions whilst HBCGM recognises individual and even sub-genic regions (50). 
The QTL approach is a lengthy process requiring three to six years to breed enough generations of 
intercross progeny, when compared to HBCGM which can be performed the same day as the 
measurement of the phenotype of interest is completed (51). 
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The basis for HBCGM relies on an observable physiological or pathological difference being 
recognised amongst selected inbred mouse strains of variable genetic patterns. By correlating the 
distribution of specific trait values amongst the population of inbred strains with a specific genetic 
fingerprint, the isolation of genomic regions with the highest correlation can be made possible (50-
52). Originally developed as a technique to analyse the genetic traits in mice, HBCGM has allowed 
causative genetic factors to be identified in a number of pathological conditions (50). HBCGM 
requires ten or more inbred mouse strains to examine a specific trait, which can be quantitatively or 
qualitatively measured (50-52). 
An ANOVA-based statistical model is employed to determine the extent of correlation between trait 
values and strain groupings within each haplotype block. To achieve this, an accurate, high-resolution 
representation of genetic variation patterns within inbred strains is required. Consequently, 16 inbred 
mouse strains were utilised to construct a map of the haplotypic block structure of the mouse genome; 
in addition, 19 mouse strains were used to create a dense set of SNPs (50, 51). A p-value was assigned 
to quantify correlation and determine if the data was consistent with the null hypothesis that ‘the mean 
trait values for inbred strains with the same genotypic haplotype are equal’. The p-value and the 
correlation of the haplotype block with the observed trait are inversely related, hence lower p-value 
denote greater correlation (50). The likelihood of detecting causative genetic factors (detection 
power) is dependent on the proportion of phenotypic variance accounted for by the genotypic 
difference (genetic effect). The use of HBCGM has allowed the genetic cause underlying certain 
phenotypic traits of inbred strains to be swiftly diagnosed (50). 
The strength of HBCGM relies on large data samples, whereby single genetic loci with smaller 
genetic effect sizes can be detected by increasing number of inbred mouse strains used. Conversely, 
the method has limited power in identifying genetic loci of rare occurrence or those with minimal 
contribution to the trait being observed (51). Another drawback to the approach is that it struggles to 
identify causative genetic loci involved in complex traits orchestrated by multiple alleles in 
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disconnected locations of the genome, which unfortunately is the basis for many biological traits (52). 
The tolerant filtering criterion used to evaluate HBCGM results aims to safeguard true positives but 
consequently results in larger numbers of false positives (52). Therefore, the list of candidate genes 
produced from HBCGM becomes quite extensive and requires certain measures to be taken to narrow 
down results and characterise the genetic influences responsible for variation in the observed 
phenotype. 
The aims of this chapters are to: 1) utilise HBCGM to generate a list of potential genes correlated to 
the distribution of the ciguatoxin-induced pain trait seen in the mouse strains used, 2) identify patterns 
within these gene lists using gene ontology, gene expression details and correlation with established 
pain gene databases, and 3) identify if a single gene locus with potential effects of nociception can be 
isolated further investigation. 
3.3 METHOD 
3.3.1 Haplotype-Based Computational Genetic Mapping 
After the Z-transformation data was calculated, both the clean data and the z-scores were sent to the 
Peltz’s Lab of Stanford University in California USA, where the all the HBCGM results were 
generated. Flinching and licking data representing the mouse phenotype were analysed separately via 
the HBCGM method, outlined in an article by Zheng et al. (53) as well as Wang et al. (50), to yield 
a list of genes correlating the observed phenotype with the known mouse genotypes. The raw gene 
lists were sent to the thesis candidate for analysis. The list of genes was sorted based on their p-value 
with a cut-off set at 0.01, and each list was examined independently. Before each list could be 
analysed, each collection of genes for flinching and licking was refined as they were inclusive of both 
coding and non-coding genes. Non-coding genes were excluded from the analysis due to their non-
influential effect on the phenotype since they are not expressed. Only genes in coding regions or 
genes active at regulatory, promotor or enzyme binding sites were considered; once non-coding genes 
were removed, the refined lists were used for the rest of the analyses. 
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3.3.2 Gene Ontology 
Gene ontology was sought to analyse the functional relationships of the genes within the lists 
generated by HBCGM. Gene ontology encompasses three major gene attributes, namely biological 
process, molecular function and cellular component. Biological process describes the biological 
objective of the gene via a series of chemical or physical transformations; examples including ‘signal 
transduction’ and ‘cell growth and maintenance’. Molecular function defines the biochemical activity 
of a gene product with examples such as ‘transporter’, ‘ligand’ and ‘enzyme’. Cellular component 
denotes the location where the gene product is active such as ‘ribosome’ and ‘proteasome’. Each one 
of these descriptors can be divided further into more specific terms which extend down to many 
sublevels (54). Gene ontology can be of use when managing vast lists of genes as it categorises each 
gene based on their characteristics and allows them to be sorted into distinct groups. Providing the 
gene list with gene ontology descriptors can aid in deducing the properties the members of the list 
and determine potential effects on the pain phenotype. Employing online tools such as STRING (55) 
and PANTHER (56) enable specific patterns within the data to become more apparent and potential 
target genes can then be identified with greater ease. 
The PANTHER (Protein ANalysis THrough Evolutionary Relationships) classification system is a 
method for sorting proteins based on the three gene ontology descriptors. Genes of interest are 
inputted into the online database (www.pantherdb.org), which then generates pie charts depicting the 
proportion of genes related to the gene ontology terms (56). These charts can then be explored to 
show the breakdown of each category into their sublevels. 
STRING uses known and predicted protein-protein interactions of either physical or functional 
properties. The interactions are generated using genomic context predictions, high-throughput lab 
experiments, conserved co-expression, automated text mining and previous knowledge in databases. 
The database contains information from over two thousand organisms and can find interactions for 
over 9.6 million proteins. This information is accessed via the STRING online database (www.string-
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db.org) to produce figures representing the interactions between the proteins of interest and the 
strength of each interaction based on known data (55). 
3.3.3 BioGPS 
To ascertain further information pertaining to the specific genes from the HBCGM gene list, the 
BioGPS online resource was utilised. BioGPS (www.biogps.org/#goto=welcome) is an online “gene 
portal system” providing a platform for users to access gene annotation resources provided by the 
research community as well as the BioGPS group. The portal houses the “Gene expression/activity 
chart” plugin which was developed by the BioGPS group to utilise data from public sources in 
combination with data produced from the BioGPS team (57). The plugin is maintained by the creators 
and utilises updated MyGene.info gene annotation services to allow matching of user specific queries 
with the corresponding genes (58). With regards to the gene expression plugin, the “GeneAtlas 
MOE430, gcrma” dataset (59) is used to provide details on the prevalence of each gene at certain 
tissue sites. The dataset was developed via oligonucleotide array methods using Affymetrix Genechip 
microarrays, with the degree of fluorescence intensity corresponding to the degree of gene expression 
(60). This plugin was employed to determine characteristics of the gene the list in terms the tissues 
each gene was most predominantly expressed in. Hence, the BioGPS gene expression plugin could 
help distinguish the relevance of specific genes based on their location in certain tissues; an example 
of the gene expression plugin is shown in Figure 1. Tissue expression graphs were created by labelling 
the HBGCM genes with their corresponding tissue; if no clear tissue or data was available, a gene 
was deemed ‘indeterminate’. The purpose of defining single tissue sites for each gene is to describe 
which cell types are most influential in nociception. Segregating each gene via this method enables 
the importance of SNPs to be described in terms of which biological systems is most likely involved 
in pain. Since the gene list was generated based on differences in pain responses, we expect the tissues 
described by the collection of genes to represent the systems involved in nociception. 
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3.3.4 Pain Gene Database 
The Pain Gene Database is a an online tool (www.jbldesign.com/jmogil/enter.html) containing genes 
with known associations with nociception compiled after searching MEDLINE and PubMed using a 
specific search technique (61). This database contains 430 genes which have been investigated for 
their roles in pain in mice models. This list of recognised pain genes was compared with the list of 
genes generated from the HBCGM step. Any genes which were present in both lists was examined 
in more detail to determine suitability for subsequent examination which includes knockout testing. 
Figure 3.1: Example of gene expression plugin from BioGPS for Nedd4l (57). BioGPS is an online platform housing 
gene expression data from the GeneAtlas MOE430, gcrma dataset. Gene expression from this dataset utilises 
Affymetrix Genechip microarrays to determine gene expression intensities at specific tissues. The Nedd4l gene is 
expressed at multiple tissue locations but most clearly within the neurological system, as such it was categorised as a 
“neural” gene. 
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A literature review was conducted for each gene to further establish their potential implications in 
nociception (Appendix 4). 
3.4 RESULTS 
3.4.1 HBCGM allows flagging of genes with relevant SNP variations and potential contribution 
to ciguatoxin-induced pain 
The flinching and licking data was processed with HBCGM and a list of genes sorted based on their 
correlation to the phenotype of the mouse strains was generated (Figure 3.2). In essence, the table 
contains genes in order of their likelihood to explain the phenotype distribution between the various 
mouse strains, with the list being limited based on a p-value cut-off of 0.01. The chromosome number 
and position on that chromosome was also included for each gene. The initial lists of genes contained 
2668 items for the flinching data and 3248 items for the licking data. Once the non-coding genes were 
removed, the resultant lists yielded 422 genes for the flinching data (Appendix 1) and 683 genes for 
the licking data (Appendix 2). When comparing the similarities between the two lists, 148 genes were 
found to overlap between the two pain reactions (Appendix 3), demonstrating a total of 957 genes 
with 809 being unique to either flinching or licking (Figure 3.3). Many genes found from HBCGM 
were produced from the licking data, having the largest contribution to the gene list with 56% of 
genes specific to the licking gene list only. Several genes have been strongly correlated with the 
variation seen with phenotypic data for flinching and licking reaction in ciguatoxin-induced pain, any 
of which may play a vital role in the nociceptive pathway. 
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Figure 3.3: Proportion of genes from flinching and licking lists as 
well as the overlapping genes. The gene list contained subjects with 
p-values of 0.01 or lower. The total number of non-overlapping genes 
is 809. 
 
3.4.2 PANTHER gene ontology associates specific roles to potential genes involved in pain 
perception 
Graphs generated with the PANTHER gene ontology tool for flinching and licking gene lists were 
used to determine the functional and structural features of the entire group of genes. Molecular 
function characteristics for flinching genes (Figure 3.4) involved mainly catalytic activity (39%) and 
binding roles, (31%). Within the catalytic activity child category, the majority of genes possessed 
 
Figure 3.2: Example of gene list for flinching data with non-coding regions removed. Each gene name was 
coloured according to its effect of the amino acid sequence, such that orange indicated significant changes, yellow 
indicated minor changes, and blue (not shown) indicated splice site changes. The haplotype block for each mouse strain 
were also colour coded, denoted by the colours red, blue, green, orange and pink in order of how common the haplotype 
block is; the red signifies the common haplotype, while the blue signifies the second most common and so on, with 
pink being the least common haplotype. 
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hydrolase activity (50.4%) or transferase roles (26.4%). For the binding category, a sizeable 
proportion of genes participated in protein (57.5%) and nucleic acid binding (32.2%). This is also 
quite similar with licking genes (Figure 5), where catalytic activity (34.2%) and binding (30.7%) 
contributed a similar degree of roles. Hydrolase (39.1%) and transferase (25.9%) activities appeared 
to be the predominant types of catalytic functions for licking genes, though at a small percentage of 
hydrolase activity than that for flinching genes. Binding functions also consisted of the same 
categories with protein (45.9%) and nucleic acid binding (42.9%) being characteristic of most licking 
genes in proportions similar to flinching genes. 
Regarding biological processes, flinching genes (Figure 3.6) had roles consisting of mainly cellular 
(28.0%) and metabolic (24.1%) processes. Cellular processes pertaining to flinching genes included 
cell communication (63.2%) and cell cycle (15.8%). Metabolic processes were predominantly 
composed of primary metabolic processes (50.2%) and a smaller role of nitrogen compound 
metabolic processes (17.5%). As for licking genes (Figure 3.7), the distributions of these roles were 
almost identical, with cellular (25.4%) and metabolic (22.9%) processes having the largest 
proportions of genes. The child categories also mirrored the numbers of flinching genes, including 
cell communication (65.8%) and cell cycle (16.2%) as the two most common cellular processes and 
primary metabolic (50.1%) and nitrogen compound metabolic processes (16.4%) as the two principal 
categories within the metabolic process family. 
The cellular component graph for flinching genes (Figure 3.8) described most genes as having cell 
part (34.1%), organelle (22.7%) and membrane (21.3%) involvement. The cell part child category 
consisted of mainly intracellular (68.0%) and plasma membrane (25.2%) components. The nucleus 
(28.6%) and cytoskeleton (18.4%) were the two most common organelles involved for flinching 
genes. There was some overlap between the membrane and cell part categories as the membrane child 
category also consisted of plasma membrane (51.0%), with structures integral to the membrane 
(35.3%) being the second item. Again, licking genes had the same predominating categories for 
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cellular components, however the proportions for cell part (36.2%), membrane (23.2%) and organelle 
(20.1%) were dissimilar. Cell part was made up of chiefly intracellular (68.0%) and plasma membrane 
(29.4%) components, very similar to that of flinching genes. Organelles proportions were greater 
amongst licking genes with nucleus (33.9%) and cytoskeleton (22.0%) involvement being larger than 
flinching genes. The membrane child category also overlapped for licking genes with plasma 
membrane (47.9%) and components integral to membrane (47.9%) having equal distribution. 
The major use of the percentages of the roles of genes is to gain a better understanding of the 
collection of genes being examined, therefore, the most important findings from these graphs are the 
descriptions given to the gene lists. Both flinching and licking genes involved in pain had 
characteristics including catalytic and binding roles which may be contribute to cell communication 
or primary metabolic processes involving the plasma membrane or intracellular structures such as the 
nucleus. 
Flinching Molecular Function Pie Chart
Figure 3.4: Molecular function PANTHER pie chart for flinching. PANTHER is a gene ontology tool which 
categorises a collection of genes into the three gene ontology descriptors and their subcategories. Predominant 
categories for flinching genes include catalytic activity and binding. 
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Licking Molecular Function Pie Chart 
Figure 3.5: Molecular function PANTHER pie chart for licking. Predominant categories for licking genes include 
catalytic activity and binding. 
 
Flinching Biological Process Pie Chart 
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Figure 3.6: Biological process PANTHER pie chart for flinching. Predominant categories for flinching genes 
include cellular process and metabolic process. 
 
Licking Biological Process Pie Chart 
Figure 3.7: Biological process PANTHER pie chart for licking. Predominant categories for licking genes include 
cellular process and metabolic process. 
 
Flinching Cellular Component Pie Chart
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Figure 3.8: Cellular component PANTHER pie chart for flinching. Predominant categories for flinching genes 
include cell part, organelle and membrane. 
 
 
Licking Cellular Component Pie Chart 
Figure 3.9: Cellular component PANTHER pie chart for licking. Predominant categories for licking genes include 
cell part, organelle and membrane. 
 
3.4.3 BioGPS Gene Expression Plugin 
In a similar manner to the PANTHER pie charts, the BioGPS gene expression plugin was employed 
to extract specific characteristics from the gene list, however using their presence at certain tissues 
instead of gene ontology (Figure 3.10). Genes from both flinching and licking data were mainly 
labelled as indeterminate as almost a third of the population for each trait contributing to this category; 
the percentage of genes for flinching (33%) was nearly identical to that of licking genes (31%). The 
three next most common tissues found to accommodate these genes were immune, neural and male 
related tissues. Immune tissues include cells in both innate immunity, such as macrophages and NK 
cells, as well as those involved in adaptive immunity, such as B cells and T cells (57). The proportion 
of flinching genes (18%) for this group was only slightly higher than numbers of licking genes (16%). 
Neural tissues include both the peripheral nervous system, such the dorsal root ganglion, and the 
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central nervous system, such as the cerebral cortex and spinal cord (57). For this group, licking genes 
(9%) presented with a slightly higher percentage than flinching genes (7%). Male tissues were chiefly 
composed of the testis and prostate (57), with flinching (7%) and licking (8%) having similar 
contributions to this tissue. Each of the remaining tissue sites comprised individually of 5% or less 
each, and the contribution of each tissue to the total amount of genes was not very substantial. 
Although the four most common sites for flinching and licking traits were identical, the remaining 
tissues displayed varying proportion between the two phenotypes.  
Flinching Gene Tissue Distribution Licking Gene Tissue Distribution 
Figure 3.10: Tissue distribution pie charts for flinching and licking genes from BioGPS gene expression plugin 
(57). 420 genes were examined from the flinching gene list and 678 genes from the licking gene list.  
 
3.4.4 STRING networks utilisation to display relationships between proteins 
To visualise associations between genes assumed to have associations with variation in ciguatoxin-
induced pain, networks displaying protein to protein interactions via STRING were constructed. Each 
line represents the confidence of the relationship based on known data, with thicker lines indicating 
greater confidence. As it is possible for the genetic cause for the variation seen in pain responses to 
contain a complex pathway involving multiple genes, it is important to recognise how individual 
genes relate to one another. From the flinching trait (Figure 3.11), a few large clusters containing at 
least four individual proteins exist. The largest structure contains a couple of interesting proteins such 
as Oprm1 (opioid receptor mu 1) and Nmur2 (neuromedin-U receptor 2), which also connects to other 
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proteins including Apc, Cdh1, Rgs5, Prdm2 and Etv6; the Apc gene being the central protein 
connecting the cluster of proteins together. Another sizeable cluster comprised of five proteins has 
the members Igdcc3, Myo7a, Obscn, Rhobtb3 and Uhmk1. Within the licking network (Figure 3.12), 
Obscn is also present, and appears to be included in the largest cluster comprised of 15 proteins, with 
Itgb4 (integrin beta 4) having an essential role in connecting this group of proteins consisting of 
Arhgap30, Cd48, Col6a4, Col6a5, Col6a6, Cyth3, Erbb4, Gnat1, Itgb4, Lamb2, Msi2, Obscn, 
Sema3f, Spna1 and Rhobtb3. Other genes present in both networks include Etv6 (ETS variant 6), 
Fancc (Fanconi anaemia complementation group C) and Olfr414 (olfactory receptor 414). 
Figure 3.11: STRING network for flinching genes. STRING is a tool which is used to visualise the protein-protein 
interactions between a collection of genes. Interactions are determined from genomic context predictions, high-
throughput lab experiments, conserved co-expression, automated text mining and previous knowledge in databases. 
First 200 genes selected to produce a diagram of manageable size. 55 proteins with at least one connection remained 
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as disconnected nodes were not displayed. Lines indicate confidence, the thicker the line the stronger the data support. 
Minimum required interaction score set at medium confidence (0.400). Disconnected nodes not displayed. 
 
Figure 3.12: STRING network for licking genes. First 200 genes selected to produce a diagram of manageable size. 
41 proteins with at least one connection remained as disconnected nodes were not displayed.  Lines indicate confidence, 
the thicker the line the stronger the data support. Minimum required interaction score set at medium confidence (0.400). 
Disconnected nodes not displayed. 
 
3.4.4 The Pain Gene Database used for correlation with HBCGM gene lists 
The Pain Gene Database contains 430 genes found in literature describing their roles in nociception 
(61). By comparing the database with the flinching and licking gene lists, five established pain genes 
were found to correlate with the HBCGM genes. Four genes were matched from the flinching genes: 
Nedd4l, Nmur2, Il1r1 and Nf1; and one gene was matched from the licking genes: Bdnf (Table 3.1). 
A literature was conducted to examine the potential roles of each gene and its role in pain perception 
(Appendix 4).  
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Gene P-value Tissue Gene Ontology
Nedd4l 0.000013 Neural Molecular Function 
Biological Process 
 Cellular process 
 Metabolic process 
 Primary metabolic process 
 Protein metabolic process 
Cellular Component 
 Cell part  
 Intracellular 
 Cytoplasm
Nmur2 0.000013 Indeterminate Molecular Function 
 Receptor activity 
Biological Process 
 Biological regulation 
 Homeostatic process 
 Cellular process 
 Metabolic process 
 Primary metabolic process 
 Carbohydrate metabolic process 
 Multicellular organismal process 
 Response to stimuli  
 Response to stress 
Cellular Component 
Bdnf 0.00098 Neural Molecular Function 
 Binding 
 Protein binding 
 Receptor binding 
Biological Process 
 Biological regulation 
 Regulation of biological process 
 Negative regulation of apoptotic process 
 Cellular component organisation or biogenesis 
 Cellular component organisation 
 Cellular component morphogenesis 
 Cellular process 
 Cell communication 
 Cell-cell signally 
 Signal transduction 
 Developmental process 
 Cell differentiation 
 System development 
 Nervous system development 
 Multicellular organismal process 
 Response to stimulus Response to stress 
Cellular Component 
 Cell part  
 Intracellular 
 Cytoplasm  
 Organelle 
 Cytoplasmic membrane-bounded vesicle 
Il1r1 0.0081 Indeterminate Molecular Function 
 Receptor activity 
Biological Process 
 Cellular process 
Cellular Component 
Nf1 0.0053 Indeterminate Molecular Function 
 Catalytic activity 
 Enzyme regulator activity 
 Enzyme activator activity 
 Small GTPase regulator activity 
 Hydrolase 
 GTPase activity 
 Pyrophosphatase activity 
Biological Process 
 Cellular process
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 Cell communication 
 Signal transduction 
 Metabolic process 
 Catabolic process 
 Nitrogen compound metabolic process 
 Phosphate-containing compound metabolic process 
 Primary metabolic process 
 Nucleobase-containing compound metabolic 
process 
 Response to stimulus 
Cellular Component 
 Cell part  
 Intracellular 
 Cytoplasm 
 Plasma membrane 
 Membrane 
 Plasma membrane
 Table 3.1: Genes from HBCGM matched with the Pain Gene Database. Established pain genes with matched p-
values from HBCGM shown. Predominant tissue and gene ontology descriptors are included. 
 
3.5 DISCUSSION AND CONCLUSIONS 
The set of genes generated from HBCGM signify the correlation between known genetic differences 
between a diverse group of mouse strains and the observed variations seen in nociception of these 
strains. The list essentially labels genes with their association to the pain phenotype based on their 
SNP profiles. Presence of a gene in the list merely suggests a SNP variation in the gene could be 
involved in the altered pain responses seen and manipulating the SNP could potentially produce a 
distinct change in these pain behaviours. The strength of the correlation does not necessarily translate 
directly to causation; it can only be used to suggest that a gene has a higher likelihood of being 
implicated in the variation of ciguatoxin-induced spontaneous pain. A large quantity of genes was 
generated using the phenotype data for flinching and licking, however the overlap between the two 
responses was only equal to 15% of the total number of individual genes between both lists. This 
finding further advocates that flinching and licking pain responses are two unrelated reactions seen 
in mice and the underlying genetic influences for these reactions are likely separate. On the other 
hand, the lack of congruency may suggest that the HBCGM technique allows for too many false 
positives to be included, causing genes with little relevance to pain to be associated with nociception. 
Selecting specific targets from the extensive list of candidates is a challenging task and the ideal 
method for determining the effect of each individual gene is to knockout each gene and observe the 
outcomes; however, this approach is impractical, and a more feasible method is to look for clues and 
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patterns which could direct attention to potential target genes. To filter through the vast number of 
genes produced from the phenotype data, various methods were implemented to describe and find 
meaning in the array of information produced from HBCGM and help determine if specific genes or 
gene clusters have influential roles in the perception pain in mice.  
The tissue expression pie charts helped characterise which sites have importance in to processes 
involved with spontaneous pain. The findings from both flinching and licking figures correspond 
strongly to each other, demonstrating a clear predominance of the same tissue sites over others. Most 
genes could not be attributed with a single tissue site since it was common for genes to be expressed 
at a multitude of tissues, and approximately a third of flinching and licking genes did not fall neatly 
into a specific category. Labelled as indeterminate, it is difficult to determine how much of an effect 
these gene have on individual tissues as higher levels of expression may not necessarily translate to 
higher levels of activity. This creates problems when attempting to deduce which tissues are 
influenced by certain genes since their effects at each site are uncertain. In contrast, genes which were 
obviously expressed at a single site can be used to direct the search towards a specific location to 
pursue further, making it possible to narrow down the immense number of genes being considered. 
Although a drawback to this method is that it ignores the importance of genes expressed ubiquitously 
which may have critical roles in nociception, these genes are not helpful for refining genes into 
specific sites where further exploration can be directed. 
When focussing on genes with single tissue predominance, the distribution for both flinching and 
licking genes seems to favour immune, neural and male-related cell; these three types contributing to 
many sites identified. Having a substantial percentage of genes related to the immune or neural system 
will potentially focus the search for pain specific genes or clusters of genes within these two systems 
as they both have known implications in nociception. The notion that potential targets exist in these 
systems does is not surprising as pain transmission is mainly coordinated by cells within the nervous 
system, while immune cells are known have pain modulating effects (62). Interestingly, immune 
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tissues yielded higher proportions compared with neural tissues, despite the understanding that the 
nervous system is the major component of the pain system. Inflammatory mediators are secreted via 
immune cells and impact multiple aspects of the nervous system including neurones, glial cells and 
neurotransmitters. Hence, the immune system has effects on the sensitivity of nociceptive pathways 
and has also been documented to lessen pain via analgesic and anti-inflammatory mediators (62).  
The other relevant finding from tissue expression graphs is the high proportion of male-related cells, 
which is placed as the fourth most common tissue site after neural tissues. As mentioned in the 
previous chapter, no clear difference was seen between males and females in terms of phenotype 
observation, therefore this finding reintroduces the issue that gender differences in mice may have 
influences of nociception. From previous pain studies involving mus musculus, it was found that 
female mice had increased sensitivity to noxious stimuli and male mice had greater responses when 
administered μ-agonists (63). This occurrence was attributed to the effects on sex steroids on 
morphine analgesia, with testosterone causing increased analgesia via its activating effects and 
oestriol leading the opposite by decreasing the efficacy of analgesia (63). The proportion of male-
related genes correlated with ciguatoxin-induced pain signifies that these genes may have roles in 
nociception in mice, such that altering these genes could increase or decrease the pain response in the 
subjects. Unfortunately, observation did not demonstrate a notable difference between male and 
female pain behaviours in the mouse subjects, therefore, it cannot be determined how genes affecting 
male tissues will alter nociception. Despite finding no difference between the two genders in this 
study, genetic alterations within gender specific genes may still exist since male genes appear to 
correlate with pain to some degree and their identity could be another avenue to explore in future 
projects. 
Although many other genes are located at various other sites, finding a notable target is more likely 
in areas with larger numbers of genes correlating to the pain phenotype measured are expressed. This 
process relies on probability to concentrate the search for potential pain genes towards tissues 
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associated with the flinching and licking phenotypes. It appeared that both flinching and licking genes 
had identical locations for the most common tissues despite having divergent observed pain 
behaviours. To delineate whether this finding was coincidental or representative of non-pain genes 
as well, a randomised sample of 601 genes were selected from the entire mus musculus genome to 
determine the native percentage of genes attributed to each tissue site (Appendix 5). When compared 
to the flinching and licking graphs, the sample representing the genome showed very similar 
percentages for the four most common tissues in practically the same sequence as well. This discovery 
undermines the usefulness of examining the specific tissue sites of putative genes, as it was assumed 
that physiological systems involved in pain would contain larger numbers of genes correlated to pain. 
The finding that genes which have not been associated with pain produce a similar tissue distribution 
to those found via the pain phenotype data with HBCGM means expression of genes at specific tissue 
locations is not a promising approach to refine targets and that the genes populating immunological 
and neurological tissues found in this study cannot be considered as potential pain genes solely based 
on tissue expression data. The only finding that can be reasoned is that genes related to ciguatoxin-
related nociception can be expressed at any body site and other methods must be sought to support 
their potential roles in pain. 
The other method used to examine the gene lists was via the PANTHER classification system, which 
allowed for further analysis based on the three main gene ontology categories: molecular function, 
biological process and cellular component. When attempting to isolate the pertinent descriptions 
within these categories, the results of flinching and licking sets seem to mirror one another quite 
similarly. 
Within the molecular function category, no noteworthy difference in the distribution of the various 
functions was seen between flinches and licks. Both pain reactions possessed genes favouring 
catalytic activity and binding, with some contribution from receptor activity. Within the catalytic 
activity category, it appeared that hydrolase activity and transferase activity are the most prevalent 
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subcategories describing the genes. Interest in hydrolase enzymes and their role in pain has been 
growing over the last couple decades due to their relationship with endogenous bioactive lipids which 
include epoxy fatty acids (EFAs) and fatty acid amides (FAAs) (64, 65). The endocannabinoid system 
is the target of such lipids, with studies outlining interest in cannabinoid receptor type 1 (CB1) 
receptors for their role in analgesia. Direct CB1 agonists such as tetrahydrocannabinol (THC) have 
been shown to have analgesic effects, however unwanted systemic effects on cognition and motor 
control have made their use impractical. A promising method involves augmenting the effects of 
endocannabinoids by reducing the breakdown of endogenous agonists and aims to increase 
“endocannabinoid tone” and avert the unwanted effects associated with the use of exogenous 
compounds (64, 65). Fatty acid amide hydrolase (FAAH) is responsible for removal of endogenous 
cannabinoids, and reversible inhibition of these hydrolase enzymes has proven to increase the 
concentration of FAAs in the CNS and produce analgesic effects in multiple rodent pain models (65, 
66). In addition, the blockade of FAAH has not shown to produce the undesirable psychomimetic 
effects associated with THC (67). This finding was also supported by a study utilising FAAH 
knockout mice, which experienced a decreased response to pain via both analgesic and anti-
inflammatory effects (68). Examples such as these support the importance of hydrolase systems in 
nociception and the findings that hydrolase activity may be implicated in the variation seen between 
mouse strains in terms of ciguatoxin-induced pain draws light towards the idea that potential target 
genes could have hydrolase activity. 
Transferase activity was also flagged as a common description for flinching and licking genes, and 
an example of a gene with transferase roles in pain is Comt. Catecholamine-O-methyltransferase 
(COMT) is a soluble and membrane bound enzyme responsible for the governance of extracellular 
catecholamine levels in prefrontal brain areas and peripheral tissues (69). A study demonstrated that 
in the absence of COMT activity, such as in homozygous Comt knockout mice, increased pain 
sensitivity was experienced in terms of tail flicks (70). The introduction of exogenous COMT 
inhibitors have also been responsible for increased thermal and mechanical pain responses when 
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administered systemically (71). A distinct SNP has been of interest in terms of chronic pain which 
involves the val158met polymorphism and has been featured in multiple articles outlining its role in 
fibromyalgia (69, 72). The change from valine to methionine renders the COMT enzyme less 
thermostable in physiological condition, resulting in up to four times reduction in activity (73, 74). 
The consequence of this reduction is a diminished capacity to stimulate μ-opioid receptors in the 
presence of a painful stimulus due to decreased concentrations of endogenous enkephalin. This is 
thought to be the result of unopposed activation of dopaminergic receptors since dopamine is 
normally metabolised by COMT, leading to decreased neuronal enkephalin and compensatory 
changes in μ-opioid receptor binding (74). The net outcome of these changes is increased pain 
sensitivity, supporting the theory that transferase activity may be implemented in nociception.  
The most important types of binding within the binding parent category have been shown to be 
proteins and nucleic acids. This finding is quite generalised and is only useful to show that proteins 
and nucleic acids are the most likely macromolecules to be implemented in pain. The biological 
processes described for flinching and licking gene lists depicted cellular and metabolic processes as 
the most common processes related in both phenotypes. The major subcategory within cellular 
process was cell communication, and this seemed to be appropriate when relating to pain, compared 
to the other subcategories such as cell cycle. The cell communication subcategory included actions 
such as signal transduction and cell-cell signalling, which are important mechanisms required for 
transferring information within the body, such as for pain responses. 
The major component of the metabolic process parent category was primary metabolic processes, 
which encompasses macromolecule metabolism such as nucleotides and proteins. As mentioned for 
the binding category, there are an extensive range of protein and nucleotide-containing compounds 
and pinpointing a specific interest from this broad finding is unlikely. The deduction from this result 
is that the gene list may be narrowed down based on selecting genes involved in primary metabolism 
of macromolecules, however doing so may not filter the compilation drastically. 
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The last gene ontology term, cellular component, also depicts comparable results between flinching 
and licking genes. For both phenotypes, cell part is the most common parent category, which 
comprises of mainly intracellular components, which is also very non-specific and not particularly 
helpful in screening the gene lists since it denotes all structures within the cytoplasm. The plasma 
membrane has also been noted to be a common structure involved with the gene lists, suggesting that 
proteins involved may also reside within the membrane of cells. The organelle child category labels 
the nucleus as the most prevalent site for genes, which may suggest that the downstream effects of 
potential SNPs may affect expression of genes within the nucleus. 
As with the tissue expression graphs, flinching and licking genes appears to follow a similar pattern 
when comparing the proportions of the PANTHER pie charts. The entire mouse genome was 
examined to contrast the results of the supposed pain genes against the genes in mus musculus 
(Appendix 5). The resulting PANTHER charts presented a few noteworthy differences for each of 
the three gene ontology categories. For molecular function, the genome appeared to have a lower 
representation for catalytic activity compared to flinching genes, while licking remained similar in 
distribution. This could infer that functions such as hydrolase and transferase activity may in fact be 
more prevalent amongst genes with roles in nociception. Flinching genes also showed a greater 
preference for cellular and metabolic processes compared to the entire genome, however this finding 
was not shared by licking genes which only showed a slightly higher proportion for metabolic 
processes. The difference further supports the finding that features such as cell communication and 
primary metabolic processes may be common roles amongst pain genes. Lastly, the cellular 
component term showed a noticeable increase in the contribution for the membrane category for both 
flinching and licking genes, meaning that pain genes may be more likely to be involved in membrane 
processes. 
Gene ontology has established its usefulness in characterising the roles of a group of genes, making 
it a useful tool in deciphering potential functions of putative genes, however its usefulness is marred 
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by the considerable number of genes with unknown functions. The total number of hits for the three 
gene ontology terms ranges from 26% to 60% of the total number of possible genes, which also 
includes genes falling into more than one categories. This underrepresentation of the entire genome 
creates difficulty in signifying which functions are important for potential pain genes. The 
predicament was also an issue for the tissue expression graphs, limiting the effectiveness of both 
methods due to the shortfall in knowledge available on each gene. Genes lacking information on 
location and function were discounted as being unimportant in pain perception as it was impossible 
to determine the true effects of the gene, effectively secluding these genes from the rest of the 
analysis. This issue also affects the STRING analysis, which relies on protein to protein interactions 
which have been established in the literature, also excluding proteins of unknown significance.  
The STRING diagrams attempt to connect individual genes with associated roles to demonstrate the 
presence of gene clusters with plausible roles in pain pathways. It is highly probable that nociception 
is a product of more than a singular gene, therefore, investigating interactions between genes is a key 
step in ascertaining the likely causes for pain behaviour variation are. The network for flinching genes 
determined in this study is interesting as the largest network contains two proteins with known roles 
in pain regulation, Oprm1 and Nmur2. Contrarily, the other members of the network (Apc, Cdh1, 
Rgs5, Prdm2 and Etv6) appear to be from independent systems such as tumour suppressor roles. (57) 
The largest network for licking genes contains 15 proteins (Arhgap30, Cd48, Col6a4, Col6a5, Col6a6, 
Cyth3, Erbb4, Gnat1, Itgb4, Lamb2, Msi2, Obscn, Sema3f, Spna1 and Rhobtb3), however the 
individual roles for the proteins pertain to the immune system, collagen, protein trafficking, vision, 
and cardiac sarcomere assembly (57). The idea of identifying a cluster of pain genes from a list of 
possible genes is desirous feat and the likely strength of this method would be examination of the 
protein interactions of a specific gene after a known gene has already been identified and further 
characterisation is required. Searching for pain genes without any known starting points breeds 
immense difficulty and a more appropriate technique may be to re-examine the protein interactions 
once a putative pain gene is identified. 
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The HBCGM gene lists were contrasted against established pain genes found on an online database 
to confirm if known pain genes had a presence within the flinching and licking gene lists being 
examined. Of the 430 genes registered in the Pain Gene Database, five genes with known association 
with nociception corresponded with genes found from HBCGM. The role of each gene in pain 
pathways was examined and each gene was examined for any potential contributions to ciguatoxin-
induced pain. Given that the mechanism of ciguatoxin primarily involves NaV channels, the Nedd4l 
gene appears to be most likely to have an influence on the mode of action of ciguatoxin due to its 
associations with Nav1.7 and Nav1.8 trafficking (75, 76). It was decided to further investigate Nedd4l 
as putative pain gene given that it may have solitary effects on ciguatoxin-induced nociception.  
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4. CHAPTER FOUR: Nedd4-2 and ubiquitination of voltage-gated 
sodium channels 
4.1 FOREWORD 
Haplotype-based computational genetic mapping is a technique which allows for identification of 
genetic correlation between genes of an explicit SNP distribution and a specific phenotype in 
question. By examining the possible genetic targets generated by this method, it is possible to 
recognise a contributing gene which may be implicated in nociception. As outlined in Chapter 3, the 
array of potential candidates produced from the method is vast and selecting an individual gene to 
interrogate is a challenging task since many occult interactions between genes blurs the singular effect 
of distinct genes. However, the NEDD4-2 gene (otherwise known as NEDD4L) has stood out as a 
likely gene with possible ramifications in ciguatoxin-induced spontaneous pain, and its role should 
be further explored. To achieve this, the effects of NEDD4-2 on nociception and the consequences of 
SNP alterations will be investigated; in addition, knockout mice will be utilised to characterise the 
phenotypic changes in the absence of the gene. 
I would like to acknowledge Sharad Kumar from the University of South Australia for providing the 
Yang Nedd4-2 KO mice and Jennifer Deuis from the University of Queensland for their technical 
assistance with the animal preparation and experimental steps of this project. 
4.1. INTRODUCTION 
The NEDD4 (Neuronally Expressed Developmentally Downregulated 4) family of genes encodes 
HECT (homologous to the E6-AP Carboxyl Terminus) E3 ubiquitin ligases, with Nedd4-2 expression 
predominantly involving the kidney, liver and brain (77). The expression of Nedd4-2 in the DRG is 
of particular interest as high levels of NEDD4-2 activity in this area has been shown to impact on 
nociception (78). Nedd4-2 has been associated with the regulation of NaV expression and trafficking, 
with NaV1.7 and NaV1.8 being selectively downregulated in neurons where NEDD4-2 levels have 
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been overexpressed (75, 76). The mechanism for this regulation is believed to be executed via the 
ubiquitin associated processes controlled by NEDD4-2 E3 ubiquitin ligase expression (79). 
Ubiquitination is a process for marking membrane 
proteins for internalisation and degradation. The 
ubiquitin molecule itself is a highly conserved 
polypeptide consisting of 76 amino acids (Figure 4.1), 
seven of which are lysine residues capable of linking 
with other ubiquitin molecules to form chains (75). A 
target protein can have one ubiquitin molecule attached 
to a single lysine residue (monoubiquitinated), one ubiquitin molecule attached to multiple lysine 
residues (multi-monoubiquitinated) or have a chain of ubiquitin attached to a lysine residue 
(polyubiquitinated) (75, 77). 
The mechanism of ubiquitination requires three consecutive steps involving three distinct enzymes 
(Figure 2). The first step implicates the ubiquitin molecule to be activated by ubiquitin activating 
enzyme (E1). The following step involves transferring the activated ubiquitin to a cysteine residue 
found on ubiquitin conjugating enzyme (E2). The last step is the binding of ubiquitin ligase (E3) to 
the E2 ubiquitin conjugating enzyme and the activated ubiquitin, which ultimately transfers the 
ubiquitin molecule onto the lysine residue on the target protein. All three stages are essential for this 
process, although substrate specificity is determined by the E3 ligase enzyme which recognises 
specific motifs located on proteins (75, 77). The attachment of ubiquitin necessitates recognition of 
proline-rich PY motifs (PPxY) found on target proteins via a tryptophan (WW) domain found on E3 
ligases. The subsequent outcome of a ubiquitinated protein depends on the manner of conjugation as 
well as the number of ubiquitin moieties attached. Degradation can occur via three pathways: via the 
proteasome, the endoplasmic reticulum or lysosomes (77). The ubiquitin protease system is important 
for regulating the population of membrane proteins as insertion must be balanced with removal, which 
Figure 4.1: Structure of ubiquitin (80). 
Ubiquitin is a compound used for marking 
specific protein and is composed of alpha helices 
(blue), beta sheets (green) and lysine residues 
(yellow).
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is why adequate NEDD4 functioning has been found to crucial for proper neuronal development and 
function in the brain (75, 77). 
Figure 4.2: KEGG pathway for ubiquitin mediated proteolysis in humans (81). The process of ubiquitin mediated 
proteolysis is a three step enzymatic process involving the recognition of target substrates and ultimately the recycling 
of targeted membrane proteins. Genes implicated in E1, E2 and E3 enzymes are shown in green. E3 ubiquitin ligases 
are involved in substrate specificity and exists in three distinct subtypes: HECT type U-box type and single RING-
finger type. The Nedd4 gene is implicated in HECT type ubiquitin ligases (highlighted in red). 
 
NEDD4 proteins comprise of a calcium-phospholipid-binding domain (C2), three to four tryptophan 
(WW) modules and a catalytic terminal HECT domain. This structure is highly preserved across 
eukaryotes with the only variance being the number of WW modules (75, 77). The HECT domain is 
a 350 amino acid section of the NEDD4 protein responsible for transferring the ubiquitin molecule 
from a conserved cysteine residue on the carboxyl end to the lysine residue of the target substrate 
(75). WW domains are 35-40 amino acid structures containing tryptophan residues found 21 amino 
acid residues apart and a hydrophobic core surrounded by beta-sheets, in a structure that 
communicates with the PY motifs in target proteins. Not all WW domains are equal, as it has been 
suggested from in vitro studies that WW3 and WW4 are most commonly employed domains for 
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substrate recruitment (75, 77). The number of WW areas between species is also variable, with the 
mus musculus E3 ubiquitin ligase containing three WW domains (Figure 3) as opposed to the human 
variant which has four (82). 
 
 
1WR3 (First WW domain) 
r221-254 
1WR4 (Second WW domain) 
r414-447 
1WR7 (Third WW domain) 
r525-560 
Figure 4.3: Solution structures of the three WW domains of NEDD4-2 in mus musculus from the Research 
Collaboratory for Structural Bioinformatics Protein Data Bank (82). WW domains are the active components of 
the ubiquitin ligase enzyme responsible for substrate recognition. 
 
In mouse models, homozygous Nedd4-2 knockouts (Nedd4-2 –/–) have been associated with perinatal 
mortality due to respiratory failure, therefore have not been a suitable model for testing nociception. 
Despite having only half the level of expression, heterozygous Nedd4-2 +/– mice have been shown 
to have increased sensitivity to formalin-induced inflammation, meaning this model would be useful 
in testing the impact of Nedd4-2 on pain perception (79). The effects of Nedd4-2 in humans is less 
established than in animals, however a few extrapolations can be made animal studies as the structure 
of Nedd4-2 is highly conserved within vertebrates as shown via phylogenetic analysis (83). Within 
the human genome, hundreds of E3 proteins exist, which all display varying specificities to a vast 
number of substrates. These proteins can be grouped as RING (really interesting new gene) and 
HECT families, where the minority of E3 proteins fall within the HECT group. NEDD4 contributes 
the largest portion of members in the HECT family, constituting nine members (84). In humans, the 
Nedd4-2 gene is situated on chromosome 18q21.31 and is expressed in various tissues, principally 
the kidneys, lungs, heart and liver (84). 
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The first and most well characterised target for Nedd4-2 is the ENaC (epithelial Na cotransporter) 
channel found in the respiratory and gastrointestinal systems, but most notably in the distal 
convoluted tubules of the kidney (75, 77, 84). Trafficking of ENaC proteins via endocytosis and 
degradation has been shown to be regulated by Nedd4-2-mediated ubiquitination. Heightened ENaC 
activity can be induced by loss of Nedd4-2 regulation in mice, which consequently leads to poor lung 
development secondary to early fluid clearance and eventually perinatal death (85). ENaC 
hyperactivity has also been demonstrated in Liddle’s syndrome, where altered NEDD4-2-mediated 
ENaC trafficking in the kidney leads to hypertension secondary to sodium retention (84). Currently, 
the known manifestations of Nedd4-2 in human disease are still left to be explored, with only a 
handful of effects being characterised. A couple of studies have described the role of Nedd4-2 in 
hypertension, explaining that specific SNPs can lead to essential hypertension depending on a 
person’s ethnicity (86, 87). The effects of Nedd4-2 have also been linked with numerous oncological 
diseases in humans, with altered levels of expression seen in prostate, lung, gastric, hepatobiliary, 
pancreatic, brain, blood and skin cancers, although this interaction has not been shown in vivo (84). 
The influence of Nedd4-2 on pain perception has yet to be fully investigated and the potential for the 
gene to be involved in human pain syndromes requires further attention. 
Nedd4-2’s involvement in the regulation of ion channels is of great interest, as it includes influences 
on voltage-gated sodium channels and potassium channels (42). In the mature DRG, Nedd4-2 has 
been shown to control the cell-surface levels of NaVs and was also downregulated in a spared nerve 
injury (SNI) neuropathic pain animal model (76). Of the nine NaVs, seven channels (NaV1.1, 1.2, 1.3, 
1.5, 1.6, 1.7 and 1.8) display the PY motif which is recognised by NEDD4-2, and all seven have been 
shown to be ubiquitinated and downregulated by NEDD4-2 except for NaV1.1 (88). Interference with 
the PY motif has been shown to avert the effects of NEDD4-2 as observed during experimentation 
with NaV1.8. (75). At this stage, there is sparse data related to Nedd4-2 in human pain syndromes, 
however involvement of Nedd4-2 in the regulation of animal NaVs and voltage-gated potassium 
channels such as KCNQs has shown the potential for altered nociception secondary NEDD4-2 
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modification (84). In Xenopus oocytes, NEDD4-2 and serum and glucocorticoid-regulated kinase-1 
(SGK-1) co-expression has been associated with changes in neuronal excitability via the governance 
of voltage gated KCNQ2/3 and KCNQ3/5 channels (89). An example of this interaction involves 
NEDD4-2 inactivation by SGK-1, resulting in increased levels of KCNQ3 on membrane surfaces and 
increased potassium currents (90). It is therefore crucial to gain a better understanding of the effects 
of Nedd4-2 SNPs as they seem to have important roles in trafficking, expression and consequently 
the function of NaV and KV channels. 
Recapping the effects of ciguatoxin, the compound is already known to cause membrane 
depolarisation via both TTX-sensitive NaV channels such as NaV1.7 as well as TTX-resistant NaV 
channels such as NaV1.8 (41). P-CTX-1 has also been shown to inhibit the activity of voltage-gated 
potassium channels (KV) in the DRG, in particularly the delayed-rectifier (KDR) and transient ‘A-
type’ (KA) subtypes, which alters action potential firing thresholds and resting membrane potentials 
(42). The effects of sodium channel depolarisation and potassium channel blockade are thought to 
work in union to hyperpolarise the threshold of NaV activation and depolarise the basal membrane 
potential via permanent NaV stimulation (42).  
It is therefore hypothesised that alterations in NEDD4-2 activity will affect the processes underlying 
ciguatoxin-induced spontaneous pain via trafficking and expression of voltage-gated sodium channels 
and possibly voltage-gated potassium channels. The aims of this chapter are to: 1) analyse putative 
effects of Nedd4-2 SNPs in terms of potential codon and protein sequence changes, 2) quantify 
ciguatoxin-induced pain in Nedd4-2 knockout mice to assess the effects of Nedd4-2 SNPs. 
4.3. METHOD 
4.3.1 Effects of Nedd4-2 SNPs on codon and amino acid sequences 
The nucleotide changes were viewed in the context of whole protein sequence using the University 
of California Santa Cruz (USCS) Genome Browser (91), specifically the mouse NCBI37/mm9 
genome since it is the same genome used for the HBCGM. The SNP position could be searched on 
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the assembly and the codon change resulting from the nucleotide substitution was determined; the 
aberrant codon sequence was then used to isolate the resultant amino acid substitution. To locate the 
subsequent amino acid variation, the UniProt database (92) was used to define the position of the 
amino acid change in the protein sequence. Altogether, the location of each amino acid change was 
determined by comparing the amino acid sequence from UniProt to the codon sequence from the 
USCS Genome Browser. The structure of each amino acid residue change was viewed in terms of 
size, charge and polarity (Appendix 6) to decide if protein folding and structure could be affected in 
ways which would produce a difference in enzyme function. 
4.3.3 Nedd4-2 knockout mice observation 
Yang Nedd4-2 KO mice were obtained from Sharad Kumar of the University of Adelaide were 
handled at the University of Queensland with approval from the relevant animal ethics committee. 
These mice were selected over other Nedd4-2 complete knockout mice as they were more viable and 
exhibited no lung phenotype linked with perinatal death (93). The phenotype of these mice had similar 
characteristics to their heterozygous counterparts, only differing by the presence of mild salt-sensitive 
hypertension and cardiac hypertrophy (93). Analysis of the Nedd4-2 mRNA and protein bands of 
Yang mice demonstrated an incomplete knockout explaining the milder phenotype (93). The method 
for developing these hypomorphic mice is outlined in the article by Shi et al (94). Yang Nedd4-2 KO 
mice were created using the floxing technique with the creation of a Nedd4-2 targeting vector with 
two loxP sites and a neomycin antibiotic selectable marker. The construct was then electroporated 
into embryonic stem (ES) cells where it conjugates with the target gene via homologous 
recombination. The ES cells containing the construct were selected for by introduction of neomycin 
antibiotic, where the drug-resistant colonies expressing the targeting vector would remain unaffected. 
These ES cells containing the target gene were then harvested and inserted into mice embryos to 
produce heterozygous chimeras capable of being bred with C57BL/6J females. The product of this 
breeding yielded homozygous mice with the targeting vector on each allele, therefore mice selected 
based on the presence or absence of agouti fur which is used to designate the homogeneity of the 
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alleles. These mice carrying the target gene, still flanked with LoxP (floxed mice), were bred with 
mice with global expression of Cre recombinase (Ella-Cre mice) to complete the knockout via Cre-
Lox recombination. The Cre recombinase expressed by the progeny of this breeding removes the 
section of DNA between the two LoxP sequences, effectively deleting the sequence in between, in 
this case being the Nedd4-2 gene. Breeding between floxed and Ella-Cre mice allowed the production 
of offspring with global absence of Nedd4-2. Progeny from this pairing were then crossbred to create 
homozygotes, which were the hypomorphic Nedd4-2 KO mice used in this experiment (94), with 
C57BL/6J mice used as the control group. 
Preparation of mice for observation was undertaken by members of the thesis candidates advisory 
team, while observation was undertaken by the thesis candidate. Isoflurane was used to anaesthetise 
each subject and 40 microlitres of P-CTX-1 (10nM) was administered to the hindfoot of mouse. The 
mice were observed in the identical way as with the initial observation step outlined in Chapter 2: 
flinches of the affected limb were counted, and the time spent licking the limb was timed in seconds. 
Each mouse was observed by the blinded observer for 40 minutes and the phenotype of interest was 
recorded. For the cold allodynia portion of the experiment, mice were placed on a temperature-
controlled plate (Ugo Basile) maintained at 15˚C and pain responses were counted by the observer 
blinded to genotype.  
4.3.4 OD1 
OD1 is a selective NaV1.7 activator isolated from isolated from the Iranian yellow scorpion 
odonthobuthus doriae (95) used to further examine the hypothesised effects of Nedd4-2 on NaV1.7 
activity. The scorpion alpha-toxin binds to site 3 of NaVs, particularly in NaV1.7, leading to blockade 
of NaV inactivation and consequently a hyperpolarising shift in the steady-state voltage-dependence 
of channel activation (95, 96). At low nanomolar concentration, OD1 has been demonstrated to cause 
impaired steady-state fast inactivation, increased peak Na+ influx and persistent Na+ currents in 
NaV1.7 compared within control conditions. Therefore, OD1 mediates the heightened inward Na+ 
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current through NaV1.7 and improved recovery from the fast inactivation state (95). Spontaneous pain 
behaviours have been observed after intraplantar injection of OD1 in mice, and the effects of the 
agent were attenuated when administered to NaV1.7 knockout mice and reversed after co-injection 
with the NaV1.7 inhibiting tetrodotoxin (97). OD1 afflicted mice are expected to demonstrate a pain 
response via activation of NaV1.7, and in the absence of Nedd4-2 such as in knockout mice, the pain 
should be increased after administration of the toxin. OD1 inoculated Nedd4-2 knockout mice would 
therefore have a greater pain response when compared to unaffected mice due to a reduction in NaV1.7 
channel recycling and consequently an increase in the number of NaV1.7 channels available to be 
activated.  
TO prepare these mice in this experiment, isoflurane was used to anaesthetise each subject and 40 
microlitres of OD1 (300nM) was administered to the hindfoot of mouse. Again, mice were observed 
for 40 minutes and the number of flinches of the affected limb counted, and the time spent licking 
was timed in seconds. 
4.3.5 Analysis 
Graphs of the flinching and licking phenotypes were produced via GraphPad Prism 7 from the 
observation data. The F-test and t-test were used to determine if significant differences exist; the 
calculations were conducted with Microsoft Excel via the Data Analysis plugin. 
4.4 RESULTS 
4.4.1 Influence of Nedd4-2 mutations on protein folding 
Two SNPs both found on chromosome 18 were identified for the Nedd4-2 gene (Table 4.1), one in 
position 65317653 (SNP_18_65317653) and the other in position 65327222 (SNP_18_65327222). 
SNP_18_65317653 was associated with a substitution from guanosine (G) to adenosine (A), resulting 
in a codon change from CGA to CAA; this subsequently caused a change in the NEDD4-2 protein 
sequence, from arginine to glutamine in position 251 (Appendix 7). Arginine is a charged amino acid 
containing an ionising side chain with a pKa of 12.5, remaining in a positive charge state at 
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physiological pH, while glutamine is a hydrophilic amino acid which does not possess any ionisable 
side chains. Thus, an amino acid substitution from arginine to glutamine could potentially alter the 
protein structure of the NEDD4-2 protein by changes in the folding mechanics of the protein strand 
due to the alterations in the amino acid profiles. The corresponding protein structure could also have 
indirect effects of substrate binding if folding impacts of the binding site of the enzyme. The 
SNP_18_65327222 caused a substitution from thymine (T) to cytosine (C), resulting in the codon 
change from TCC to CCC and an amino acid change was from serine to proline in position 403 of 
the protein. Proline is a hydrophobic amino acid and is quite rigid, while serine is hydrophilic, 
meaning this change could also potentially alter the nature of the protein folding. The amino acids 
have quite dissimilar properties and substitution of these resides may have important structural and 
functional implications for the ubiquitin ligase. 
Nedd4-2 SNP positions and consequent amino acid changes from HBCGM 
 SNP_18_65317653 SNP_18_65327222 
SNP position Chromosome 18, Base position 
65317653
Chromosome 18, Base 
position 65327222 
Nucleotide substitution Guanosine  Adenosine Thymine  Cytosine 
Codon change CGA  CAA TCC  CCC 
Amino acid position r251 r403
Amino acid change Arginine (R)  Glutamine (Q) Serine (S)  Proline (P) 
 Table 4.1: Consequences of Nedd4-2 SNP changes on the nucleotide and amino acid level. Both SNPs result in 
codon changes which contribute to different amino acid residues. The presence of either SNP would lead to changes 
in the overall amino acid sequence in the ubiquitin ligase. 
 
 
The first WW domain (1WR3) in the mus musculus NEDD4-2 spans from r221-254, and the 
conformation of this protein sequence contains three beta-sheets and two tryptophan residues spaced 
21 amino acids apart. The SNP at position 65317653 affects the sequence of this WW domain via a 
substitution of arginine in position 33 with glutamine (Figures 4.4 & 4.5). The arginine residue does 
not appear to directly implicate the beta-sheet formations or tryptophan residue spacing, therefore it 
does not have any direct consequences on the major components of the domain. SNP_18_65327222 
does not affect the amino acid sequence of either of the three WW domains, however, the change 
may lead to more generalised alterations in context of the entire protein which may have ramification 
in overall protein activity. 
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Figure 4.4: Protein sequence of 1WR3 from the Research Collaboratory for Structural Bioinformatics Protein 
Data Bank (82). Arginine in position 33 is affected by SNP_18_65317653  (outlined in red). Amino acid substitution 
does not directly affect the key structures of the WW domain, namely the beta sheet formation and tryptophan spacing. 
 
 
  Figure 4.5: 3D structures of 1WR3 generated via on Jmol open source molecule viewer (98). Arginine residue in 
position 33 (blue) shown by black arrow. Amino acid substitution does not directly affect the key structures of the WW 
domain, namely the beta sheet formation and tryptophan spacing. 
 
4.4.2 Spontaneous pain expression of Nedd4-2 knockout mice 
The number of flinches and seconds spent licking were recorded for Nedd4-2 KO [n = 20] and WT 
mice [n = 14], with the shape of each graph depicted as time elapse against degree of pain (Figures 
4.6 & 4.7) having a resemblance to those seen in previous ciguatoxin-induced pain in mice observed 
in Chapter 2. The initial response for flinching responses was greatest within the first 15 minutes of 
observation which was then follow by a gradual decline in response. As for the licking modality, the 
reactions were inclined to build up slowly with a peak around the 20 minute mark which was then 
followed by the gradual decline. Pain responses between the two genders failed to show any 
differences, much akin to the findings from ciguatoxin-induced pain in Chapter 2, with no significant 
Back view Right view 
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difference between males and females as demonstrated with a two-tailed Student’s t-test (Table 4.2). 
Subsequent analyses were conducted using combined data for both genders together to further 
examine for contrasting features between WT and KO mice (Figures 4.8 & 4.9). Licking reactions 
demonstrated a significant difference between WT and KO mice (p-value = 0.0085), and no 
significant difference in flinching reactions (Table 4.3). Licking pain responses showed that KO mice 
had an increased length of time licking (μ = 335 seconds, 95% CI [268, 403]) compared to WT mice 
(μ = 212 seconds, 95% CI [147, 277]). Flinching pain responses had similar numbers between the 
two subjects with KO mice only having a slight lower number of flinches (μ = 120 flinches, 95% CI 
[93, 146]) compared to WT mice (μ = 147 flinches, 95% CI [114, 179]). 
Figure 4.6: No significant difference in ciguatoxin-induced flinching between male and female mice. P-CTX 
(10nM) was administered via intraplantar injection and the number of flinches was quantified over 40 minutes. 
Flinches for males and females were counted separately and data was plotted as means with error bars denoting 95% 
confidence intervals. Wildtype (WT) mice are coloured red and knockout (KO) mice are coloured blue. The flinching 
responses between males and females failed to show a significant difference on the two-tailed Student’s t-test. Nedd4-
2 WT males (n): 4, Nedd4-2 KO males (n): 13, Nedd4-2 WT females (n): 10, Nedd4-2 KO females (n): 7. 
 
Figure 4.7: No significant difference in ciguatoxin-induced licking between male and female mice. P-CTX 
(10nM) was administered via intraplantar injection and seconds spent licking was quantified over 40 minutes. Licking 
for males and females was counted separately and data was plotted as means with error bars denoting 95% confidence 
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intervals. Wildtype (WT) mice are coloured red and knockout (KO) mice are coloured blue. The licking responses 
between males and females failed to show a significant difference on the two-tailed Student’s t-test. Nedd4-2 WT 
males (n): 4, Nedd4-2 KO males (n): 13, Nedd4-2 WT females (n): 10, Nedd4-2 KO females (n): 7. 
 
Two-tail t-test of Nedd4-2 data (WT and KO): Males vs. Females
   F-test t-test
 ♂ (n) ♀ (n) F P-value F Crit t Stat P-value t Crit  
WT flinches 4 10 0.1526 0.0746 0.1135 -1.4598 0.1700 2.1788 
KO flinches 13 7 4.8065 0.0326 3.9999 1.1752 0.2552 2.1009 
WT licks 4 10 0.7811 0.4663 0.1135 0.1873 0.8576 2.4469 
KO licks 13 7 1.0215 0.5202 3.9999 0.4705 0.6436 2.1009 
 Table 4.2: No significant difference in ciguatoxin-induced spontaneous pain responses between male 
and female mice. The two-tailed Student’s t-test was utilised to compare Nedd4-2 males and females for 
both WT and KO. Alpha level set at 0.05 for the calculations.  
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Figure 4.8: Statistically significant difference in ciguatoxin-induced licking between KO and WT mice. 
Flinching and licking pain responses for both genders combined and data plotted as means with error bars denoting 
95% confidence intervals. Wildtype (WT) mice are coloured red and knockout (KO) mice are coloured blue. The 
licking responses between WT and KO mice showed a statistically significant difference on the two-tailed Student’s 
t-test with a p value of 0.0085. On the other hand, flinching responses failed to show failed to show a significant 
difference between WT and KO mice. Nedd4-2 WT (n): 14, Nedd4-2 KO (n): 20. 
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Figure 4.9: Statistically significant difference in ciguatoxin-induced licking between KO and WT mice. Mean 
number of flinches or seconds spent licking for each 5 minute interval plotted with error bars denoting 95% confidence 
intervals for WT and KO mice. WT mice are shown with a black symbol and KO mice are shown by a white symbol. 
Licking responses showed KO mice had longer times licking compared to WT mice with a statistical significant 
difference. Flinching responses failed to show a significant difference, with WT mice having a slightly higher number 
of flinches compared to KO mice. Nedd4-2 WT (n): 14, Nedd4-2 KO (n): 20. 
 
Two-tail t-test of Nedd4-2 data (Males and Females): WT vs. KO 
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   F-test t-test
 WT (n) KO (n) F P-value F Crit t Stat P-value t Crit  
Flinching 14 20 0.9797 0.4970 0.4047 1.3862 0.1766 2.0484 
Licking 14 20 0.6149 0.1867 0.4047 -2.8030 0.0085 2.0369 
 Table 4.3: Statistically significant difference in ciguatoxin-induced licking responses between WT 
and KO mice. The two-tailed Student’s t-test was utilised to compare Nedd4-2 WT and KO mice with 
responses from both genders combined. A statistically significant difference between WT and KO mice 
was seen for time spend licking with a p-value of 0.0085. Alpha level set at 0.05 for the calculations; the 
difference has been highlighted yellow. 
 
4.4.3  Cold allodynia pain expression in Nedd4-2 knockout mice 
The effects of cold allodynia were observed in terms of the number of flinches for Nedd4-2 KO and 
WT mice for both genders (Figure 4.10). A two-tailed Student’s t-test comparing the degree of male 
and female pain responses failed to show a significant difference between the two genders (Table 
4.4). When combining both sexes to compare the pain responses of WT against KO mice (Table 4.5), 
no significant difference was established between the two mouse strains for either flinching, with WT 
mice having just slightly lower numbers of flinches (μ = 38 flinches, 95% CI [27, 49]) than KO mice 
(μ = 40 flinches, 95% CI [24, 56]). 
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Figure 4.10: No significant difference in ciguatoxin-induced cold allodynia between genders or between KO and 
WT mice. Cold allodynia was assessed by subjecting mice to a 15 degrees cold plate after intraplantar injection of P-
CTX (10nM). The mean number of flinches for each 5 minute interval was plotted with error bars denoting 95% 
confidence intervals for WT and KO mice. WT mice are shown with a black symbol and KO mice are shown by a 
white symbol. Flinching responses showed similar mean number of flinches between genders as well as between WT 
and KO mice. Flinching responses failed to show a significant difference in ciguatoxin-induced cold allodynia. Nedd4-
2 WT males (n): 4, Nedd4-2 KO males (n): 13, Nedd4-2 WT females (n): 10, Nedd4-2 KO females (n): 7. 
 
Two-tail t-test of cold allodynia data: Males vs. Females
  F-test t-test
 ♂ (n) ♀ (n) F P-value F Crit t Stat P-value t Crit 
WT flinches 4 10 8.1825 0.0061 3.8625 -0.0765 0.9439 3.1824
KO flinches 13 7 0.4579 0.1121 0.3432 0.2819 0.7832 2.2010
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Table 4.4: No significant difference in ciguatoxin-induced cold allodynia between male and female mice. The 
two-tailed Student’s t-test was utilised to compare Nedd4-2 males and females for both WT and KO. Alpha level set 
at 0.05 for the calculations. 
 
Two-tail t-test of cold allodynia data: WT vs. KO
   F-test t-test
 WT (n) KO (n) F P-value F Crit t Stat P-value t Crit 
Flinching 14 20 0.2780 0.0108 0.4067 -0.1637 0.8710 2.0345
 Table 4.5: No significant difference in ciguatoxin-induced cold allodynia between WT and KO. The two-tailed 
Student’s t-test did not demonstrate a significant difference between Nedd4-2 WT and KO mice from both genders 
combined. Alpha level set at 0.05 for the calculations. 
 
4.4.4  OD1 as an NaV1.7 activator 
Considering the ciguatoxin-induced flinching and licking results observed in Nedd4-2 KO animals, 
it was decided to further explore whether pain behaviours can be altered in these animals. Based on 
previous studies demonstrating altered NaV1.7 trafficking (85), pain behaviours in Nedd4-2 KO mice 
in response to intraplantar administration of the selective NaV1.7 activator OD1 were assessed. As 
mentioned earlier, OD1 has established NaV1.7 activating effects and was implemented to investigate 
the effects of Nedd4-2 knockout in terms of NaV1.7 mediated pain responses. Male and female mice 
showed similar degrees of flinching and licking pain responses (Figures 4.11 & 4.12) and did not 
demonstrate significant differences between the two genders (Table 4.6). After collating the data from 
each gender, WT mice were compared to KO mice and results showed an increased licking response 
exhibited by KO mice (Figures 13 & 14). The longer duration of licking over the duration for KO 
mice (μ = 517 seconds, 95% CI [438, 596]) contrasted against WT mice (μ = 332 seconds, 95% CI 
[232, 431]) was statistically significant as supported by a two-tailed Student’s t-test with a p-value of 
0.0043 (Table 7). The number of flinches between the two mouse strains did not demonstrate the 
same degree of incongruency, with KO mice having only a slightly higher number of flinches (μ = 
33 flinches, 95% CI [25, 42]) than their WT counterpart (μ = 29 flinches, 95% CI [18, 41]), the 
difference not being statistically significant.  
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Figure 4.11: No significant difference in OD1-induced flinching between male and female mice. OD1 was 
administered via intraplantar injection and the number of flinches was quantified over 40 minutes. Flinches for males 
and females were counted separately and data was plotted as means with error bars denoting 95% confidence intervals. 
Wildtype (WT) mice are coloured purple and knockout (KO) mice are coloured orange. The flinching responses 
between males and females failed to show a significant difference on the two-tailed Student’s t-test. 
 
Figure 4.12: No significant difference in OD1-induced flinching between male and female mice. OD1 was 
administered via intraplantar injection and the seconds spent licking was quantified over 40 minutes. Licking for males 
and females was counted separately and data was plotted as means with error bars denoting 95% confidence intervals. 
Wildtype (WT) mice are coloured purple and knockout (KO) mice are coloured orange. The flinching responses 
between males and females failed to show a significant difference on the two-tailed Student’s t-test. 
 
Two-tail t-test of OD1 data (WT and KO): Males vs. Females
   F-test t-test
 ♂ (n) ♀ (n) F P-value F Crit t Stat P-value t Crit  
WT flinches 3 6 2.3489 0.1909 5.7861 0.3034 0.7704 2.3646 
KO flinches 8 5 0.6761 0.3051 0.2427 0.5449 0.6028 2.3646 
WT licks 3 6 1.0699 0.4104 5.7861 1.4025 0.2035 2.3646 
KO licks 8 5 0.1991 0.0315 0.2427 0.7626 0.4618 2.2010 
 Table 4.6: No significant difference in OD1-induced spontaneous pain between male and female mice. 
The two-tailed Student’s t-test was utilised to compare Nedd4-2 males and females for both WT and KO. Alpha 
level set at 0.05 for the calculations. 
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Figure 4.13: Statistically significant difference in OD1-induced licking between KO and WT mice. Flinching and 
licking pain responses for both genders combined and data plotted as means with error bars denoting 95% confidence 
intervals. Wildtype (WT) mice are coloured purple and knockout (KO) mice are coloured orange. The licking responses 
between WT and KO mice showed a statistically significant difference on the two-tailed Student’s t-test with a p value 
of 0.0043. On the other hand, flinching responses failed to show failed to show a significant difference between WT 
and KO mice. 
 
Figure 14. Statistically significant difference in OD1-induced licking between KO and WT mice: Mean number 
of flinches or seconds spent licking for each 5 minute interval plotted with error bars denoting 95% confidence intervals 
for WT and KO mice. WT mice are shown with a black symbol and KO mice are shown by a white symbol. Licking 
responses showed KO mice had longer times licking compared to WT mice with a statistical significant difference. 
Flinching responses failed to show a significant difference, with KO mice having a slightly higher number of flinches 
compared to WT mice. 
 
Two-tail t-test of OD1 data (Males and Females): WT vs. KO
   F-test t-test
 WT (n) KO (n) F P-value F Crit t Stat P-value t Crit 
Flinching 9 13 1.0806 0.4361 2.8486 -0.6231 0.5403 2.0860 
Licking 9 20 0.9885 0.5105 0.3045 -3.2913 0.0043 2.1098 
 Table 4.7: Statistically significant difference in OD1-induced licking responses between WT and KO 
mice. The two-tailed Student’s t-test was utilised to compare Nedd4-2 WT and KO mice with responses from 
both genders combined. A statistically significant difference between WT and KO mice was seen for time 
spend licking with a p-value of 0.0043. Alpha level set at 0.05 for the calculations; the difference has been 
highlighted yellow. 
 
 
4.5 DISCUSSION AND CONCLUSIONS 
Nedd4-2 was selected from the HBCGM list of potential genes generated for further exploration as it 
possessed an established role in ubiquitination of NaVs, notably NaV1.7 and NaV1.8. Studies have 
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already recognised the role of Nedd4-2 on pain transmission in other pain modalities such as formalin-
induced inflammatory pain where haploinsufficient Nedd4-2 mice demonstrated increased 
spontaneous pain behaviours compared to controls (79). A neuropathic pain model using the SNI 
approach in rats established that Nedd4-2 expression in the DRG was reduced after ligation of 
peripheral nerves, suggesting that peripheral nerve injury instigates Nedd4-2 downregulation in 
nociceptive neurons (78). Currently, the characterisation of Nedd4-2 effects in ciguatoxin induced 
spontaneous pain are not well established. It was expected that knocking out Nedd4-2 in mice would 
lead to an increased response to pain when compared to wildtype via changes in sodium channel 
recycling. Reduction in NEDD4-2 activity is hypothesised to result in decreased membrane recycling 
of sodium channels implicated in pain such as NaV1.7 and NaV 1.8, which leads to greater membrane 
populations of these channels and increased excitability. Increased NaV1.8 concentrations in 
nociceptive neurons is already shown to reduce pain thresholds (75), therefore it is speculated that 
increased NaV concentrations due to reduced ubiquitin-mediated channel recycling will result in 
greater levels of pain when mice are subjected to ciguatoxin-induced NaV activation. 
SNPs have the potential to influence the entire structure of a protein despite their minute 
modifications in nucleotide sequence. Two SNPs for Nedd4-2 were identified via HBCGM in Chapter 
3, the first SNP resulting in a substitution at position r251 and the second SNP at position r403. 
Nedd4-2 codes for the E3 ubiquitin ligase protein which contains three distinct WW domains required 
for the recognition of specific target substrates. Only the SNP at r251 falls within the region of a WW 
domain and the ensuing codon change results in an arginine to glutamine amino acid substitution at 
position 33 in the first WW domain (1WR3). The function of the WW domain is dependent on its 
structure, namely the hydrophobic core flanked by beta-sheets and the tryptophan residues spaced 21 
amino acids apart, and it is possible that the amino acid change caused by a SNP may affect the 
overall folding of the protein and ultimately on its function. On the other hand, these changes may be 
insignificant and not demonstrate any effects on the function of the enzyme since the arginine residue 
does not appear to directly implicate the beta-sheet formations or tryptophan residue spacing. 
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Although the amino acid change does not result in direct consequences on the major components of 
the domain, the contrast in amino acid properties has the potential to alter the conformation of the 
entire active site. Minor changes in protein folding mechanisms can result in varied binding 
capabilities of the active site which could potentially cause increased or decreased activity of the 
enzyme. The SNP involving r403 does not fall in a position which directly imparts changes to the 
amino acid sequence of either of the three WW domains of the protein, however, the substitution may 
result in indirect effects on the three-dimensional arrangement of the entire protein. The codon 
alteration gives rise to a serine to proline substitution, with the two amino acids having quite 
dissimilar structural functionalities. Despite not having an obvious effect the overall structure, the 
change may lead to more generalised modifications in the positions of certain active components 
which could indeed result in variation in the protein’s native function. The precise outcomes of the 
SNPs remain to be determined, but it can be concluded that the potential protein sequence adjustments 
may contribute to changes in E3 ubiquitin ligase function. It is therefore necessary to conduct further 
experimental testing of the enzymatic function in the presence and absence of the SNPs to confidently 
assess whether the two Nedd4-2 SNPs found via HBCGM can contribute to altered enzyme activity. 
The degree of ciguatoxin-induced spontaneous pain was observed for both genders for wild-type 
(WT) and knockout (KO) mice. From previous observation using ciguatoxin in Chapter 2, it was 
expected that gender would not have a key role in altered pain perception in Nedd4-2 knockout mice, 
and this was proven via a two-tailed t-test demonstrating no significant difference between male and 
female reactions in either WT or KO mice. Therefore, the presence of a specific gender would not 
play an influential role in nociception on the background of variable Nedd4-2 expression levels. By 
exposing Nedd4-2 WT and KO mice to ciguatoxin, we were able to show a significant difference 
between the two mouse strains in terms of licking responses with a p-value of 0.0085. KO mice had 
longer licking times compared to WT mice, which is expected for subjects experiencing increased 
perception of pain. The absence of Nedd4-2 is hypothesised to contribute to greater numbers of NaVs 
in the DRG including NaV1.7, which would promote the transmission of pain when stimulated by 
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ciguatoxin. Interestingly, this finding was not supported by the flinching pain response, which showed 
no significant between WT and KO mice. What makes this feature even less compelling for Nedd4-
2 involvement in nociception is that WT mice were witnessed to have a higher number of flinches 
compared to KO mice, although this difference was not significant. Another interesting feature of the 
findings is that the significant difference exists for licking behaviours only and not flinching, despite 
the Nedd4-2 gene being a potential target located on the flinching HBCGM list. 
Previous studies have demonstrated increased formalin-induced inflammatory pain in Nedd4-2 
heterozygotes compared to wild-type (76, 79), aligning with these findings for ciguatoxin induced-
spontaneous pain as both results show reduction in NEDD4-2 activity is associated with greater pain 
sensitivities. The mechanism for increased nociception is hypothesised to be due to diminished NaV 
recycling in the absence of Nedd4-2 and a resultant increase in membrane excitability and pain 
transmission. In this study, this hypothesis was not proven by measuring the expression of NaVs in 
the DRG for Nedd4-2 KO mice, which leaves room for additional experimentation to define the 
microscopic effects of NEDD4-2 on DRG channel populations through methods such as tissue 
straining or immunofluorescence. The effects of NEDD4-2 on DRG NaV channels is still uncertain, 
with one study showing that complete knockout of Nedd4-2 in nociceptive neurones caused an 
increase in the concentrations of both NaV1.7 and 1.8 (76), while another was unable to demonstrate 
changes in NaV1.7 and 1.8 levels in the DRG using incomplete knockout mice (79). This may suggest 
that reduced levels of Nedd4-2 in incomplete knockout models is not substantial enough to cause 
changes in NaV concentrations, and changes can only be seen with complete knockouts. With Yang 
Nedd4-2 mice used in this experiment, the Nedd4-2 gene is diminished using the floxing method, 
which produces hypomorphic mutants. This process spawns mice with characteristics of homozygous 
knockout mice with the additional feature of avoiding the lethality associated with complete knockout 
mice. It is therefore expected for Yang Nedd4-2 mice to have expression patterns more akin to 
heterozygous Nedd4-2 animals rather than homozygous knockout mice (93). Since the results of 
Nedd4-2 KO mice in the presence of ciguatoxin in this experiment did not clearly show a definitive 
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increase in either the number of flinches or seconds spent licking, it cannot be confidently stated that 
the absence of Nedd4-2 in Yang Nedd4-2 mice contributes to increased nociception. With Yang 
Nedd4-2 KO mice used in this experiment, the Nedd4-2 gene is not completely knocked out as a 
compromise to increased viability of the subjects, which may impact of the expression of NEDD4-2 
levels in the DRG. By not using a complete knockout model it is possible that NaV1.7 and 1.8 
concentrations in the DRG were not affected to the degree necessary to alter nociception. In light of 
these imperfect results, we can consider that Nedd4-2 may have implications in ciguatoxin-induced 
spontaneous pain with Nedd4-2 knockout mice having possible escalations in pain responses, 
although the exact mechanism was not confirmed in this study. 
Presently, there has been a lack of studies investigating the effects of Nedd4-2 on cold allodynia, with 
only one study exploring the effects of Nedd4-2 on mechanical allodynia (76). The study used the 
spared nerve injury model to simulate mechanical allodynia, which was then relieved after 
introduction of a Nedd4-2 viral vector. Ciguatoxin-mediated cold allodynia is due to TRPA1 
activation on unmyelinated C-fibres and myelinated A-fibres through indirect mechanisms, as well 
as effects via NaV1.8 and potassium channels (35, 39, 41). Normally, intraplantar administration of 
ciguatoxin induces cold allodynia in mice in a dose-dependent manner (35), however the effects of 
Nedd4-2 on cold allodynia pathways has not yet been established. From the results of this thesis, it is 
apparent that the degree of pain represented by the number of flinches shows no real difference 
between Nedd4-2 WT and KO mice. Mice lacking Nedd4-2 did show a marginally greater degree of 
flinches compared to wild-type mice, however this result was not statistically significant. As with 
ciguatoxin-induced spontaneous pain, flinching pain responses for cold allodynia were unable to 
demonstrate an association between Nedd4-2 expression and nociception. The degree of flinching 
seen between spontaneous pain and cold allodynia for ciguatoxin also differed, with mice exhibiting 
spontaneous pain having expressed greater numbers of flinches than mice being tested for cold-
allodynia. The disparity between the two pain responses may be due to differences in nociceptive 
mechanisms as cold allodynia relies on TRPA1 and NaV1.8 activation while spontaneous dermal pain 
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appears to be dependent on solely NaV channels (41). P-CTX-1 seems to affect NaV subtypes to 
varying degrees but had most potent on NaV1.6 and NaV1.7 in A-fibres, contributing to ciguatoxin-
induced spontaneous dermal pain after intraplantar injection of P-CTX-1 (41). The toxin has largely 
NaV1.8 mediated activation on C-fibres and this mechanism is attributed to abdominal pain symptoms 
secondary to intracolonic administration of P-CTX-1 (41). Nedd4-2 mediated ubiquitination has the 
potential to affect voltage-gated sodium and potassium channels, however the effects on TRPA1 have 
not been characterised. The two different mechanisms of ciguatoxin may explain why spontaneous 
pain behaviours showed larger counts of flinches compared to cold allodynia, however, the 
similarities between Nedd4-2 KO and WT mice in either pain modality could mean Nedd4-2 effects 
are not significant enough to produce changes in ciguatoxin-induced nociception. Since the sodium 
channel targets for E3 ubiquitin ligases are involved in both mechanisms for cold allodynia and 
spontaneous pain, it was expected that Nedd4-2 knockout mice would have increased sensitivities to 
pain, in particularly spontaneous pain. The paucity of altered pain responses undermines the initial 
hypothesis that reduced NEDD4-2 ubiquitin E3 ligase activity will cause an increase in pain 
transmission via decreased removal of membrane NaVs; to validate these findings, the population of 
NaV channel can be measured in future experiments. 
The alpha-scorpion toxin (OD1) was utilised as a positive control for Nedd4-2 knockout as it is 
expected to be associated with increased pain responses in the absence of Nedd4-2 mediated Nav1.7 
trafficking. OD1 selectively activates NaV1.7 to increase the propagation of pain impulses and hence, 
increase the response to inflammatory pain (95). In the presence of reduced Nedd4-2 activity, it is 
hypothesised that OD1 afflicted mice would demonstrate a greater degree of pain responses when 
compared to mice of normal Nedd4-2 expression due to the effects of NaV1.7 activation working in 
concert with increased NaV membrane numbers. When examining the results from this experiment, 
Nedd4-2 KO mice showed a statistically significant difference in terms of licking, with longer 
durations of licking than their WT counterparts. A non-significant difference was also observed for 
flinching reactions, with KO mice also contributing to a greater number of flinches than WT mice, 
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which is expected for mice with lower expression of Nedd4-2. The results of OD1 inoculated mice 
are similar to ciguatoxin affected mice when examining licking responses, where both toxins were 
able to produce statistically significant increases in pain responses in Nedd4-2 KO mice. A 
discrepancy exists when viewing nociception as a measurement of the number of flinches, where 
ciguatoxin-induced pain appears to cause WT mice to flinch more than KO mice. Given the proposed 
mechanism of NEDD4-2 on NaV recycling, it appears that the findings involving OD1 are more 
aligned with the theory that NEDD4-2 deficiency results in greater pain transmission secondary to 
increased membrane populations of NaV1.7. Since the effects of ciguatoxin on NaVs are less specific 
than OD1, the conflicting results may be a product of nonspecific interactions with multiple NaV 
subtypes. On the other hand, Nedd4-2 involvement in mechanisms opposing NaV-mediated pain may 
be implicated, which have not been tested in this study. The reduced recycling of membrane channels 
may extend to factors which alleviate pain, essentially nullifying the effects of the proposed increase 
in pain transmissibility. Regardless of the numerous confounding factors associated with 
experimenting with an incompletely characterised gene, the statistically significant difference with 
licking pain responses illustrates a considerable increase in pain for Nedd4-2 knockout mice and is a 
promising feature of this experiment worth investigating further.  
The ambitious attempt to characterise the effects of single gene variations was not as straightforward 
as initially predicted, producing more questions than answers. Although the mechanisms of 
ciguatoxin in spontaneous pain have been confidently linked with the majority of both TTX-sensitive 
and TTX-resistant NaV channels, exclusions being NaV1.1, NaV1.4 and NaV1.9 (75, 85), the effects 
of Nedd4-2 knockout were not as clearly displayed as expected. Having the two observed phenotypes 
for pain demonstrating differing results introduces the issue of which phenotype most accurately 
describes pain in mice. The underlying mechanisms underpinning flinching and licking may be 
completely discordant, meaning a more specific testing to quantify nociception is required to 
enumerate pain responses in mice. As mentioned in Chapter 2, newer technology employing tracking 
systems and complex algorithms (45) may be required to accurately represent nociception in animals, 
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and this approach may be able to produce more reliable phenotypic descriptions of pain. It is quite 
apparent from the results of this experiment that pain traits are complex processes encompassing 
many different variables. The lack of congruency between flinching and licking results is an example 
of how pain measurement is an inexact method aiming to simplify a complicated biological process. 
It is still uncertain which mechanism of Nedd4-2 impacts on nociception, however it is still possible 
that altered NaV1.7 membrane populations contributed to increased spontaneous pain in terms of 
licking response for ciguatoxin and OD1-induced nociception despite mediocre findings for flinching 
behaviours. When considering the use of these results to extrapolate into human studies, it is still too 
premature to say how changes in Nedd4-2 in human will be observed in terms of nociception. It has 
already been shown that intradermal injection of P-CTX-1 in humans produces results bearing 
resemblance to studies using intraplantar inoculation in mice (41), therefore, results of this study 
could potentially have similar findings when conducted in human models. At this stage, Nedd4-2-
mediated changes are still unclear and further investigation with animal models is still required to 
better explore these effects. From the results, the potential for Nedd4-2 to have pain influencing 
effects is promising, and additional characterisation of the effects Nedd4-2 on other modalities of 
nociception should be sought in further studies. 
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6. APPENDICES 
6.1 APPENDIX 1: LIST OF FLINCHING GENES 
Gene produced from HBCGM of the flinching data sorted based on P-value, with the non-coding 
genes removed. Total of 422 genes. 
Gene P-value Gene P-value Gene P-value 
Nos1ap 8.70E-08 Nars2 0.00025 Itih3 0.0022 
Nuf2 1.80E-07 Anxa6 0.00025 Ttc37 0.0022 
E330013P04Rik 4.30E-07 Eri1 0.00025 Tnip1 0.0023 
Myo7a 6.90E-07 Olfr414 0.00026 Fat2 0.0023 
2010111I01Rik 9.50E-07 Slc7a2 0.00026 Phf14 0.0023 
Il1rl2 1.00E-06 Col6a6 0.00026 Daglb 0.0023 
Sgcz 1.10E-06 Rhobtb3 0.00026 Vmn2r89 0.0023 
Klra4 1.50E-06 E4f1 0.00026 Mrpl49 0.0024 
Slc1a2 1.60E-06 Abca17 0.00026 Gm17359 0.0024 
Zfp934 1.70E-06 Igj 0.0003 Olfr739 0.0025 
Fbp2 1.70E-06 Utp3 0.0003 Gm5581 0.0025 
Dapk1 1.80E-06 Ikbip 0.00031 Utp18 0.0026 
4930486L24Rik 1.80E-06 Acy1 0.00035 Wfdc6b 0.0026 
Tpbpb 1.80E-06 Gpr62 0.00035 4930403N07Rik 0.0027 
Ctsj 1.80E-06 Gm16382 0.00036 Fastkd3 0.0028 
Ctla2b 1.90E-06 Eapp 0.00036 Osgep 0.0028 
Klra9 2.00E-06 Stt3b 0.00037 Apex1 0.0028 
Gm13119 2.20E-06 Col6a5 0.00037 Gdpd4 0.0028 
Gm13125 2.20E-06 Cdh1 0.00037 2610002D18Rik 0.0031 
Gm13078 2.20E-06 Olfr49 0.00037 Ugt1a6b 0.0031 
Oog3 2.20E-06 D430042O09Rik 0.00037 Ugt1a8 0.0031 
9430007A20Rik 2.20E-06 Pstpip1 0.00038 Tcf21 0.0031 
Rgs5 2.20E-06 Olfr323 0.00039 BC028777 0.0032 
1700084C01Rik 2.20E-06 Ibtk 0.00041 Tcra-V8 0.0032 
Hsd17b7 2.20E-06 Adamts20 0.00045 Tas2r113 0.0033 
Ddr2 2.20E-06 Abhd14a 0.00047 Galnt10 0.0035 
Uap1 2.20E-06 Gpr144 0.00048 Slc15a5 0.0035 
Uhmk1 2.20E-06 Gm13587 0.00048 Mgst1 0.0035 
4930500M09Rik 2.20E-06 Nr5a1 0.00048 9430097D07Rik 0.0035 
Sh2d1b1 2.20E-06 Psmb7 0.00048 Dpm2 0.0035 
Gm7694 2.20E-06 Nr6a1 0.00048 Gm17343 0.0035 
Olfml2b 2.20E-06 Sdhc 0.00051 Fam102a 0.0035 
Dusp12 2.20E-06 Mpz 0.00051 St6galnac4 0.0035 
Fcrlb 2.20E-06 Zfp71-rs1 0.00051 Pip5kl1 0.0035 
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Fcrla 2.20E-06 Etv6 0.00056 Ubr5 0.0037 
Fcgr2b 2.20E-06 Ctsm 0.00056 2810453I06Rik 0.0037 
Fcgr4 2.20E-06 Apoa2 0.00059 Dis3l 0.0037 
Pramef8 2.20E-06 Ccdc11 0.00061 Gm16901 0.0037 
Oog4 2.20E-06 Defb7 0.00063 Mypn 0.0037 
Gm13080 2.20E-06 1110028C15Rik 0.00067 Tas2r131 0.0037 
Gm13083 2.20E-06 Bpifb4 0.0007 Tas2r129 0.0037 
Gm13088 2.20E-06 Prrg4 0.00076 Zfp712 0.0038 
Gm13087 2.20E-06 Klra7 0.00076 Fam110c 0.0038 
Gm13023 2.20E-06 Klra1 0.00076 Mtfmt 0.0038 
Gm13084 2.20E-06 Gm8214 0.00078 Sbk1 0.0039 
Gm13103 2.20E-06 Dsg1a 0.00079 Pde6d 0.004 
Pramef6 2.20E-06 Ces1c 0.00081 Cops7b 0.004 
Gm13101 2.20E-06 Fam54b 0.00082 Fcrl5 0.004 
Pramef17 2.20E-06 Rad54l2 0.00082 Samd9l 0.0041 
Oog2 2.20E-06 Pigf 0.00082 Zfp738 0.0042 
C87977 2.20E-06 Nipal2 0.00084 Col5a3 0.0043 
Pramel5 2.20E-06 Klra8 0.00086 Tnfrsf1b 0.0043 
Pramef12 2.20E-06 Prdm2 0.00086 Gm11612 0.0044 
Gm9944 2.20E-06 Clec2e 0.00086 Gm16831 0.0044 
Gm13126 2.20E-06 Clec12b 0.00086 Exoc7 0.0044 
Gm13177 2.20E-06 Clec1a 0.00086 Lpl 0.0045 
Alg8 2.90E-06 Clec1b 0.00086 Pde4a 0.0045 
4930529F22Rik 3.30E-06 Klra6 0.00086 Fam160b1 0.0045 
Gm13109 4.30E-06 Oprm1 0.0009 Vmn1r88 0.0046 
Mfsd9 4.90E-06 Dsc3 0.00091 Gm4879 0.0046 
Fcrls 7.20E-06 Gm10287 0.00091 Gm16708 0.0047 
Gemin5 7.20E-06 Igsf9 0.00092 Itm2c 0.0048 
Tpo 7.20E-06 C230038L03Rik 0.00092 Slamf9 0.0049 
Abca3 7.20E-06 Ighv1-19 0.00092 Kap 0.0049 
Olfr364-ps1 7.60E-06 Lphn3 0.00094 Tep1 0.005 
BC051665 7.70E-06 Spna1 0.00094 Bpifa6 0.0051 
Caskin2 8.00E-06 Pear1 0.00096 Spag11b 0.0051 
2310067B10Rik 8.00E-06 Ncstn 0.00097 Mbd1 0.0051 
Gm7664 9.30E-06 Ryr3 0.00099 Arhgef10 0.0051 
Zfp935 9.30E-06 Aven 0.00099 Kbtbd11 0.0051 
Nanos1 9.30E-06 Prss41 0.001 Got1 0.0051 
Fam45a 9.30E-06 Fras1 0.001 Nf1 0.0053 
Sfxn4 9.30E-06 Glp2r 0.001 Zbtb6 0.0056 
Ctla2a 9.60E-06 Defb50 0.0011 Zbtb26 0.0056 
Cts3 1.00E-05 Gm15316 0.0011 Rc3h2 0.0056 
Ctsll3 1.10E-05 Fam135b 0.0011 Rabgap1 0.0056 
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Gm15292 1.10E-05 Tlr9 0.0011 Gnb4 0.0056 
Gm13124 1.20E-05 Anxa3 0.0011 Rnpep 0.0059 
Gm436 1.20E-05 Arhgef40 0.0011 Cdsn 0.0059 
Cyp2c38 1.20E-05 Ppan 0.0011 2300002M23Rik 0.0059 
Fancc 1.20E-05 Eif3g 0.0011 Bckdhb 0.0059 
Nedd4l 1.30E-05 Tdg 0.0012 Iqsec1 0.006 
Nmur2 1.30E-05 Pkhd1 0.0012 Aldh1l1 0.006 
Cilp 1.30E-05 Col6a4 0.0012 Slc41a3 0.006 
Trcg1 1.40E-05 Dsg3 0.0012 Il18r1 0.006 
Parp16 1.40E-05 Sfi1 0.0012 Olfr600 0.0062 
Obscn 1.40E-05 Unc45a 0.0012 Olfr599 0.0062 
D19Ertd737e 1.50E-05 Gm5622 0.0012 Gm438 0.0063 
Lrp1b 1.60E-05 Ccnf 0.0012 Defa26 0.0066 
Dock8 1.60E-05 Gm17175 0.0012 Zfhx2 0.0067 
Pramel4 1.60E-05 Flywch1 0.0012 Jmjd5 0.0068 
Dst 1.60E-05 Ctsa 0.0013 1700017B05Rik 0.007 
A830092H15Rik 1.60E-05 Pi4k2b 0.0013 Rag2 0.0071 
Chst8 1.60E-05 Tdpoz1 0.0013 Vnn3 0.0072 
Clpx 1.60E-05 Pigb 0.0013 Zfp457 0.0072 
Pdcd7 1.60E-05 Adamts4 0.0013 Cdhr3 0.0073 
Supt3h 1.60E-05 Klrb1f 0.0015 4933406C10Rik 0.0073 
Csf2rb2 1.80E-05 Twf2 0.0015 Sypl 0.0073 
Hemk1 1.90E-05 Defb34 0.0015 Elac1 0.0073 
Zfp950 2.30E-05 Ngdn 0.0015 Pla2g4f 0.0074 
Slc9a2 2.80E-05 Bpifb3 0.0015 Gpnmb 0.0074 
Defb46 2.80E-05 Ces1b 0.0015 2410003K15Rik 0.0074 
Defb8 2.80E-05 Tmem212 0.0016 5530400C23Rik 0.0075 
Ptch1 3.80E-05 Rrp9 0.0016 Zfp85-rs1 0.0075 
D030055H07Rik 4.00E-05 Parp3 0.0016 Parp9 0.0075 
Mcfd2 4.00E-05 Pcbp4 0.0016 0610039K10Rik 0.0077 
Tssc1 4.50E-05 Npffr2 0.0016 Serinc3 0.0077 
0610007P08Rik 4.50E-05 Kctd5 0.0017 Pkig 0.0077 
Rnaseh1 4.60E-05 Mfn1 0.0018 Ipcef1 0.0078 
Apc 4.60E-05 Pkmyt1 0.0018 Spice1 0.0078 
Olfr224 4.90E-05 Lama2 0.0018 Nthl1 0.0078 
Tpbpa 5.10E-05 Lat 0.0018 Ugt3a2 0.0078 
Dlc1 5.60E-05 Cd19 0.0018 Dcaf13 0.008 
Iqcf3 5.90E-05 Apoh 0.0019 Srcin1 0.008 
Slc24a1 7.40E-05 Herpud1 0.0019 Ttc27 0.0081 
Igdcc3 7.40E-05 Nit1 0.002 Darc 0.0081 
Gm514 7.40E-05 Esr1 0.002 Il1r1 0.0081 
Spg21 7.40E-05 Clec9a 0.002 Sh2b1 0.0082 
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Cgrrf1 8.20E-05 Rpe 0.0021 D6Ertd527e 0.0082 
Defb5 0.0001 Fcgr3 0.0021 Gjc2 0.0082 
Prr15 0.00011 Dedd 0.0021 Obsl1 0.0082 
Mcph1 0.00011 Klhdc9 0.0021 Myo9b 0.0083 
Msr1 0.00014 C86695 0.0021 Gm16814 0.0083 
Nlrx1 0.00015 Allc 0.0021 Pick1 0.0084 
Glt8d2 0.00017 Gm10495 0.0021 Baiap2l2 0.0084 
1700028P14Rik 0.00017 Trdv2-1 0.0021 G630016D24Rik 0.0084 
Dcpp2 0.00017 1600002H07Rik 0.0021 Zfp219 0.0084 
Dcpp1 0.00017 Tmem55b 0.0021 B3gat2 0.0087 
Gm15415 0.00017 Cd244 0.0021 Gmfb 0.0091 
Capn5 0.00017 Adamtsl3 0.0021 Gm10101 0.0091 
Adamts3 0.00018 Dmbt1 0.0021 Inadl 0.0092 
Nek11 0.00019 Olfr317 0.0021 Micall1 0.0093 
Tsc2 0.00019 4930441O14Rik 0.0021 1700088E04Rik 0.0093 
Gm600 0.00021 Pnp 0.0021 Atp13a4 0.0095 
Glyctk 0.00021 Zfp598 0.0021 Afm 0.0097 
Snx24 0.00021 Entpd1 0.0021 Speer3 0.0097 
Ccdc109b 0.00021 Etnk2 0.0021 Hsph1 0.0097 
Gars 0.00022 Syngr3 0.0021 Wdr95 0.0097 
Fcrl6 0.00022 Vmn2r79 0.0022 9930022D16Rik 0.0098 
Kctd14 0.00022 Cyp2d11 0.0022 Olfr876 0.0099 
U5 0.00023 Phf3 0.0022   
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6.2. APPENDIX 2: LIST OF LICKING GENES. 
Gene produced from HBCGM of the licking data sorted based on P-value, with the non-coding genes 
removed. Total of 683 genes. 
Gene P-value Gene P-value Gene P-value 
Slc9a10 1.90E-06 Vprbp 0.0006 Hmgn3 0.0032 
Gm609 9.50E-06 Dock3 0.0006 Sult6b1 0.0032 
BC016579 1.60E-05 Dnahc11 0.0006 Vmn2r15 0.0032 
Tmprss7 1.60E-05 Ttc34 0.00061 Vmn2r8 0.0032 
Acpp 1.60E-05 Uba5 0.00061 2610020C07Rik 0.0033 
Olfr414 1.70E-05 Gbe1 0.00061 Gspt1 0.0033 
2010111I01Rik 2.10E-05 Gm10807 0.00061 Gm7638 0.0033 
Rhobtb3 2.50E-05 4933403O03Rik 0.00061 Zc3h7a 0.0033 
Fancc 2.70E-05 Pms2 0.00063 Rsl1d1 0.0033 
Ptch1 2.70E-05 Rsph10b2 0.00063 Gm6305 0.0033 
Phldb2 3.00E-05 Klra7 0.00065 4930509G22Rik 0.0033 
Acad11 3.20E-05 Herc1 0.00065 Alx4 0.0033 
Cpne4 3.20E-05 Plekho2 0.00065 Gpi1 0.0033 
Galnt9 3.60E-05 Car12 0.00065 Pole 0.0034 
Hscb 3.60E-05 Abhd10 0.00066 Rad21 0.0034 
Sgcz 3.80E-05 Fcrls 0.00067 C630050I24Rik 0.0034 
Adamts3 4.30E-05 Parp14 0.00067 4930579F01Rik 0.0034 
Ikbip 4.40E-05 Btbd17 0.00068 Arhgef10 0.0035 
Fam45a 4.40E-05 Gpr142 0.00068 Kbtbd11 0.0035 
C330019G07Rik 4.90E-05 Gm16831 0.00069 Zfp275 0.0035 
Pisd 4.90E-05 Exoc7 0.00069 Gm8501 0.0035 
E330013P04Rik 7.30E-05 Fbxl22 0.0007 Tktl1 0.0035 
BB014433 7.60E-05 Got1 0.0007 Flna 0.0035 
Iqcf3 7.60E-05 Zfp950 0.00074 Gdi1 0.0035 
Sdk1 8.90E-05 Ndufc2 0.00076 Mudeng 0.0035 
Ulk1 8.90E-05 Gab2 0.00076 P2rx2 0.0036 
Fto 9.30E-05 Syde2 0.00076 Vmn2r89 0.0036 
Trpm3 9.40E-05 Cd244 0.00076 Apc 0.0037 
Gpr62 9.40E-05 Cebpz 0.00077 Lipt2 0.0037 
Pcbp4 9.40E-05 Me2 0.00078 Ppan 0.0037 
Rrp9 9.40E-05 Ccdc18 0.0008 Eif3g 0.0037 
Iqcf4 9.40E-05 Fcrl5 0.00082 Allc 0.0038 
Arhgap30 9.60E-05 4930529F22Rik 0.00084 Irgm2 0.0038 
Fmn2 9.70E-05 Gm7247 0.00086 2310007B03Rik 0.0038 
Spna1 0.0001 Thsd4 0.00087 Ankmy1 0.0039 
Fam198b 0.0001 Gm14396 0.00087 Atp6v0a2 0.0039 
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Ccdc46 0.0001 1700109F18Rik 0.00087 Ctla2a 0.004 
Poc1a 0.0001 Hoxd11 0.00087 Tpbpa 0.004 
Gm17175 0.00011 Hoxd8 0.00087 Zfp71-rs1 0.0041 
Gm5622 0.00011 Hoxd10 0.00087 Gm13125 0.0041 
Olfr319 0.00011 Hoxd12 0.00087 Pramef12 0.0041 
Erbb4 0.00011 Hoxd9 0.00087 Als2 0.0041 
Gm15446 0.00011 Gm20440 0.00087 BC080695 0.0041 
Dcpp2 0.00011 Mtx2 0.00087 Cyp2c69 0.0042 
Dcpp1 0.00011 Gm14427 0.00087 Tmem44 0.0043 
Nek11 0.00011 Nanos1 0.00087 Ncstn 0.0044 
Ggct 0.00011 Sfxn4 0.00087 Sfi1 0.0044 
Eri1 0.00011 Abca17 0.00088 C2cd3 0.0044 
6430573F11Rik 0.00011 Tmed5 0.00088 Gm6583 0.0044 
Slc7a2 0.00011 Ell2 0.00088 Hps4 0.0044 
Col6a6 0.00011 2210408I21Rik 0.00089 Pkhd1 0.0045 
Tpo 0.00011 2700078E11Rik 0.00093 Cyp2c39 0.0045 
Rsl1 0.00011 Nlrp4e 0.00096 Zfp692 0.0045 
Olfr1513 0.00011 Gm10287 0.00097 Ryr3 0.0046 
E4f1 0.00011 D19Ertd737e 0.00098 Gm6570 0.0046 
Exoc6 0.00011 Bdnf 0.00098 Cd300a 0.0046 
Tssc1 0.00012 Rbl2 0.00098 Gm11698 0.0046 
Adam24 0.00012 Apoh 0.00098 Fdxr 0.0048 
Col6a4 0.00012 Zfp932 0.001 Zfp30 0.0048 
Ces1b 0.00012 Zfp708 0.001 Ercc1 0.0048 
Aste1 0.00012 Tnfrsf1b 0.0011 Ceacam20 0.0048 
Col6a5 0.00012 Slc25a19 0.0011 Vmn1r169 0.0048 
4932415D10Rik 0.00012 Olfr462 0.0011 Dnahc10 0.0049 
Zfp938 0.00012 Gm7664 0.0011 Ces1c 0.0049 
Gm15608 0.00012 Olfr313 0.0011 A530095I07Rik 0.0049 
AU041133 0.00012 Strn 0.0011 Isoc2b 0.005 
Olfr218 0.00012 Ttc15 0.0011 Actl9 0.0051 
Zfp462 0.00012 Grm2 0.0011 2810021J22Rik 0.0051 
Lilra5 0.00012 Hemk1 0.0011 Speer3 0.0051 
Dlc1 0.00012 Bdh1 0.0011 C2cd4d 0.0051 
Msr1 0.00012 Colec11 0.0012 Stfa1 0.0054 
Zdhhc2 0.00012 Nkd1 0.0012 Gm5356 0.0054 
Pdgfrl 0.00012 Zfp710 0.0012 Gm597 0.0054 
4933436C20Rik 0.00012 Anxa3 0.0012 Gm9934 0.0054 
Ces1a 0.00012 Itprip 0.0012 AI429214 0.0054 
Olfr978 0.00012 Zfp935 0.0012 Trdv2-1 0.0054 
Fam55b 0.00012 Rnf212 0.0012 Gm17015 0.0054 
Fam55d 0.00012 Nlrp5 0.0012 Adam25 0.0054 
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Msi2 0.00012 Rtp3 0.0012 Cdh1 0.0054 
Recql5 0.00012 Mpo 0.0012 Olfr320 0.0054 
Zfp273 0.00012 Plce1 0.0012 Osgep 0.0054 
Gm10037 0.00012 Pld5 0.0012 Ang4 0.0054 
Ttc37 0.00012 Cep170 0.0012 Prdm14 0.0054 
3632451O06Rik 0.00012 Opa3 0.0013 Gm13291 0.0054 
AY358078 0.00012 Idua 0.0013 Gm13292 0.0054 
Tmprss2 0.00012 Mrps7 0.0013 Gm13293 0.0054 
Abca3 0.00012 Llgl2 0.0014 Gm13296 0.0054 
2410091C18Rik 0.00012 Cadm3 0.0014 Pfkfb3 0.0054 
Qpct 0.00012 Atrip 0.0014 Gm13295 0.0054 
I830134H01Rik 0.00012 Trex1 0.0014 Prkcq 0.0054 
Aff2 0.00012 Shisa5 0.0014 Slc1a2 0.0054 
Tarm1 0.00012 Pik3r4 0.0014 Frrs1 0.0054 
Obscn 0.00013 Smarcc1 0.0014 Pigo 0.0054 
Prss41 0.00013 Col7a1 0.0014 Slc46a2 0.0054 
Ccrl1 0.00013 Gdpd5 0.0014 Snx30 0.0054 
Lpl 0.00013 Tcra-V8 0.0015 Crhr2 0.0054 
Tlr9 0.00013 Zfp934 0.0015 Pira5 0.0054 
Acy1 0.00013 Arhgef16 0.0015 Gm15448 0.0054 
Abhd14a 0.00013 Shisa7 0.0015 D330012F22Rik 0.0054 
Abhd14b 0.00013 Cyp2c37 0.0016 Vmn2r74 0.0054 
Parp3 0.00013 Atp8b5 0.0016 Tmed6 0.0054 
Eif2ak1 0.00013 Cyp2c29 0.0016 Terf2 0.0054 
Aimp2 0.00013 Entpd3 0.0016 Mrpl22 0.0054 
Mtus1 0.00013 Irx3 0.0016 Gm12253 0.0054 
Pcm1 0.00013 Adam39 0.0016 Polg2 0.0054 
Lpcat2 0.00013 Acin1 0.0017 Ccdc45 0.0054 
Zfp609 0.00013 C230052I12Rik 0.0017 Ddx5 0.0054 
Nphp3 0.00013 Fgf2 0.0017 Ttc5 0.0054 
Twf2 0.00013 Nudt6 0.0017 Olfr221 0.0054 
Rpl29 0.00013 Gm15415 0.0017 Trav17 0.0054 
Slc38a3 0.00013 Aktip 0.0017 Trav18 0.0054 
Gnat1 0.00013 E430025E21Rik 0.0017 Gm13893 0.0054 
Sema3f 0.00013 Hyal2 0.0017 Abhd4 0.0054 
Prss50 0.00013 Hgsnat 0.0018 Oxa1l 0.0054 
1190007I07Rik 0.00013 Muc4 0.0018 Cdh24 0.0054 
Olfr743 0.00013 Gm13892 0.0018 Cyp2d11 0.0054 
Pnp 0.00013 Myo7a 0.0018 Spice1 0.0054 
Zfhx2 0.00013 Capn5 0.0018 Nthl1 0.0054 
Dcpp3 0.00013 Oprm1 0.0018 1110001A16Rik 0.0054 
Olfr1303 0.00014 Zfp712 0.0018 Magea4 0.0054 
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2210415F13Rik 0.00015 Ctsm 0.0018 Copa 0.0054 
Cnnm2 0.00015 Cd300lb 0.0018 Atp1a4 0.0054 
Atp2c1 0.00015 Cd300c 0.0018 Bcas1 0.0054 
Kcns3 0.00015 Cts3 0.0018 Adh7 0.0054 
Trdv1 0.00015 Pnp2 0.0019 Ggh 0.0054 
2810453I06Rik 0.00017 Csf2ra 0.0019 Gars 0.0054 
Daglb 0.00017 Larp1 0.0019 Inmt 0.0054 
Cyth3 0.00017 Hoxd3 0.0019 Fgl1 0.0054 
Mn1 0.00017 Gm16938 0.0019 Ints10 0.0054 
Prlhr 0.00018 B3gnt6 0.0019 Capns2 0.0054 
Evx2 0.00019 Alg8 0.0019 Rfx7 0.0054 
Pitpnb 0.0002 Usp35 0.0019 Myo5c 0.0054 
Mtf2 0.0002 Ints4 0.0019 Atp10b 0.0054 
Pigg 0.0002 1810020D17Rik 0.0019 Mrpl55 0.0054 
5430403G16Rik 0.0002 Gm15623 0.0019 Naglu 0.0054 
Ddx51 0.0002 Rsf1 0.0019 Bptf 0.0054 
1810030J14Rik 0.0002 Nars2 0.0019 Hfe 0.0054 
Naip5 0.00021 Clns1a 0.0019 Olfr466 0.0054 
Flywch1 0.00025 Gm9990 0.0019 Olfr728 0.0054 
Myom2 0.00026 Aqp11 0.0019 Olfr739 0.0054 
Ep400 0.00027 Gdpd4 0.0019 Mettl17 0.0054 
Gm17598 0.00027 Tsku 0.0019 Olfr49 0.0054 
Pus1 0.00027 P4ha3 0.0019 Zfp395 0.0054 
Noc4l 0.00027 Arap1 0.0019 Cldn10 0.0054 
Chek2 0.00027 Tmem225 0.0019 Bace2 0.0054 
Etv6 0.00027 Ptpn23 0.0019 Taf5 0.0054 
Oaz2 0.00029 Scap 0.0019 Calhm2 0.0054 
Sipa1l3 0.0003 Hmha1 0.0019 Pdcd11 0.0054 
Cd48 0.00031 ORF61 0.0019 Slk 0.0054 
Sorbs1 0.00031 Robo1 0.0019 Gabre 0.0054 
Wdr96 0.00032 Vit 0.0019 Aven 0.0054 
Prss42 0.00033 Heatr5b 0.0019 Gm8214 0.0055 
Gga3 0.00033 Uap1 0.0019 Nkx2-9 0.0057 
Fbp2 0.00035 Crp 0.0019 Srrd 0.0058 
Vmn2r10 0.00035 Kcne3 0.0019 Olfr68 0.006 
Dlgap2 0.00036 Olfr224 0.002 Dll3 0.0061 
Gpr4 0.00037 Srrm4 0.002 Gm11711 0.0062 
Tep1 0.00037 Ccdc72 0.002 Gm11709 0.0062 
Kcnj10 0.00037 Olfr980 0.002 Oxct2a 0.0063 
Cyp17a1 0.00038 Moxd1 0.0021 Bmp8a 0.0063 
Zfp605 0.00038 Ccdc15 0.0021 4933412E24Rik 0.0063 
Gtpbp6 0.00038 Hyal1 0.0021 4930569F06Rik 0.0064 
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Igsf8 0.00039 Gm16343 0.0021 Olfr419 0.0065 
Pkmyt1 0.0004 Manf 0.0021 Ip6k2 0.0067 
Pif1 0.00043 9230019H11Rik 0.0021 Art1 0.0068 
Vmn2r9 0.00043 Zfp369 0.0021 1600002H07Rik 0.0069 
Butr1 0.00044 Gm10775 0.0021 Tmem55b 0.0069 
Itpr2 0.00045 Fcrl6 0.0021 Hist1h1a 0.0069 
Slc35f4 0.00046 Egf 0.0021 Pabpc1l 0.0069 
Glt8d2 0.00046 4833420G17Rik 0.0021 Egr3 0.0069 
Rnaseh1 0.00046 Darc 0.0021 Pebp4 0.0069 
Gm17116 0.00047 Kif19a 0.0021 Bin3 0.0069 
Prss52 0.00047 Morc2b 0.0022 2610301G19Rik 0.0069 
Msra 0.00047 Pdhx 0.0022 Ina 0.0069 
Mamdc2 0.00047 Usp42 0.0022 Usmg5 0.0069 
1700028P14Rik 0.00047 Vmn2r14 0.0022 Gba2 0.0069 
Cyp2c38 0.00048 Zfp457 0.0022 Dzip1 0.0069 
Dclk3 0.00049 Crlf2 0.0022 Lsg1 0.007 
Sbno2 0.00051 Rbm15b 0.0023 Cdon 0.0072 
Gpx4 0.00051 D430042O09Rik 0.0023 Camsap2 0.0073 
Zfp598 0.00051 Ifrd2 0.0023 Gm17543 0.0073 
Zfp759 0.00051 Hyal3 0.0023 Mro 0.0074 
Klra9 0.00051 Sema3b 0.0023 Pde4a 0.0074 
Usp19 0.00054 BY080835 0.0023 Olfr520 0.0074 
Lamb2 0.00054 Sdccag8 0.0023 Ankrd17 0.0075 
D030055H07Rik 0.00054 A630091E08Rik 0.0023 Pdzk1 0.0075 
Glyctk 0.00054 Olfr521 0.0023 Nlrp12 0.0075 
Adam32 0.00054 Iqcf6 0.0023 Ccdc51 0.0076 
Adam9 0.00054 Tex264 0.0023 Lrrc32 0.0076 
Itgb4 0.00054 Rad54l2 0.0023 Art2b 0.0076 
Nlrp4f 0.00054 Zmynd10 0.0023 Lama2 0.0076 
Gm600 0.00054 Taar7d 0.0023 Eapp 0.0077 
Fcrl1 0.00054 Taar6 0.0023 Gm16382 0.0077 
Arhgef11 0.00054 Taar4 0.0023 Etnk2 0.0077 
Pear1 0.00054 Taar7a 0.0023 Taar7e 0.0079 
Negr1 0.00054 Taar8a 0.0023 Gm6884 0.0079 
Megf6 0.00054 Taar7f 0.0023 Taar9 0.0079 
Fam188b 0.00054 Olfr323 0.0023 Taar8c 0.0079 
Rpgrip1l 0.00054 Gp5 0.0023 Taar8b 0.0079 
Ets1 0.00054 Atp13a3 0.0023 4930524O07Rik 0.0079 
Siae 0.00054 Kctd14 0.0023 Nat6 0.0079 
Olfr945 0.00054 Lyplal1 0.0023 Klf17 0.0079 
Wdr82 0.00054 Poln 0.0023 Rgp1 0.0079 
Ppm1m 0.00054 Cyp26c1 0.0024 Slc17a3 0.0082 
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Mon1a 0.00054 Cyp26a1 0.0024 Fcgr3 0.0083 
Clasp2 0.00054 Cyp2c54 0.0024 Npffr2 0.0083 
Sptlc1 0.00054 Cyp2c50 0.0024 Olfr1537-ps1 0.0084 
Zfp874a 0.00054 C230038L03Rik 0.0024 Skint6 0.0084 
Nsun2 0.00054 Pigm 0.0024 Olfr918 0.0084 
Srd5a1 0.00054 Slamf8 0.0024 Olfr917 0.0084 
Ptk2b 0.00054 2210018M11Rik 0.0024 Olfr944 0.0084 
Srrm2 0.00054 Plekhb1 0.0024 Vwa5a 0.0084 
Tsc2 0.00054 Cyp2c68 0.0024 AW551984 0.0084 
Epas1 0.00054 Defb50 0.0024 Slamf9 0.0084 
Pcsk5 0.00054 Olfr248 0.0026 Tmod1 0.0085 
Col17a1 0.00054 Dlgap5 0.0026 Tstd2 0.0085 
Chd9 0.00055 Lig1 0.0026 Lgals3 0.0085 
Xpr1 0.00055 Igsf9 0.0026 M5C1000I18Rik 0.0086 
Mtrr 0.00055 9830107B12Rik 0.0026 C2cd4b 0.0086 
Adam18 0.00056 AF251705 0.0027 Haus7 0.0086 
Capn9 0.00057 Tdg 0.0027 Zfp92 0.0086 
Lmtk2 0.00057 Ssh1 0.0027 Hsd17b7 0.0087 
Dalrd3 0.00058 Eif2ak2 0.0027 Dhx34 0.0088 
Wdr6 0.00058 Gm16710 0.0027 Gm14085 0.0091 
P4htm 0.00058 4931408C20Rik 0.0027 1700031F05Rik 0.0093 
Tex9 0.00058 Ly9 0.0028 Steap3 0.0098 
Nsmce2 0.00059 Plcxd1 0.003 Ifna7 0.0099 
Odz4 0.00059 Gemin5 0.0031   
 
108 
 
6.3. APPENDIX 3: LIST OF OVERLAPPING GENES. 
Overlapping genes between flinching and licking gene lists sorted based on P-value. Total of 148 
genes found. 
Gene P-value (flinching) P-value (licking) 
1600002H07Rik 0.0021 0.0069 
1700028P14Rik 0.00017 0.00047 
2010111I01Rik 9.50E-07 2.10E-05 
2810453I06Rik 0.0037 0.00017 
4930529F22Rik 3.30E-06 0.00084 
Abca17 0.00026 0.00088 
Abca3 7.20E-06 0.00012 
Abhd14a 0.00047 0.00013 
Acy1 0.00035 0.00013 
Adamts3 0.00018 4.30E-05 
Alg8 2.90E-06 0.0019 
Allc 0.0021 0.0038 
Anxa3 0.0011 0.0012 
Apc 4.60E-05 0.0037 
Apoh 0.0019 0.00098 
Arhgef10 0.0051 0.0035 
Aven 0.00099 0.0054 
C230038L03Rik 0.00092 0.0024 
Capn5 0.00017 0.0018 
Cd244 0.0021 0.00076 
Cdh1 0.00037 0.0054 
Ces1b 0.0015 0.00012 
Ces1c 0.00081 0.0049 
Col6a4 0.0012 0.00012 
Col6a5 0.00037 0.00012 
Col6a6 0.00026 0.00011 
Ctla2a 9.60E-06 0.004 
Cts3 1.00E-05 0.0018 
Ctsm 0.00056 0.0018 
Cyp2c38 1.20E-05 0.00048 
Cyp2d11 0.0022 0.0054 
D030055H07Rik 4.00E-05 0.00054 
D19Ertd737e 1.50E-05 0.00098 
D430042O09Rik 0.00037 0.0023 
Daglb 0.0023 0.00017 
Darc 0.0081 0.0021 
Dcpp1 0.00017 0.00011 
Dcpp2 0.00017 0.00011 
Defb50 0.0011 0.0024 
Dlc1 5.60E-05 0.00012 
E330013P04Rik 4.30E-07 7.30E-05 
E4f1 0.00026 0.00011 
Eapp 0.00036 0.0077 
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Eif3g 0.0011 0.0037 
Eri1 0.00025 0.00011 
Etnk2 0.0021 0.0077 
Etv6 0.00056 0.00027 
Exoc7 0.0044 0.00069 
Fam45a 9.30E-06 4.40E-05 
Fancc 1.20E-05 2.70E-05 
Fbp2 1.70E-06 0.00035 
Fcgr3 0.0021 0.0083 
Fcrl5 0.004 0.00082 
Fcrl6 0.00022 0.0021 
Fcrls 7.20E-06 0.00067 
Flywch1 0.0012 0.00025 
Gars 0.00022 0.0054 
Gdpd4 0.0028 0.0019 
Gemin5 7.20E-06 0.0031 
Glt8d2 0.00017 0.00046 
Glyctk 0.00021 0.00054 
Gm10287 0.00091 0.00097 
Gm13125 2.20E-06 0.0041 
Gm15415 0.00017 0.0017 
Gm16382 0.00036 0.0077 
Gm16831 0.0044 0.00069 
Gm17175 0.0012 0.00011 
Gm5622 0.0012 0.00011 
Gm600 0.00021 0.00054 
Gm7664 9.30E-06 0.0011 
Gm8214 0.00078 0.0055 
Got1 0.0051 0.0007 
Gpr62 0.00035 9.40E-05 
Hemk1 1.90E-05 0.0011 
Hsd17b7 2.20E-06 0.0087 
Igsf9 0.00092 0.0026 
Ikbip 0.00031 4.40E-05 
Iqcf3 5.90E-05 7.60E-05 
Kbtbd11 0.0051 0.0035 
Kctd14 0.00022 0.0023 
Klra7 0.00076 0.00065 
Klra9 2.00E-06 0.00051 
Lama2 0.0018 0.0076 
Lpl 0.0045 0.00013 
Msr1 0.00014 0.00012 
Myo7a 6.90E-07 0.0018 
Nanos1 9.30E-06 0.00087 
Nars2 0.00025 0.0019 
Ncstn 0.00097 0.0044 
Nek11 0.00019 0.00011 
Npffr2 0.0016 0.0083 
Nthl1 0.0078 0.0054 
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Obscn 1.40E-05 0.00013 
Olfr224 4.90E-05 0.002 
Olfr323 0.00039 0.0023 
Olfr414 0.00026 1.70E-05 
Olfr49 0.00037 0.0054 
Olfr739 0.0025 0.0054 
Oprm1 0.0009 0.0018 
Osgep 0.0028 0.0054 
Parp3 0.0016 0.00013 
Pcbp4 0.0016 9.40E-05 
Pde4a 0.0045 0.0074 
Pear1 0.00096 0.00054 
Pkhd1 0.0012 0.0045 
Pkmyt1 0.0018 0.0004 
Pnp 0.0021 0.00013 
Ppan 0.0011 0.0037 
Pramef12 2.20E-06 0.0041 
Prss41 0.001 0.00013 
Ptch1 3.80E-05 2.70E-05 
Rad54l2 0.00082 0.0023 
Rhobtb3 0.00026 2.50E-05 
Rnaseh1 4.60E-05 0.00046 
Rrp9 0.0016 9.40E-05 
Ryr3 0.00099 0.0046 
Sfi1 0.0012 0.0044 
Sfxn4 9.30E-06 0.00087 
Sgcz 1.10E-06 3.80E-05 
Slamf9 0.0049 0.0084 
Slc1a2 1.60E-06 0.0054 
Slc7a2 0.00026 0.00011 
Speer3 0.0097 0.0051 
Spice1 0.0078 0.0054 
Spna1 0.00094 0.0001 
Tcra-V8 0.0032 0.0015 
Tdg 0.0012 0.0027 
Tep1 0.005 0.00037 
Tlr9 0.0011 0.00013 
Tmem55b 0.0021 0.0069 
Tnfrsf1b 0.0043 0.0011 
Tpbpa 5.10E-05 0.004 
Tpo 7.20E-06 0.00011 
Trdv2-1 0.0021 0.0054 
Tsc2 0.00019 0.00054 
Tssc1 4.50E-05 0.00012 
Ttc37 0.0022 0.00012 
Twf2 0.0015 0.00013 
Uap1 2.20E-06 0.0019 
Vmn2r89 0.0023 0.0036 
Zfhx2 0.0067 0.00013 
111 
 
Zfp457 0.0072 0.0022 
Zfp598 0.0021 0.00051 
Zfp712 0.0038 0.0018 
Zfp71-rs1 0.00051 0.0041 
Zfp934 1.70E-06 0.0015 
Zfp935 9.30E-06 0.0012 
Zfp950 2.30E-05 0.00074 
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6.4. APPENDIX 4: POTENTIAL GENE CANDIDATES FOR CIGUATOXIN-INDUCED 
PAIN 
Five potential genes were identified for flinching and licking results from HBCGM: Nedd4l, Nmur2, 
Bdnf, Il1r1 and Nf1. A brief literature review was conducted to explore the role for each potential 
gene in nociception. 
1. Nedd4l 
The Nedd4l gene is part of the family of E3 ubiquitin ligases, otherwise known as Nedd4-2 (neuronal 
precursor cell expressed developmentally downregulated-4 type 2). This gene is responsible for controlling 
the presence of voltage-gated ion channels along the membranes of neurons. (76, 79) Ubiquitination is a 
biological process involved in the tagging of membrane proteins for internalisation and recycling. The 
process involves many steps, the last step involving ubiquitin E3 ligase which must recognise specific motifs 
carried by membrane proteins. (75) NEDD4L is a regulator of various proteins, however the target most 
relevant in nociception studies is voltage gated sodium channels (NaVs). (79) There have been a few studies 
examining the role of Nedd4l and E3 ubiquitin ligase of pain. It has been established that Nedd4l is 
expression in high concentrations in the dorsal root ganglion (DRG) in both mice and rats. (78, 79) This 
finding is important as the DRG is home to almost all type of NaVs, in particular NaV1.7, which has elevated 
levels of expression and is known to have a key role in pain perception in humans. (76, 78) In mice studies 
where NaV1.7, NaV1.8 and NaV1.9 have been selectively knocked out in the DRG, a diminished response 
to inflammatory pain and an overall decrease in pain sensitivity was noted. (78)  Nedd4l overexpression has 
been demonstrated to downregulate concentrations of NaVs, including NaV1.7 and NaV1.8, in neurons. (75, 
76) Mice bred as homozygous Nedd4l knockouts (Nedd4l –/–) were found to have complete inactivation of 
the gene and hence no detectable NEDD4L protein level, however, these mice would die in their peri-natal 
life. Conversely, heterozygous Nedd4l +/– mice were shown to have around half the level of protein, which 
was attributed to compensatory mechanisms from the single functioning allele. Heterozygous mice were 
then found to have increased sensitivities in spontaneous pain tests with formalin-induced inflammation. 
(79) 
2. Nmur2 
Neuromedin U (NMU) is a neuropeptide expressed in various body sites including the gastrointestinal tract, 
genitourinary tract, anterior pituitary, brain and spinal cord. This ligand is a 25-amino-acid peptide in humans 
(NMU-25) and a 23-amino-acid peptide (NMU-23) in rodents.  (99) It was first isolated from porcine spinal 
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cords and was found to have potent activity on uterine contractions. (100) Local subcutaneous 
administration of NMU causes an acute inflammatory reaction (101); however, central administration via 
intracerebroventricular or intrathecal routes caused a rise in pain sensitivities in rodents. (99) This increased 
pain response was demonstrated as thermal hyperalgesia, mechanical allodynia and protracted pain after 
injection with formalin. (99) Concordantly, mice deficient in NMU have decreased pain responses in hot 
plate and formalin tests. (100, 102) The effects of NMU in terms of nociception are thought to be conducted 
via two distinct G-protein coupled receptors, NMUR1 and NMUR2. (100, 102) NMUR1 populates peripheral 
tissues such as the lung, pancreas, intestine, kidney and leukocytes with minor contribution to the DRG. 
Conversely, NMUR2 appears to be present in higher concentrations in the central nervous system, 
particularly the spinal cord and DRG. (101, 102) NMUR2 is largely seen in lamina I and other layer of lamina 
II in the DRG, which are important ascending pathways for nociception. (99, 103) In Nmur1 –/– mice, no 
change in pain response in hot plate, capsaicin or formalin tests was observed, while Nmur2 –/– mice 
showed an general decrease in pain responses in hot plate, capsaicin or formalin tests (102) 
Intracerebroventricular injection of NMU-23 causes increased nociception in wild-type mice, however in 
Nmur2 –/– mice, this response is not seen and an overall decrease in pain sensitivity is observed instead. 
(99) One article investigated the potential implications of NMUR2 blockade after nerve injury or inflammation 
via Freund's Complete Adjuvant (FCA). This study concluded that Nmur2 is not important in the progression 
of hypersensitivity after nerve injury or tissue inflammation, meaning that isolating Nmur2 as a target for 
chronic pain is unlikely to be a fruitful approach. (101) Interestingly, amongst these studies cold allodynia 
was not investigated, which would mean there could be potential changes in cold sensitivity with Nmur2 
deletions. (101) 
3. Bdnf 
Brain-derived neurotrophic factor (BDNF) is a protein associated with neuronal development and pain 
perception and sensitisation (104) It is synthesised in the small to medium sized neurons in the DRG and 
transported to the central terminal of primary afferents before being secreted into the spinal dorsal horn 
(104, 105) BDNF binds to two receptors, high affinity tropomyosin receptor kinase B (trkB) or low affinity 
p75 neurotrophin receptors. (104) BDNF synthesis is induced by peripheral tissue inflammation as well as 
central or peripheral nerve damage. (105, 106) The binding of BDNF on trkB receptors located on second-
order sensory neurons leads to the downstream effect of reduction of GABAAR inhibitory action. (105, 106) 
Subsequent blockade of BDNF and trkB removes the actions on GABAAR, resulting in a decrease in 
nociceptive threshold after nerve injury. (106) In GABAAR deficient mice, BDNF or nerve lesions cannot 
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induce further sensitisation of thermal hypersensitivity which is possible in their wild-type counterparts. (106) 
Exogenously introduced BDNF via intrathecal and intracerebroventricular route has been showed to 
produce mixed findings or pronociceptive and antinociceptive effects. (107) In diabetic rats, DRG neurons 
have been shown to demonstrate increased excitability, with resultant reductions in mechanical and thermal 
nociceptive thresholds. This hyperalgesia was not affected by single administration of BDNF, however 
continued intrathecal administration produced decreased DRG hyperexcitability and thus reduced 
mechanical and thermal hyperalgesia. (104) Another study demonstrated conflicting results, with protracted 
hyperalgesia and allodynia in naïve healthy rats after introduction of BDNF in the spine. (107)  
4. Il1r1 
Interleukin 1 (IL-1) is a pro-inflammatory cytokine associated with inflammatory pain in certain cancers, such 
as breast cancer. A study investigating the occurrence rate of pre-operative breast pain found that patients 
with a specific SNP in Ilr1r (interleukin 1-receptor 1) had decreased breast pain prior to surgery. (108) 
5. Nf1 
Neurofibromatosis 1 (NF1) is a significant disease in humans, causing chronic pain in a quarter of those 
afflicted with the autosomal dominant condition. (109) The germline mutation in the NF1 tumour suppressor 
genes results in a reduction in neurofibromin, a guanosine triphosphatase activating protein (GAP) for 
p21ras distributed within the nervous system. (110, 111) This transduction pathway is vital for cell survival, 
growth and proliferation, which translate to abnormal neuron, Schwann cell, mast cell and fibroblast function. 
(110) Increased pain perception is also worsened by the incidence of neurofibromas on spinal roots and 
tumours peripheral nerve sheaths. (109) An in vitro study demonstrated increased sensitivity of capsaicin 
responsive neurons in heterozygous Nf1 deletion mice, which may be the explanation for the pain and 
pruritus associated with neurofibromatosis. This finding was not supported by another study which 
concluded that these mice did not have hypersensitivity to acute inflammatory or neuropathic pain, 
suggesting that more than just heterozygosity is required to explain the pain and pruritus associated with 
neurofibromatosis. (111) It was also noted that capsaicin sensitive neurons secreted increased amounts of 
calcitonin gene releasing peptide (CGRP) when provoked (111), and CGRP has been established to have 
roles in nociception and inflammation in the periphery and spinal cord (109). CGRP-sensitive fibres have 
also been found in high proportions in neurofibromas in human patients. (109) Homozygous Nf1 mice (Nf1 
–/– mice) die in utero while heterozygous mice (Nf1 +/–), which have the mutation analogous to the human 
disorder, live to their normal lifespan. (110) In a rodent model, it was shown that haploinsufficiency of 
neurofibromin such as in Nf1 resulted in heightened CGRP release from the spinal cord and DRG. It was 
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also shown in these mice that peripheral afferent neurons had increased excitability and the DRG contained 
greater transcripts for NaV1.7 and NaV1.8. (109) Despite these findings, no difference was seen between 
Nf1 +/– and wild type mice in both acute heat and mechanical stimuli tests, and it was concluded that 
reduction in Nf1 +/– mice are not the most appropriate animal model to explain increased nociception in 
NF1 patients. (109) 
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6.5. APPENDIX 5: GENE ONTOLOGY FOR MUS MUSCULUS GENOME 
Gene ontology was used to analyse the entire mus musculus genome which contains 52014 genes. 
(112) PANTHER pie charts were created using the genes which had information contained in the 
PANTHER database already existing. Graphs for each of the three gene ontology headings were 
created for comparison to graphs created for flinching and licking gene lists. A tissue expression pie 
chart was also created to present the mus musculus genome, which was developed using 601 randomly 
selected with known data regarding their biological locations on the BioGPS gene expression plugin. 
The purpose for this graph was also for comparison with previously generated flinching and licking 
tissue expression graphs.  
Genome Molecular Function 
PANTHER Pie Chart 
Genome Biological Process 
PANTHER Pie Chart 
Genome Cellular Component
PANTHER Pie Chart 
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Genome Tissue Expression Pie Chart 
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6.6. APPENDIX 6: AMINO ACID STRUCTURES AND PROPERTIES  
Structures and physical properties of the four amino acids involved in the codon changes due to 
Nedd4-2 SNPs (via NCBI Amino Acid Explorer) (113).  
Arginine (R) 
Side chain flexibility: High 
Interaction modes: Ionic, H-bonds, van der Waals 
Potential side chain H-bonds: 7 
Residue molecular weight: 156 
Isoelectric point: 10.8 
Hydrophobicity:  0.000 
Properties: 
 Positive 
 Methylene 
 Aliphatic 
 Essential 
Glutamine (Q) 
Side chain flexibility: High 
Interaction modes: H-bonds, van der Waals 
Potential side chain H-bonds: 5 
Residue molecular weight: 128 
Isoelectric point: 5.7 
Hydrophobicity:  0.430 
Properties: 
 Polar 
 Amide 
 Aliphatic 
 Nonessential 
Serine (S) 
Side chain flexibility: Low 
Interaction modes: H-bonds, van der Waals 
Potential side chain H-bonds: 3 
Residue molecular weight: 87 
Isoelectric point: 5.7 
Hydrophobicity:  0.601 
Properties: 
 Polar 
 Hydroxyl 
 Aliphatic 
 Nonessential 
Proline (P) 
Side chain flexibility: Restricted 
Interaction modes: van der Waals 
Potential side chain H-bonds: 0 
Residue molecular weight: 97 
Isoelectric point: 6.3 
Hydrophobicity:  0.678 
Properties: 
 Nonpolar 
 Methylene 
 Imino 
 Nonessential 
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6.7. APPENDIX 7: NEDD4-2 AMINO ACID SEQUENCE  
The NEDD4-2 protein sequence was found on the UniProt database for mus musculus (Q8CFI0) 
(112). The sequence contains 1004 amino acids, the two SNPs of interest (highlighted in red) are in 
positions r251 and r403. 
        10         20         30         40         50
MSLCEAPVHV GDKELKYFQI PQMLSQLSLL ASHHSRGLEF SGGQGESRIL 
        60         70         80         90        100
RVKVVSGIDL AKKDIFGASD PYVKLSLYVA DENRELALVQ TKTIKKTLNP 
       110        120        130        140        150
KWNEEFYFRV NPSNHRLLFE VFDENRLTRD DFLGQVDVPL SHLPTEDPTM 
       160        170        180        190        200
ERPYTFKDFL LRPRSHKSRV KGFLRLKMAY MPKNGGQDEE NSEQRDDMEH 
       210        220        230        240        250
GWEVVDSNDS ASQHQEELPP PPLPPGWEEK VDNLGRTYYV NHNNRSTQWH 
       260        270        280        290        300
RPSLMDVSSE SDNNIRQINQ EAAHRRFRSR RHISEDLEPE ASEGGGEGPE 
       310        320        330        340        350
PWETISEEMN MAGDSLSLAL PPPPASPVSR TSPQELSEEV SRRLQITPDS 
       360        370        380        390        400
NGEQFSSLIQ REPSSRLRSC SVTDTVAEQA HLPPPSTPTR RARSSTVTGG 
       410        420        430        440        450
EEPTPSVAYV HTTPGLPSGW EERKDAKGRT YYVNHNNRTT TWTRPIMQLA 
       460        470        480        490        500
EDGASGSATN SNNHLVEPQI RRPRSLSSPT VTLSAPLEGA KDSPIRRAVK 
       510        520        530        540        550
DTLSNPQSPQ PSPYNSPKPQ HKVTQSFLPP GWEMRIAPNG RPFFIDHNTK 
       560        570        580        590        600
TTTWEDPRLK FPVHMRSKAS LNPNDLGPLP PGWEERIHLD GRTFYIDHNS 
       610        620        630        640        650
KITQWEDPRL QNPAITGPAV PYSREFKQKY DYFRKKLKKP ADIPNRFEMK 
       660        670        680        690        700
LHRNNIFEES YRRIMSVKRP DVLKARLWIE FESEKGLDYG GVAREWFFLL 
       710        720        730        740        750
SKEMFNPYYG LFEYSATDNY TLQINPNSGL CNEDHLSYFT FIGRVAGLAV 
       760        770        780        790        800
FHGKLLDGFF IRPFYKMMLG KQITLNDMES VDSEYYNSLK WILENDPTEL 
       810        820        830        840        850
DLMFCIDEEN FGQTYQVDLK PNGSEIMVTN ENKREYIDLV IQWRFVNRVQ 
       860        870        880        890        900
KQMNAFLEGF TELLPIDLIK IFDENELELL MCGLGDVDVN DWRQHSIYKN 
       910        920        930        940        950
GYCPNHPVIQ WFWKAVLLMD AEKRIRLLQF VTGTSRVPMN GFAELYGSNG 
       960        970        980        990       1000
PQLFTIEQWG SPEKLPRAHT CFNRLDLPPY ETFEDLREKL LMAVENAQGF 
 
EGVD  
 
